Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABCC9	"CMD1O, SUR2"	ENSG00000069431	"ATP binding cassette subfamily C member 9"	O60706	12	21797389-21942529	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Atrial fibrillation, Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 45.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 60.3;Astrocytes: 72.1;Hepatocytes: 99.4;Sertoli cells: 131.5;Smooth muscle cells: 140.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.9;BJ hTERT+: 14.0;CACO-2: 20.8;HSkMC: 27.1;U-138 MG: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007279	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA007279: AB_1844435"	"unprognostic (4.82e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.51e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.30e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.47e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (1.85e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.10e-3)"	"unprognostic (8.22e-5)"	27.4	5.9	4.5	3.4	5.4	1.7	9.2	3.1	9.2	8.2	11.6	7.4	4.0	19.1	8.3	6.2	12.3	11.7	28.3	5.4	3.6	6.6	45.2	7.7	3.5	4.8	7.4	10.9	3.5	1.9	2.2	3.6	3.7	7.9	1.8	3.2	4.5	9.9	41.9	4.2	3.1	21.0	3.4	4.4	8.1	1.2	5.1	1.8	6.3	30.3	1.5	5.3	5.1	7.2	0.9	0.2	11.9	0.3	24.9	11.0	0.3	6.1	14.0	7.0	3.5	20.8	1.0	0.5	1.2	0.6	0.8	0.3	0.0	0.0	7.2	0.3	0.2	0.5	0.8	0.3	0.1	0.5	0.6	27.1	0.0	6.7	2.5	0.4	0.0	0.4	0.3	1.2	0.3	1.4	0.2	0.4	1.4	1.2	0.6	0.5	0.3	0.3	0.0	1.2	0.4	1.7	0.4	0.5	0.2	1.7	1.2	0.3	0.3	27.0	1.9	2.2	8.7	1.1	1.3	0.4	6.7	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	4.5	5.4	3.1	9.2	5.4	3.6	4.8	7.4	3.7	3.4	5.1	7.2	33.8	35.3	60.3	72.1	0.2	3.4	1.5	5.0	0.6	0.8	0.5	0.8	38.2	0.0	25.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.6	0.8	20.6	19.7	0.0	0.0	17.2	0.2	0.1	26.2	1.1	0.6	24.0	0.0	7.1	99.4	0.1	1.7	1.0	0.0	0.0	2.4	5.9	0.1	0.3	2.5	10.6	2.8	0.0	15.9	0.0	1.5	1.4	0.1	0.0	0.4	0.0	0.5	0.0	0.1	20.4	1.2	131.5	11.1	140.7	0.4	1.6	1.1	2.3	0.3	2.5	0.2	0.0	2.2
ACTC1	"ACTC, CMD1R"	ENSG00000159251	"Actin alpha cardiac muscle 1"	P68032	15	34790230-34795549	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Atrial septal defect, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"heart muscle: 11410.0"	"Cell type enriched"	"Detected in some"	30	"Cardiomyocytes: 9746.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 20.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1131.8;LHCN-M2: 4544.5;RH-30: 2053.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB037330, HPA041264, HPA041271"	Enhanced					NA	NA		2400000000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB037330: , HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (8.18e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (3.72e-5)"	"unprognostic (3.26e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.26e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-3)"	"unprognostic (5.68e-4)"	"unprognostic (8.79e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (9.32e-4)"	51.1	1.8	1.9	24.7	1.7	0.0	11.9	2.1	2.6	8.6	1.3	4.0	0.8	6.9	1.1	22.8	1.6	11.8	11410.0	1.9	2.8	1.5	0.6	3.9	2.6	2.7	2.8	3.2	12.9	1.0	2.2	8.9	3.0	73.0	3.6	31.6	11.5	538.1	135.2	4.6	0.6	8.8	1.4	1.3	9.3	0.5	4.0	11.3	2.4	195.0	0.2	439.6	16.1	1.5	0.0	0.2	0.1	0.0	0.2	3.3	0.2	2.2	0.7	5.2	1.3	0.0	0.0	0.0	1.3	1131.8	0.2	0.0	0.4	0.0	1.3	0.0	0.0	0.1	23.9	0.0	0.1	1.4	0.0	457.2	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	4544.5	0.0	0.0	0.0	3.8	0.0	0.0	0.0	2053.3	0.0	0.0	0.0	0.1	0.1	4.0	0.0	0.0	31.2	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.7	2.1	2.6	1.9	2.8	2.7	2.8	3.0	1.4	4.0	1.5	0.0	0.0	0.0	0.3	0.0	0.5	0.3	0.0	0.0	11.9	0.1	0.0	9746.1	0.0	0.0	0.0	20.9	0.1	0.0	0.0	1.9	0.0	5.0	0.0	0.1	69.2	0.0	0.0	0.2	0.2	4.3	315.2	0.0	0.0	0.0	0.1	0.4	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.2	0.0	63.4	86.5	1.0	0.7	0.0	0.4	0.3	0.1	0.1	0.0	0.0
ACTN2		ENSG00000077522	"Actinin alpha 2"	P35609	1	236664141-236764631	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	53	"heart muscle: 772.7;skeletal muscle: 2134.7;tongue: 1262.2"	"Cell type enriched"	"Detected in some"	11	"Cardiomyocytes: 1762.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 2.0;HEK 293: 1.3;HSkMC: 5.9;hTEC/SVTERT24-B: 2.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 66.6"	"Region enhanced"	"Detected in all"		"basal ganglia: 44.5"	"HPA006035, HPA008315"	Enhanced		Uncertain	"Actin filaments"		NA	NA		25000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Actin filaments"		"HPA006035: AB_1078095, HPA008315: AB_1844543"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.91e-1)"	"unprognostic (4.32e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-11)"	"unprognostic (1.30e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	0.7	0.2	12.0	0.0	26.3	0.1	0.9	8.0	20.1	0.3	11.0	0.4	0.0	0.5	0.0	21.8	0.5	0.7	772.7	13.2	12.1	0.5	0.3	3.9	0.2	9.7	8.1	1.1	1.6	0.1	0.5	0.1	10.7	16.1	0.0	1.3	18.4	0.1	2134.7	1.3	0.5	1.8	8.0	0.2	3.8	4.2	8.7	0.5	0.7	1262.2	0.1	3.5	0.4	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	1.0	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	1.3	0.0	0.0	0.2	0.0	0.0	0.2	5.9	0.0	2.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	26.3	8.0	20.1	13.2	12.1	9.7	8.1	10.7	8.0	8.7	14.2	0.3	0.0	0.6	18.6	0.0	0.3	0.4	0.0	1.2	2.6	0.4	0.5	1762.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	8.6	0.5	1.2	10.4	0.0	0.0	40.9	0.7	0.0	43.7	3.6	1.4	0.0	0.1	1.8	0.2	0.1	0.0	11.3	0.0	0.0	0.0	0.3	24.6	0.6	1.2	0.0	11.2	0.0	0.0	0.0	24.6	156.9	0.2	0.0	0.4	0.0	0.2	0.0	1.4	0.0	1.2	0.0	66.3	12.4	3.1	2.0	1.2	0.1	0.0	0.4	0.4	0.0	0.2
AKAP9	"AKAP350, AKAP450, CG-NAP, HYPERION, KIAA0803, LQT11, MU-RMS-40.16A, PPP1R45, PRKA9, YOTIAO"	ENSG00000127914	"A-kinase anchoring protein 9"	Q99996	7	91940840-92110673	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 2230.9;Rod photoreceptor cells: 1279.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008548, CAB012909, HPA026109"	Supported		Enhanced	"Golgi apparatus,Vesicles,Centrosome"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	"Vesicles, Centrosome"	"CAB012909: AB_2533235, HPA008548: AB_1078121, HPA026109: AB_1844688"	"unprognostic (9.57e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.32e-2)"	"prognostic favorable (2.10e-6)"	"unprognostic (8.89e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.96e-2)"	7.1	8.3	8.6	6.2	9.0	8.6	11.0	15.3	14.1	6.5	15.5	16.0	16.5	6.4	3.9	7.9	8.4	10.4	6.5	8.6	11.0	13.2	16.2	7.8	5.8	8.8	9.6	11.9	9.5	12.7	8.6	5.4	9.0	7.5	14.6	31.4	9.6	3.8	16.2	6.8	18.6	4.0	7.7	5.0	9.4	4.1	11.9	9.3	9.3	10.0	5.3	5.5	7.2	9.7	11.7	8.1	9.6	5.8	11.6	11.3	6.2	8.7	6.3	4.9	5.9	10.3	8.0	9.2	12.5	7.3	7.5	8.3	10.5	5.6	9.2	9.8	8.2	10.9	11.6	7.3	4.0	18.5	9.6	6.2	6.2	9.1	8.8	7.7	10.3	10.6	19.3	13.0	7.4	14.1	10.4	7.0	8.3	6.5	8.4	7.6	18.2	6.2	4.9	11.5	13.3	11.0	19.0	16.9	10.1	11.1	5.1	9.8	17.5	9.5	11.2	14.5	12.6	7.3	13.0	13.6	6.2	7.8	9.4	1.1	0.6	0.9	1.3	0.6	0.9	1.9	1.1	1.1	0.4	1.6	1.2	1.0	0.7	1.2	0.6	3.2	1.0	0.2	8.6	9.0	15.3	14.1	8.6	11.0	8.8	9.6	9.0	7.7	11.9	9.7	123.3	525.6	357.0	141.3	143.3	103.5	126.5	112.6	170.8	273.5	165.4	150.9	253.2	297.4	208.4	176.6	2230.9	141.4	201.5	293.4	101.8	131.0	22.5	392.3	157.7	115.9	185.1	129.4	142.6	92.6	81.9	123.5	152.9	185.0	136.6	386.1	98.2	153.5	57.2	360.1	182.6	350.8	136.3	78.3	88.4	17.5	173.4	101.6	58.7	115.2	121.5	155.7	119.4	169.9	187.1	102.4	218.9	135.8	193.5	91.4	298.5	47.2	506.3	1279.6	138.1	206.1	116.1	83.0	129.0	87.3	111.8	333.8	145.7	135.8	171.4	97.6
ANK2	"CFAP87, FAP87, LQT4"	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818032-113384221	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 165.7;retina: 191.2;skeletal muscle: 171.7;tongue: 150.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 1101.2;Bipolar cells: 376.6;Cone photoreceptor cells: 479.6;Excitatory neurons: 1282.0;Horizontal cells: 1431.8;Inhibitory neurons: 1060.7;Oligodendrocyte precursor cells: 497.1;Oligodendrocytes: 1351.0;Rod photoreceptor cells: 484.4"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.2;ASC TERT1: 32.2;RH-30: 49.6;SH-SY5Y: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: AB_2674893"	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	31.0	13.6	94.9	11.2	109.0	0.1	18.3	63.1	165.7	31.6	0.0	30.1	8.5	15.8	5.9	12.9	9.6	22.5	119.5	103.9	77.5	110.1	2.4	7.2	9.2	130.2	61.1	27.3	3.2	1.2	19.3	2.1	119.5	7.8	11.4	191.2	6.7	13.3	171.7	8.7	12.7	24.9	51.9	28.3	8.3	9.4	84.8	4.4	9.6	150.5	7.2	9.5	12.3	116.2	0.1	2.9	18.7	5.2	29.2	32.2	0.1	1.5	3.4	0.9	2.6	4.2	0.0	6.9	2.1	5.9	4.1	0.1	11.0	0.6	1.0	2.3	7.3	4.0	0.0	2.9	1.7	1.9	1.2	15.2	3.0	1.2	6.0	3.9	0.0	0.4	0.0	9.3	5.8	0.3	0.2	0.1	9.4	0.1	2.0	0.7	49.6	0.0	0.2	0.0	13.6	24.1	0.2	0.7	8.1	11.7	0.1	1.1	0.0	4.7	2.2	0.4	3.0	6.8	1.8	0.9	20.1	0.6	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	109.0	63.1	165.7	103.9	77.5	130.2	61.1	119.5	51.9	84.8	116.2	6.9	0.0	3.9	1101.2	1.1	10.5	0.0	0.0	1.8	376.6	0.2	0.6	188.5	0.0	1.3	20.2	479.6	0.1	0.0	0.0	15.6	0.0	111.2	36.4	6.0	6.4	66.0	0.0	1282.0	1.6	0.1	79.0	2.0	7.2	1.3	81.8	0.0	0.4	1.0	1431.8	1060.7	0.4	8.2	0.0	19.7	49.8	36.4	2.9	17.8	90.9	0.6	44.5	0.0	497.1	1351.0	0.1	5.0	30.1	0.9	0.4	0.1	127.9	0.8	484.4	6.6	24.3	26.5	2.3	1.5	0.8	9.5	0.0	1.9	2.6	0.3	0.2
BAG3		ENSG00000151929	"BAG cochaperone 3"	O95817	10	119651380-119677819	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	Chaperone	"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 349.1;skeletal muscle: 514.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 882.2;Basal squamous epithelial cells: 414.9;Squamous epithelial cells: 370.2;Urothelial cells: 488.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 4.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 4.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018493, HPA020586"	Enhanced		Supported	Cytosol		NA	NA		460000	"Cluster 32: T-cells - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA018493: AB_1845257, HPA020586: AB_1845258"	"unprognostic (1.18e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.31e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.03e-2)"	73.5	40.3	81.6	16.1	80.6	5.1	40.5	96.9	349.1	41.7	61.3	72.4	12.3	45.2	20.4	86.0	37.7	35.1	153.3	82.1	124.3	42.2	38.4	77.9	8.2	127.2	100.2	33.3	20.5	53.6	36.6	36.0	101.3	39.1	12.6	12.6	50.1	24.5	514.4	61.9	25.9	43.3	106.3	15.9	72.4	23.1	84.1	5.7	31.1	187.8	17.3	60.4	55.3	95.5	100.1	111.2	30.5	39.6	77.2	53.9	56.9	89.1	74.7	66.6	56.8	47.5	47.6	3.8	41.4	76.9	86.6	145.2	31.5	157.2	45.7	49.1	51.8	5.4	28.6	60.1	65.2	0.3	22.1	54.6	89.0	48.6	76.2	70.5	75.5	17.1	43.3	24.0	67.2	142.7	5.5	22.3	12.0	33.1	125.8	0.3	43.2	17.2	50.7	22.3	5.6	5.1	35.4	61.9	47.2	32.9	38.8	13.4	94.8	35.0	30.1	47.8	129.5	22.1	14.0	2.4	65.2	1.5	27.1	0.0	0.6	0.0	0.6	0.7	1.1	0.1	2.4	0.8	0.4	0.0	4.1	1.4	0.2	0.1	0.3	0.1	1.7	0.6	81.6	80.6	96.9	349.1	82.1	124.3	127.2	100.2	101.3	106.3	84.1	95.5	77.8	22.4	43.2	34.9	10.9	79.4	882.2	51.0	414.9	6.1	48.3	62.9	196.0	18.6	48.1	7.3	18.8	41.4	4.9	61.7	27.4	19.4	29.3	56.7	60.0	107.0	38.5	0.8	1.3	25.3	57.0	142.7	51.5	89.1	23.6	7.3	22.5	15.3	33.7	1.7	2.5	87.0	46.8	8.7	95.4	32.8	22.4	146.9	55.2	10.3	4.7	32.6	3.1	1.0	1.2	37.3	69.2	24.0	29.5	225.1	8.3	42.8	39.4	1.7	19.7	141.6	134.3	21.8	18.7	370.2	76.1	73.5	85.6	10.0	53.9	488.1
CACNA1C	"CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS"	ENSG00000151067	"Calcium voltage-gated channel subunit alpha1 C"	Q13936	12	1970786-2697950	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Host-virus interaction, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Brugada syndrome, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 20.7;heart muscle: 27.1;intestine: 29.9"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 606.7;Horizontal cells: 301.2;Inhibitory neurons: 476.2;Oligodendrocyte precursor cells: 194.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"HDLM-2: 87.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039796, CAB079031"	Enhanced	Approved				NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB079031: , HPA039796: AB_10673019"	"unprognostic (1.76e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.02e-7)"	"unprognostic (8.85e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.39e-2)"	3.0	0.9	4.5	1.4	0.9	0.0	1.9	0.0	3.0	5.6	0.0	29.9	0.7	20.7	0.5	2.1	4.2	2.3	27.1	2.0	0.5	2.5	0.4	4.6	0.3	0.0	0.5	1.9	0.9	0.1	5.2	2.1	0.0	6.5	1.3	1.7	1.0	3.3	0.9	1.3	5.0	10.2	0.0	3.0	5.4	2.5	1.8	0.2	1.3	0.8	0.3	12.3	3.4	0.1	0.0	0.0	0.1	0.0	3.3	2.0	0.2	3.4	4.1	2.2	1.5	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.8	87.0	0.8	0.1	0.0	0.0	2.1	0.0	0.1	5.1	0.0	1.1	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	5.4	0.6	5.2	0.0	0.1	0.2	0.0	4.3	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	4.5	0.9	0.0	3.0	2.0	0.5	0.0	0.5	0.0	0.0	1.8	0.1	2.2	0.0	0.0	96.6	0.2	0.6	1.0	0.0	0.0	20.7	0.8	8.3	48.8	0.0	0.0	0.0	2.1	0.2	1.3	0.6	0.0	0.1	35.6	5.1	14.6	5.2	36.6	0.8	606.7	0.0	0.4	4.2	2.0	0.9	0.0	2.7	2.2	0.1	0.3	301.2	476.2	0.6	0.0	0.0	1.1	90.3	0.9	0.2	0.0	72.1	0.0	6.0	1.0	194.5	21.7	0.4	1.2	4.1	0.2	1.2	0.0	0.1	0.0	1.3	13.1	1.6	26.7	3.4	5.8	0.1	0.1	0.1	1.1	0.2	0.5	3.1
CACNB2	"CACNLB2, MYSB"	ENSG00000165995	"Calcium voltage-gated channel auxiliary subunit beta 2"	Q08289	10	18140424-18543557	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Brugada syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 35.1"	"Group enriched"	"Detected in many"	5	"Astrocytes: 863.5;Excitatory neurons: 545.7;Inhibitory neurons: 357.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 6.4;HSkMC: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035326	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035326: AB_10669903"	"unprognostic (3.03e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.67e-4)"	"unprognostic (8.03e-2)"	"unprognostic (3.76e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.78e-4)"	"unprognostic (1.40e-1)"	"prognostic favorable (3.56e-5)"	"unprognostic (3.48e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.16e-2)"	2.8	9.4	1.3	2.1	3.9	1.3	3.8	5.4	12.9	7.4	0.1	17.6	1.1	12.8	2.7	5.0	10.1	2.2	17.8	5.4	7.4	3.2	10.7	3.9	0.9	0.0	0.1	13.6	7.5	0.6	19.3	0.5	0.0	8.5	3.2	35.1	3.9	8.8	1.1	4.2	11.4	5.3	0.0	1.5	7.7	2.1	2.2	0.7	2.5	0.7	0.2	16.8	4.6	1.5	0.2	1.0	0.7	0.5	0.3	0.3	0.5	0.3	0.0	0.0	0.3	0.4	0.5	0.9	0.2	0.2	0.3	0.7	6.4	0.0	0.0	0.3	2.4	0.8	1.7	1.5	1.6	0.5	1.5	8.1	0.0	0.0	0.0	0.3	0.0	1.4	0.9	1.6	0.0	0.7	0.8	1.0	2.4	0.0	0.0	0.7	0.7	0.8	0.0	0.8	2.9	0.8	0.1	0.0	0.4	0.8	0.1	0.9	0.0	0.6	1.5	0.3	0.6	1.6	1.8	1.7	0.2	1.2	0.3	1.4	0.1	0.2	0.2	0.2	0.4	0.4	0.3	0.1	0.0	0.5	0.5	0.8	0.1	0.3	0.2	0.2	1.1	0.0	1.3	3.9	5.4	12.9	5.4	7.4	0.0	0.1	0.0	0.0	2.2	1.5	2.1	0.0	0.6	863.5	0.1	3.3	1.3	0.0	1.8	31.9	1.1	1.3	22.4	0.0	0.0	0.0	108.4	0.4	0.7	2.8	1.9	0.4	0.9	1.1	13.9	1.5	37.1	0.8	545.7	0.2	0.0	3.0	0.0	2.6	0.0	3.8	0.0	0.9	0.1	8.4	357.8	9.4	0.0	0.0	1.1	0.8	0.9	0.5	1.8	96.5	0.0	15.9	0.0	95.5	13.7	0.2	2.4	4.5	0.3	2.1	5.9	0.8	0.0	75.7	6.6	2.6	14.2	0.1	0.1	0.0	4.1	0.3	1.0	5.3	5.7	1.3
CALM1	"CALML2, CAMI, DD132, PHKD"	ENSG00000198668	"Calmodulin 1"	P0DP23	14	90396502-90408268	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"		"Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018558, HPA044999"	Supported		Supported	Cytosol		NA	NA		75000000	"Cluster 44: Non-specific - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"CAB018558: AB_2069454, HPA044999: AB_2679177"	"unprognostic (5.35e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.16e-3)"	"prognostic favorable (5.62e-4)"	"unprognostic (2.77e-1)"	"prognostic favorable (6.49e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (2.38e-5)"	264.2	143.5	429.9	152.3	537.5	349.1	123.1	442.8	839.7	134.2	259.8	332.9	289.6	105.1	209.7	304.6	251.4	153.8	287.0	635.9	371.6	326.3	210.9	209.1	165.7	466.2	374.6	104.4	121.7	225.5	143.9	207.4	447.5	169.5	312.2	241.6	188.0	215.3	588.9	104.0	279.2	227.2	328.7	166.6	202.2	123.6	443.5	146.5	118.0	185.6	210.5	191.6	125.2	527.2	189.3	256.3	308.0	115.7	332.2	286.5	256.9	347.4	295.3	260.0	283.2	278.1	320.9	200.8	171.1	413.0	123.4	309.4	194.6	490.1	431.0	398.3	119.7	212.4	211.0	264.1	185.9	327.6	167.2	188.0	232.7	261.6	93.1	173.6	592.9	140.3	101.3	270.0	353.9	653.7	112.4	316.2	178.4	521.1	351.6	216.9	264.9	134.4	215.3	574.5	621.2	259.1	292.3	507.7	195.5	254.0	335.6	112.0	363.1	212.9	137.7	224.8	289.0	149.5	371.0	222.2	335.9	267.6	301.5	1289.6	356.8	826.7	1005.3	420.4	1230.3	496.8	1039.1	1079.6	483.1	400.2	745.7	882.7	513.3	1036.9	647.3	453.3	1168.3	1477.9	429.9	537.5	442.8	839.7	635.9	371.6	466.2	374.6	447.5	328.7	443.5	527.2	1812.3	387.8	374.4	119.8	573.2	567.1	572.2	604.2	543.5	1729.1	343.7	514.8	867.5	346.0	523.1	399.1	123.0	427.7	1471.8	828.8	459.7	550.8	154.9	1026.1	249.0	996.0	599.8	143.5	367.6	444.7	984.2	521.4	317.0	377.6	490.3	148.5	652.5	333.7	795.1	604.0	258.9	513.9	730.4	286.5	837.4	101.5	210.6	639.9	627.9	131.2	856.3	1061.8	1100.9	108.0	188.9	534.2	615.8	500.2	591.8	287.7	1637.2	1430.5	1618.4	321.1	315.5	387.5	901.6	128.8	199.8	553.8	580.4	1147.6	1139.3	247.8	666.6	458.5
CALM2	"CAMII, PHKD"	ENSG00000143933	"Calmodulin 2"	P0DP24	2	47160083-47176921	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"			"Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007790, HPA044999"	Approved					NA	Yes			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB007790: AB_562257, HPA044999: AB_2679177"	"prognostic unfavorable (5.05e-4)"	"unprognostic (2.94e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (9.21e-2)"	"unprognostic (2.04e-3)"	"prognostic unfavorable (8.35e-5)"	"unprognostic (1.63e-2)"	"unprognostic (4.67e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.29e-2)"	"prognostic favorable (1.94e-5)"	"unprognostic (1.24e-1)"	509.3	652.1	1177.9	334.4	1219.1	240.3	686.1	1229.7	1745.6	420.1	988.8	683.9	549.8	507.6	551.1	366.8	526.5	390.8	443.0	1229.0	1219.0	445.7	493.1	505.6	427.9	1209.1	1192.8	416.1	213.3	332.3	441.3	468.9	1227.6	449.1	706.0	574.8	490.8	561.5	262.9	304.2	621.2	634.7	1209.4	643.0	390.4	508.8	1257.9	571.0	443.3	258.1	467.2	459.0	340.2	1411.8	2459.6	905.8	1062.2	459.7	579.4	679.5	655.8	2177.2	1504.3	1437.1	1240.1	958.1	923.2	956.1	979.5	1753.2	1030.4	624.7	878.3	855.6	1907.0	729.3	438.6	821.6	526.6	1409.6	779.5	996.3	686.2	381.2	825.0	1265.3	1347.0	1230.4	977.3	312.8	812.1	854.7	3485.7	635.9	1270.2	984.3	801.3	2961.6	488.6	314.3	1142.9	1021.9	1631.0	441.0	756.8	2016.6	726.5	756.0	1120.1	1144.3	573.7	556.7	1084.8	1060.8	1135.8	627.0	1703.6	648.8	529.1	1038.2	718.8	711.3	1357.7	944.7	447.6	776.8	139.7	844.1	177.2	285.6	203.4	213.2	354.0	182.1	173.7	201.6	417.9	277.1	761.4	445.6	227.4	496.5	1177.9	1219.1	1229.7	1745.6	1229.0	1219.0	1209.1	1192.8	1227.6	1209.4	1257.9	1411.8	597.4	1387.8	613.5	195.2	570.7	1780.5	1101.0	2616.3	524.8	654.3	844.4	572.9	639.6	581.9	1751.8	759.6	98.0	931.4	649.8	906.5	2304.8	1977.0	312.7	889.1	363.8	652.0	597.1	697.1	317.5	683.4	627.9	943.6	354.8	452.5	665.4	484.5	280.6	536.6	1267.1	341.6	179.0	1020.1	3352.8	867.1	1858.2	287.0	1055.3	911.0	1771.6	143.4	1167.2	2063.1	350.1	129.7	339.8	2584.9	1114.4	863.6	309.7	1016.8	1231.6	1020.2	3245.3	334.2	907.2	671.6	1882.0	2193.5	714.3	503.0	1663.1	255.3	669.1	615.4	771.1	1062.2
CALM3	PHKD	ENSG00000160014	"Calmodulin 3"	P0DP25	19	46601074-46610782	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"			"Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 868.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 1863.5;Late spermatids: 2674.8;Spermatocytes: 875.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044999	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"			"HPA044999: AB_2679177"	"unprognostic (3.39e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (4.01e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.10e-4)"	"unprognostic (2.72e-1)"	136.3	186.9	309.9	153.9	428.0	194.4	113.2	19.8	868.1	187.9	0.0	178.8	203.6	175.4	97.6	118.4	148.8	135.9	272.4	498.5	183.4	177.3	137.2	125.7	179.4	240.2	77.0	189.0	116.3	110.3	138.6	133.3	199.8	143.6	158.2	152.0	73.1	157.7	340.0	85.6	228.9	166.8	25.8	122.2	143.4	469.0	184.3	270.8	118.1	253.0	172.2	173.2	150.8	505.1	392.6	437.1	493.9	174.6	256.1	338.9	119.5	405.8	333.6	358.0	473.1	374.8	342.5	322.3	185.2	599.0	249.7	297.6	496.9	322.0	453.5	498.0	387.6	433.7	201.8	404.5	139.0	324.5	596.5	334.6	106.9	281.1	218.3	274.2	450.6	353.4	335.7	447.0	345.3	250.1	354.3	818.1	251.6	575.7	192.3	644.7	254.5	121.9	341.4	463.3	253.6	279.7	304.6	194.1	123.7	484.3	227.9	364.7	329.2	197.6	366.2	150.5	298.5	370.2	280.6	262.1	197.9	279.5	255.7	190.6	158.2	262.4	67.2	193.9	61.0	74.7	95.5	90.0	93.5	68.6	112.0	71.6	433.7	103.6	194.3	55.1	195.6	150.7	309.9	428.0	19.8	868.1	498.5	183.4	240.2	77.0	199.8	25.8	184.3	505.1	77.6	41.7	56.8	23.8	101.8	57.2	82.8	82.0	32.5	136.2	82.4	86.1	177.5	87.2	59.9	69.9	12.5	202.9	120.0	301.1	260.3	265.0	1863.5	101.6	76.4	88.7	122.4	318.4	114.1	221.5	545.1	112.3	89.2	82.4	106.0	130.6	125.7	106.4	760.3	89.2	89.4	178.2	59.0	307.8	112.7	2674.8	106.9	349.8	92.5	32.8	525.0	184.2	225.6	23.1	30.2	205.1	273.5	122.6	143.3	67.6	457.2	365.6	85.4	88.2	92.1	47.8	130.9	875.3	157.4	64.6	65.9	184.8	161.1	192.7	208.8	111.9
CASQ2	PDIB2	ENSG00000118729	"Calsequestrin 2"	O14958	1	115700021-115768714	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 1056.7"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 777.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"HSkMC: 13.6"	"Region enriched"	"Detected in all"	6	"cerebellum: 43.1"	"Low region specificity"	"Detected in all"			"HPA027285, HPA055298"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA027285: AB_1845933, HPA055298: AB_2682777"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.03e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.25e-5)"	31.9	3.0	3.5	6.4	2.3	0.0	8.9	2.8	4.0	8.0	2.0	59.8	3.3	17.2	6.5	38.5	14.7	6.6	1056.7	1.8	3.6	3.5	0.6	5.3	0.8	1.9	4.8	5.3	1.2	1.6	0.9	1.6	2.1	13.8	17.0	0.3	7.6	20.2	182.1	4.9	9.1	39.1	1.9	0.8	14.2	1.5	6.4	1.6	4.1	165.0	1.3	43.9	6.9	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	2.3	2.8	4.0	1.8	3.6	1.9	4.8	2.1	1.9	6.4	1.9	2.7	0.0	0.0	0.3	0.0	0.6	0.3	0.0	0.6	0.2	0.1	0.4	777.8	0.0	0.0	1.8	0.0	0.4	0.1	0.0	0.0	0.0	15.5	0.3	0.0	4.8	0.0	0.0	0.7	0.0	0.3	17.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	20.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	1.3	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	92.1	11.0	73.4	0.1	0.4	0.2	0.3	0.0	0.1	0.0	0.0	0.0
CAV3	"LGMD1C, LQT9, VIP-21, VIP21"	ENSG00000182533	"Caveolin 3"	P56539	3	8733802-8841808	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 182.7;tongue: 72.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 22.9;Early spermatids: 4.2;Sertoli cells: 6.6;Skeletal myocytes: 11.0"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RH-30: 94.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017518, CAB018557, HPA054488"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	Vesicles	"CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: AB_2682504"	"unprognostic (1.79e-1)"				"unprognostic (1.43e-1)"	"unprognostic (1.40e-2)"		"unprognostic (6.43e-2)"		"unprognostic (8.79e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.38e-3)"		"unprognostic (9.79e-2)"	"unprognostic (1.36e-1)"			0.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	5.7	0.1	0.1	27.4	0.1	0.1	0.0	0.0	0.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	2.5	0.2	182.7	0.2	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.2	0.1	72.8	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	11.0	2.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0
CFC1	"CRYPTIC, HTX2"	ENSG00000136698	"Cripto, FRL-1, cryptic family 1"	P0CG37	2	130592165-130599575	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Gastrulation	"Developmental protein"	"Disease variant, Heterotaxy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 24.0;pancreas: 30.7;pituitary gland: 59.3"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 14.9;Enteroendocrine cells: 20.5"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 4.3"	"Region enhanced"	"Detected in all"		"hypothalamus: 24.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"RPMI-8226: 12.1;SCLC-21H: 6.7;SuSa: 4.0"									HPA041773	Uncertain				"Secreted - unknown location"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA041773: AB_2677664"					"unprognostic (6.65e-2)"						"unprognostic (2.19e-3)"	"unprognostic (1.11e-3)"			"unprognostic (2.01e-1)"			1.7	0.6	4.6	0.0	2.3	0.0	0.0	2.9	3.5	0.1	0.0	0.2	0.0	0.2	0.1	0.0	1.5	0.0	1.9	1.3	24.0	0.0	0.0	0.1	0.0	3.9	8.1	0.0	30.7	0.0	59.3	0.0	5.6	7.2	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	10.7	0.6	8.6	5.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	2.3	2.9	3.5	1.3	24.0	3.9	8.1	5.6	3.9	8.6	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	20.5	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CITED2	MRG1	ENSG00000164442	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2"	Q99967	6	139371807-139374648	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Stress response, Transcription, Transcription regulation"	"Activator, Developmental protein, Repressor"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 685.3;Plasma cells: 619.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 27.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 618.3;fHDF/TERT166: 1070.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016157, CAB069879"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"CAB016157: AB_668099, CAB069879: AB_10003446"	"unprognostic (7.42e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.40e-4)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.03e-1)"	177.7	107.4	3.8	49.8	2.2	313.6	117.5	29.3	24.0	60.5	5.4	88.0	36.7	188.0	38.7	75.5	207.7	32.6	70.9	1.9	9.3	70.7	203.4	134.0	37.9	8.5	6.5	270.3	74.7	179.0	17.7	104.1	8.3	44.2	42.5	36.4	120.5	42.8	107.6	131.7	65.3	81.9	0.9	136.5	69.5	22.0	19.4	25.1	227.7	24.9	30.4	37.9	64.0	0.7	23.7	13.7	46.7	138.2	191.8	203.7	175.6	618.3	456.0	274.7	255.7	122.5	35.2	17.0	88.5	1070.3	58.5	28.0	14.2	14.5	192.4	467.0	45.8	346.9	76.0	10.1	157.1	103.1	36.5	164.6	64.4	121.3	91.4	177.9	51.2	10.1	132.9	80.1	359.2	51.0	17.5	128.3	43.8	15.0	21.2	24.7	34.2	152.3	131.7	52.5	51.8	0.8	45.2	167.6	21.2	106.8	72.3	348.3	283.6	219.9	69.5	66.4	35.0	23.4	22.6	26.3	68.0	86.9	15.8	3.1	8.2	27.7	3.4	4.6	5.0	1.2	5.4	4.9	3.6	3.1	4.7	2.4	4.0	3.0	6.6	1.6	3.6	3.3	3.8	2.2	29.3	24.0	1.9	9.3	8.5	6.5	8.3	0.9	19.4	0.7	157.1	115.4	272.8	3.6	138.8	35.8	111.5	12.7	347.8	30.6	164.4	180.0	114.1	80.1	36.5	103.0	12.5	173.1	156.5	159.6	185.9	20.5	1.5	122.6	131.7	68.9	99.7	274.3	6.9	14.9	685.3	200.3	121.8	262.3	46.9	133.9	61.1	65.5	372.6	30.3	22.2	111.6	20.3	124.4	67.7	7.7	99.4	188.9	83.6	9.4	44.2	51.9	55.6	1.0	1.3	23.1	97.7	60.9	619.4	46.6	88.8	121.0	27.4	52.5	98.6	107.9	179.1	1.8	20.8	200.8	33.8	269.3	291.8	272.9	112.6	38.4
CRYAB	"CRYA2, HSPB5"	ENSG00000109846	"Crystallin alpha B"	P02511	11	111908564-111923722	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Eye lens protein"	"Cancer-related genes, Cardiomyopathy, Cataract, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5623.2;heart muscle: 10683.1;skeletal muscle: 6972.0;tongue: 9406.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 2889.5;Cardiomyocytes: 6878.2;Muller glia cells: 1664.3;Proximal tubular cells: 7285.9"	"Group enriched"	"Detected in all"	6	"glioma: 426.4;renal cancer: 575.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"ASC diff: 2663.1;fHDF/TERT166: 775.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002053, CAB040560, HPA057100"	Enhanced		Enhanced	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		370000		"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"		"CAB002053: AB_442024, CAB040560: , HPA057100: AB_2683337"	"unprognostic (1.06e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (4.90e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.41e-3)"	"unprognostic (9.29e-3)"	"unprognostic (7.35e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.68e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.70e-5)"	1035.0	106.6	2466.0	113.9	3113.8	0.4	592.2	3032.2	5623.2	439.1	2077.7	678.9	24.6	351.4	179.1	312.2	204.0	71.7	10683.1	2424.9	2666.2	2123.2	37.2	253.4	15.0	3215.2	2856.7	136.0	50.6	24.9	209.2	107.8	3147.1	317.9	78.2	478.7	428.7	358.5	6972.0	317.3	158.5	338.1	2877.3	88.5	263.8	23.5	2815.5	20.9	477.7	9406.7	34.4	490.0	477.5	4060.6	0.1	0.5	0.1	45.0	2663.1	90.9	15.0	54.5	2.5	0.8	2.5	1.7	0.2	0.0	41.7	775.8	0.2	2.0	1.8	2.3	1.4	0.3	0.0	0.0	11.9	3.9	16.9	0.4	0.7	77.1	11.1	0.6	6.2	44.3	0.2	0.0	4.6	2.5	169.5	0.1	0.1	1.1	0.5	0.0	1.0	0.2	0.0	0.6	29.8	0.8	0.1	0.4	5.3	9.1	39.8	63.5	4.9	0.0	1.7	310.1	105.0	6.5	4.1	0.5	0.1	0.6	7.1	0.4	39.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2466.0	3113.8	3032.2	5623.2	2424.9	2666.2	3215.2	2856.7	3147.1	2877.3	2815.5	4060.6	38.4	83.3	4.1	96.0	51.3	174.9	2889.5	32.1	72.8	16.2	334.4	696.1	6878.2	84.4	15.2	1338.9	18.8	3.9	6.8	0.4	677.0	320.3	24.7	345.4	265.3	88.4	7.1	0.0	6.7	11.5	7.4	880.6	0.0	1008.4	0.0	16.1	35.7	0.7	5.8	10.1	12.6	2.4	8.2	0.3	85.8	12.6	228.6	67.7	483.8	11.2	3.6	1664.3	0.0	7.5	615.7	12.1	0.0	187.7	1.6	855.4	0.0	7285.9	23.2	59.4	138.1	799.9	1053.3	21.6	1.4	56.5	155.1	33.4	55.4	6.7	1.2	249.0
CSRP3	"CLP, CMD1M, MLP"	ENSG00000129170	"Cysteine and glycine rich protein 3"	P50461	11	19182030-19210571	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Actin-binding, Developmental protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 2613.3;skeletal muscle: 1649.3;tongue: 579.0"	"Cell type enriched"	"Detected in some"	35	"Cardiomyocytes: 3433.6"	"Cancer enriched"	"Detected in some"	6	"head and neck cancer: 18.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HSkMC: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042581	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		250000		"Cluster 38: Heart - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	Nucleoplasm	"HPA042581: AB_2678061"				"unprognostic (1.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-2)"				"unprognostic (4.72e-2)"				"unprognostic (5.99e-2)"	"unprognostic (1.08e-1)"			0.3	0.2	0.3	0.0	0.1	0.1	2.8	0.5	0.3	0.0	0.0	0.2	0.0	0.1	0.0	39.6	0.0	0.5	2613.3	0.1	0.2	0.2	0.2	1.2	1.2	0.2	0.1	0.5	2.6	0.0	0.1	0.1	0.2	32.8	0.0	0.0	24.8	0.0	1649.3	0.4	0.2	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.7	579.0	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.5	0.3	0.1	0.2	0.2	0.1	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3433.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	28.8	0.0	0.0	0.3	6.0	0.0	79.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	95.5	32.7	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0
DCHS1	"CDH25, CDHR6, FIB1, FLJ11790, KIAA1773, PCDH16"	ENSG00000166341	"Dachsous cadherin-related 1"	Q96JQ0	11	6621330-6655809	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 34.8;Endometrial stromal cells: 17.3;Endothelial cells: 29.0;Fibroblasts: 17.0;Granulosa cells: 19.3;Hepatic stellate cells: 61.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 33.5;HUVEC TERT2: 47.1;REH: 23.5;SH-SY5Y: 32.4;TIME: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017970, HPA050246"	Approved		Approved	"Plasma membrane"		NA	NA		4000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA017970: AB_2669718, HPA050246: AB_2681062"	"unprognostic (2.42e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.38e-3)"	"unprognostic (2.52e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.93e-2)"	"unprognostic (5.96e-2)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (5.62e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-3)"	9.4	2.5	7.4	8.4	6.8	0.7	9.3	6.1	6.3	19.5	0.9	19.0	4.1	28.9	2.4	5.0	13.2	8.3	9.2	6.6	10.1	4.6	2.0	10.1	4.0	7.6	6.3	11.6	3.3	2.0	3.2	10.1	5.7	9.3	3.4	0.6	3.5	11.5	4.2	3.7	8.3	16.2	4.7	12.9	8.2	3.0	8.7	3.8	4.1	4.6	2.2	14.8	9.3	3.8	0.0	0.1	33.5	0.1	0.0	0.1	0.3	1.2	8.7	5.4	6.0	0.3	0.0	0.1	5.1	9.9	0.4	0.0	2.7	0.1	3.7	0.1	0.9	0.7	0.0	0.0	0.3	0.2	0.0	1.0	0.1	2.5	0.0	0.0	47.1	0.1	0.2	0.0	2.0	0.0	1.2	0.6	5.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	2.4	32.4	0.0	0.3	0.2	3.5	0.0	1.3	20.4	0.1	10.0	0.1	0.0	0.1	0.0	0.1	0.3	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	7.4	6.8	6.1	6.3	6.6	10.1	7.6	6.3	5.7	4.7	8.7	3.8	34.8	0.0	0.5	12.1	0.2	2.9	0.3	0.0	0.0	1.5	1.7	3.0	3.8	4.3	0.0	0.0	0.0	0.2	1.4	0.2	0.0	1.0	3.1	0.8	17.3	29.0	0.0	2.7	2.0	0.4	0.3	17.0	1.1	0.7	0.0	19.3	61.1	0.2	2.2	0.0	7.4	0.7	0.0	4.7	4.2	3.4	1.2	2.4	16.0	4.7	0.2	0.9	0.0	10.1	1.4	0.1	0.1	1.9	0.2	0.3	0.1	0.1	0.0	0.5	0.0	7.4	4.9	4.9	0.6	0.5	1.7	0.3	1.2	4.6	1.1	0.1
DES	"CMD1I, CSM1, CSM2"	ENSG00000175084	Desmin	P17661	2	219418377-219426734	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cancer-related genes, Cardiomyopathy, Desmin-related myopathy, Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 13020.7;intestine: 8627.2;skeletal muscle: 16532.0"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 2531.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 562.1;stomach cancer: 400.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 70.2;LHCN-M2: 145.3;NB-4: 39.5;RH-30: 333.1"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"midbrain: 29.5"	"CAB000034, HPA018803"	Enhanced		Supported	"Intermediate filaments"		NA	NA		1600000	"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"		"CAB000034: , HPA018803: AB_1847616"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.76e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.61e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (5.08e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-3)"	235.3	57.1	2.1	436.2	4.9	1.1	51.2	2.1	9.6	504.3	5.0	8627.2	291.3	3015.2	86.0	1481.2	1085.0	452.1	13020.7	2.4	2.5	37.6	15.5	173.9	7.2	3.4	2.5	171.8	14.6	0.5	8.4	52.7	2.4	2218.8	245.6	0.0	255.3	2253.1	16532.0	152.4	1343.5	2557.5	2.1	25.2	1965.6	16.1	2.6	3.2	66.2	5753.8	1.2	4761.8	669.4	2.4	0.0	0.0	0.1	0.0	0.0	2.2	5.3	0.2	0.0	0.1	0.1	0.5	0.0	0.0	9.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	17.0	0.1	1.3	70.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	145.3	0.0	0.0	39.5	0.5	0.0	0.0	0.0	333.1	2.1	0.0	0.0	0.2	1.2	0.0	0.0	0.0	9.2	0.0	5.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	2.1	4.9	2.1	9.6	2.4	2.5	3.4	2.5	2.4	2.1	2.6	2.4	0.4	0.0	0.0	0.0	0.0	4.1	2.7	0.0	0.0	0.0	0.1	0.0	2531.9	1.5	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	90.6	0.5	6.7	22.7	0.0	0.0	0.1	0.0	5.2	104.6	0.0	0.1	0.0	0.0	1.8	0.0	5.6	0.0	0.0	0.9	0.0	0.0	10.7	71.6	28.9	2.8	12.4	0.0	0.6	0.0	0.0	0.5	0.0	0.5	0.0	50.4	0.0	8.7	0.0	0.1	0.0	0.0	46.0	497.8	210.5	5.0	5.1	0.1	9.8	8.5	2.4	0.0	0.2	2.9
DMD	"BMD, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272, MRX85"	ENSG00000198947	Dystrophin	P11532	X	31097677-33339609	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"		Actin-binding	"Cancer-related genes, Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 452.8;Excitatory neurons: 1275.8;Inhibitory neurons: 719.8;Oligodendrocyte precursor cells: 1161.6;Oligodendrocytes: 610.2;Rod photoreceptor cells: 375.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 8.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.3"	"Group enriched"	"Detected in many"	7	"B-cells: 1.1;granulocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"AF22: 27.9;Hep G2: 30.3;RH-30: 25.0;SuSa: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000119, HPA002725, HPA023885"	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB000119: , HPA002725: AB_1078714, HPA023885: AB_1847931"	"unprognostic (3.91e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-4)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.84e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.82e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.51e-2)"	16.3	14.7	11.8	5.3	12.5	0.6	16.8	0.2	14.2	7.1	7.1	38.0	5.4	18.1	11.2	9.1	16.8	21.5	37.8	15.5	0.5	5.4	50.0	7.2	4.7	1.1	0.6	13.9	52.9	4.3	4.4	15.1	0.4	13.4	8.4	80.0	30.2	30.7	73.4	11.5	9.4	22.0	0.0	2.3	15.5	8.3	4.8	3.3	7.3	67.4	6.4	21.1	7.2	9.9	0.3	0.2	27.9	0.3	0.3	0.3	7.6	6.1	0.6	2.8	3.1	13.3	0.6	0.4	0.2	12.5	2.3	8.5	10.5	15.0	4.2	7.4	8.6	3.3	10.5	30.3	14.7	1.2	3.7	3.3	9.5	4.6	17.1	15.3	6.1	2.0	2.9	0.4	8.3	0.5	4.4	0.6	13.3	0.1	9.8	0.3	25.0	0.1	0.3	3.3	0.5	8.5	0.1	2.3	2.8	27.7	2.2	0.1	1.6	0.3	0.5	1.1	4.6	0.4	23.8	0.6	1.0	2.3	14.4	0.8	0.1	2.0	0.1	0.1	0.1	1.1	0.1	0.1	0.3	0.9	0.1	0.1	4.3	0.1	0.1	0.4	0.2	0.1	11.8	12.5	0.2	14.2	15.5	0.5	1.1	0.6	0.4	0.0	4.8	9.9	8.5	28.9	25.3	164.9	6.7	20.1	7.0	6.3	3.4	78.0	26.5	50.0	452.8	7.2	15.0	3.7	308.6	33.7	0.7	0.8	3.9	3.8	22.4	22.5	1.4	9.9	8.4	0.0	1275.8	12.3	9.5	26.1	3.6	5.6	1.3	37.9	6.1	49.8	4.2	11.8	719.8	1.3	6.1	4.8	5.4	20.5	89.2	3.5	19.6	94.6	6.7	54.9	0.0	1161.6	610.2	6.0	0.1	118.8	0.2	3.6	3.6	2.1	60.4	375.9	118.3	95.2	50.3	4.0	8.8	1.8	11.5	5.1	1.0	33.1	4.2	4.8
DPP6	"DPL1, DPPX"	ENSG00000130226	"Dipeptidyl peptidase like 6"	P42658	7	153887097-154894285	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.0;endometrium 1: 58.2"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 673.4;Inhibitory neurons: 1195.9;Oligodendrocyte precursor cells: 1947.8"	"Cancer enriched"	"Detected in some"	11	"glioma: 12.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"NTERA-2: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050509	Enhanced	Supported				NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA050509: AB_2681150"	"unprognostic (1.29e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.83e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.04e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.85e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.61e-3)"	"unprognostic (6.11e-2)"	0.6	8.2	16.5	0.2	24.5	0.1	0.5	32.0	34.5	5.8	0.0	19.8	0.5	58.2	2.5	0.3	5.2	0.1	0.2	42.7	21.6	5.3	0.0	1.4	0.1	54.0	24.5	0.7	3.9	0.0	10.8	0.2	53.1	0.3	1.6	11.1	0.1	8.9	6.0	3.6	3.4	19.9	8.6	4.7	7.8	7.3	32.2	1.9	17.1	0.9	0.0	0.3	1.1	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	11.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.6	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.0	16.5	24.5	32.0	34.5	42.7	21.6	54.0	24.5	53.1	8.6	32.2	14.8	0.1	0.0	0.0	147.9	0.0	3.3	0.4	0.0	0.0	27.0	0.4	1.3	7.4	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	13.4	0.9	21.6	0.4	10.3	0.0	673.4	4.0	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	32.0	1195.9	0.4	0.0	0.0	0.0	18.4	1.2	0.2	16.0	22.5	0.0	17.1	0.0	1947.8	290.8	0.3	0.0	3.8	0.0	0.1	0.1	0.4	0.8	6.1	0.0	0.7	0.9	1.2	4.0	0.0	1.6	0.0	0.2	0.0	0.0	0.2
DSC2	"CDHF2, DSC3"	ENSG00000134755	"Desmocollin 2"	Q02487	18	31058840-31102522	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 164.0;vagina: 97.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 384.0;Paneth cells: 324.8;Squamous epithelial cells: 705.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 48.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"eosinophil: 28.9;neutrophil: 8.1"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 28.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 37.6;CAPAN-2: 48.3;HaCaT: 71.1;hTCEpi: 76.0;OE19: 60.7;SK-BR-3: 44.4;SuSa: 43.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011911, HPA012615"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		24000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"	Cytosol	"HPA011911: AB_1847618, HPA012615: AB_1847619"	"unprognostic (3.28e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (7.66e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (3.01e-4)"	5.5	1.8	1.3	12.7	1.4	0.7	22.2	1.3	1.6	59.2	1.9	50.5	41.6	1.5	5.9	164.0	6.1	3.7	10.6	1.2	2.0	5.9	7.3	7.9	3.7	2.6	1.5	0.6	10.5	27.0	0.5	21.3	2.2	15.8	44.5	1.0	46.8	1.0	0.3	11.9	42.9	4.0	1.8	3.0	43.2	0.8	1.6	6.6	4.0	3.1	62.2	3.6	97.4	2.3	18.1	1.9	2.9	0.0	0.0	0.0	37.6	0.0	0.0	0.0	0.0	9.8	48.3	0.0	0.7	0.0	0.9	71.1	11.8	4.9	0.0	0.0	6.9	27.1	8.4	16.9	0.3	0.2	0.5	0.4	76.0	0.0	7.3	6.1	0.0	0.0	13.4	0.0	0.0	14.7	0.0	1.1	11.3	60.7	17.4	13.2	0.0	0.2	0.1	0.7	0.0	0.1	0.0	44.4	0.0	43.4	12.2	18.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	28.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.4	1.3	1.4	1.3	1.6	1.2	2.0	2.6	1.5	2.2	1.8	1.6	2.3	25.1	28.9	5.6	3.3	1.0	83.7	44.5	16.4	67.7	0.8	75.3	65.7	33.8	32.9	11.1	7.3	0.0	100.8	1.0	384.0	0.0	83.5	0.1	19.1	4.0	6.7	69.4	0.4	3.3	33.2	186.6	5.9	47.4	43.8	0.0	2.7	8.2	16.0	24.8	0.0	1.5	83.1	20.3	48.8	29.3	0.2	0.3	35.3	14.2	4.7	25.2	11.2	0.0	2.0	0.2	155.7	324.8	0.7	0.3	140.6	118.2	9.7	3.8	0.7	0.0	1.2	3.0	0.1	1.3	705.6	55.0	83.9	2.0	0.3	114.0	76.1
DSG2	CDHF5	ENSG00000046604	"Desmoglein 2"	Q14126	18	31498177-31549008	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 105.3;parathyroid gland: 157.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 404.6;Pancreatic endocrine cells: 254.9;Undifferentiated cells: 216.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	13	"basophil: 8.4"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 172.9;HaCaT: 269.2;HBEC3-KT: 201.2;hTERT-HME1: 212.1;OE19: 229.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004896, CAB025122"	Enhanced		Supported	"Cell Junctions"		NA	NA		140000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"CAB025122: , HPA004896: AB_1078643"	"unprognostic (1.56e-3)"	"prognostic unfavorable (8.22e-4)"	"prognostic favorable (7.81e-4)"	"unprognostic (8.77e-3)"	"unprognostic (3.53e-4)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (2.86e-3)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (4.94e-5)"	"unprognostic (3.40e-1)"	"prognostic favorable (3.14e-10)"	"unprognostic (1.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-1)"	"unprognostic (8.57e-3)"	23.6	1.2	0.2	14.6	0.2	0.8	40.2	0.6	0.2	13.0	26.4	105.3	79.1	8.6	10.6	10.2	22.4	31.4	31.4	0.7	0.1	33.8	15.1	15.0	1.6	0.3	0.5	13.6	39.5	157.8	1.6	22.9	0.7	31.5	100.0	0.3	68.6	6.5	1.2	6.7	84.6	7.3	0.0	0.4	77.1	3.7	0.4	24.2	42.2	0.7	4.6	41.6	5.7	0.5	119.2	45.3	4.0	0.1	0.6	7.2	143.0	0.0	0.0	0.3	0.0	31.7	172.9	0.0	64.2	0.0	54.4	269.2	54.7	201.2	0.0	0.2	33.9	0.1	46.7	35.9	20.2	15.2	0.3	9.9	136.7	4.2	212.1	102.4	0.0	34.7	47.8	0.2	0.0	31.5	32.2	2.0	55.4	229.5	23.1	52.8	0.0	76.2	65.8	58.5	23.9	0.2	88.3	61.8	0.3	117.8	44.3	12.7	0.1	0.2	25.0	0.3	29.3	5.7	0.2	0.2	19.8	0.1	25.3	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.2	0.6	0.2	0.7	0.1	0.3	0.5	0.7	0.0	0.4	0.5	120.8	54.5	45.4	0.0	1.3	13.5	79.4	76.2	28.5	0.4	68.9	49.3	57.3	101.5	79.6	12.9	0.0	80.1	4.4	404.6	3.9	105.5	1.0	48.6	9.4	13.1	79.9	9.0	3.3	76.1	116.2	12.0	70.3	82.1	4.5	18.8	2.2	26.4	10.3	1.7	0.3	165.7	79.3	0.8	4.0	2.5	1.5	2.2	17.8	0.0	6.3	5.3	1.0	0.5	0.1	254.9	152.0	0.4	0.3	133.5	145.1	10.0	75.4	0.7	0.0	0.6	8.2	2.7	8.9	23.1	6.0	59.9	2.6	6.6	216.8	179.9
DSP	"DPI, DPII, KPPS2, PPKS2"	ENSG00000096696	Desmoplakin	P15924	6	7541617-7586714	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant, Epidermolysis bullosa, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 460.7;skin 1: 854.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 902.0;Cardiomyocytes: 729.7;Squamous epithelial cells: 1657.5;Suprabasal keratinocytes: 2018.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 314.1"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	13	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 278.0;HaCaT: 302.6;HBEC3-KT: 217.5;hTCEpi: 666.3;SuSa: 204.1"	"Region enriched"	"Detected in single"	23	"hippocampal formation: 11.6"	"Region enhanced"	"Detected in many"		"spinal cord: 9.5"	"CAB037324, HPA045840, HPA054950"	Enhanced		Supported	"Cell Junctions"		NA	NA		100000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"CAB037324: , HPA045840: AB_2679468, HPA054950: AB_2682645"	"unprognostic (1.65e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.94e-2)"	"prognostic favorable (1.53e-9)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (1.82e-4)"	5.2	11.6	4.2	7.0	1.8	0.6	65.8	2.5	3.5	151.0	19.3	46.0	52.0	5.4	27.5	460.7	16.3	7.8	84.9	3.4	0.9	22.4	41.9	6.1	3.7	1.6	2.0	2.0	111.5	54.9	9.0	63.3	1.5	29.9	43.5	21.2	125.1	11.7	3.4	854.8	42.3	2.9	2.4	3.2	48.1	1.5	2.2	37.1	41.5	0.6	78.7	13.1	286.1	0.9	132.2	38.9	0.0	0.1	5.6	8.2	278.0	25.5	21.8	12.4	12.0	110.8	33.5	0.1	35.8	40.9	10.0	302.6	46.1	217.5	2.2	0.1	54.1	0.0	21.5	149.5	0.0	0.6	0.9	1.9	666.3	11.0	121.7	30.0	0.0	0.6	0.2	0.2	22.0	61.4	0.1	1.0	5.6	62.6	19.6	0.1	0.1	32.9	45.3	34.8	12.6	0.3	28.5	59.9	0.2	204.1	71.0	0.3	0.0	4.8	1.2	0.3	0.3	0.1	0.2	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	1.8	2.5	3.5	3.4	0.9	1.6	2.0	1.5	2.4	2.2	0.9	7.6	51.3	17.0	0.0	7.5	902.0	164.5	157.3	278.3	4.4	184.5	126.4	729.7	97.2	197.5	60.7	14.6	273.0	1.2	357.1	1.9	160.6	1.8	306.5	42.4	46.9	174.6	0.0	0.1	111.9	273.1	51.2	237.0	560.1	3.8	532.2	4.6	186.6	27.5	0.0	0.9	204.7	111.9	1.9	77.8	1.3	0.9	5.9	101.4	3.7	2.6	14.7	0.0	0.0	0.1	167.4	284.2	0.0	5.7	204.0	180.7	12.0	176.6	28.6	0.0	0.4	67.4	1.3	2.7	1657.5	2018.0	385.7	8.1	0.3	247.8	269.9
DTNA	"D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3"	ENSG00000134769	"Dystrobrevin alpha"	Q9Y4J8	18	34493290-34891844	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 461.9;choroid plexus: 120.6;heart muscle: 150.0;skeletal muscle: 166.9;tongue: 209.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1756.1;Excitatory neurons: 506.0;Inhibitory neurons: 650.9;Oligodendrocyte precursor cells: 491.6;Oligodendrocytes: 367.4"	"Cancer enriched"	"Detected in many"	9	"glioma: 28.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 37.7;NTERA-2: 42.0;SCLC-21H: 51.9;U-87 MG: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015196, HPA071177"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Intermediate filaments"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cell Junctions, Intermediate filaments"	Nucleoplasm	"CAB015196: AB_2261797, HPA071177: "	"unprognostic (1.57e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.13e-3)"	"unprognostic (7.82e-6)"	"unprognostic (5.03e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.35e-4)"	"unprognostic (6.89e-2)"	"prognostic favorable (2.64e-7)"	"unprognostic (6.08e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.27e-5)"	11.6	6.6	252.7	5.4	248.2	0.8	9.6	243.3	260.1	5.4	120.6	22.4	3.9	8.1	20.5	22.9	11.7	9.4	150.0	250.1	423.0	2.3	2.2	6.6	2.3	461.9	326.9	7.0	18.1	2.4	10.8	4.1	360.4	23.6	7.6	19.8	11.3	25.3	166.9	2.7	8.4	19.4	308.1	4.8	6.8	6.1	269.2	0.5	12.3	209.9	2.0	32.0	5.2	331.0	0.7	0.5	17.3	0.0	9.5	25.1	2.6	3.2	14.8	0.6	1.7	3.8	0.2	0.1	8.9	1.9	15.3	1.1	2.1	7.5	1.8	0.0	10.7	0.1	0.9	5.7	7.1	0.2	0.2	19.2	1.8	11.9	4.5	14.2	6.7	0.1	2.4	1.9	3.8	37.7	0.1	0.2	42.0	0.6	8.1	0.1	7.7	24.1	0.9	0.3	51.9	6.9	0.0	1.7	4.9	23.8	21.8	6.3	0.5	16.7	9.9	0.3	5.2	1.3	2.0	1.0	52.5	0.0	8.4	1.0	0.7	0.0	0.8	0.0	1.1	0.8	1.5	1.1	3.5	0.7	1.6	1.3	0.3	0.8	0.0	0.1	4.3	1.0	252.7	248.2	243.3	260.1	250.1	423.0	461.9	326.9	360.4	308.1	269.2	331.0	5.1	0.0	1.1	1756.1	0.1	1.5	0.1	0.8	0.0	18.3	22.2	12.3	134.3	27.1	1.4	0.0	6.2	0.1	0.4	0.0	5.9	12.6	3.1	7.0	2.6	6.4	0.0	0.0	506.0	25.1	0.1	5.7	0.0	0.4	0.0	2.3	0.0	0.2	9.0	1.7	650.9	0.1	4.1	4.0	21.5	3.7	5.9	8.0	5.4	105.9	0.9	34.0	0.0	491.6	367.4	8.0	0.0	0.4	0.0	1.8	0.1	2.0	7.1	3.8	13.1	22.7	17.3	0.9	4.8	0.2	1.0	0.0	0.2	0.3	0.2	0.2
DZIP1	"DZIP, KIAA0996"	ENSG00000134874	"DAZ interacting zinc finger protein 1"	Q86YF9	13	95578202-95644706	"Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 384.1;Late spermatids: 774.5;Spermatocytes: 222.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054891, HPA057272"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Centrosome"		"HPA054891: AB_2682631, HPA057272: AB_2683390"	"unprognostic (6.74e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.64e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.89e-3)"	5.0	3.4	8.6	2.5	8.5	0.1	4.4	6.9	9.4	12.4	5.7	10.7	1.0	12.6	7.2	3.2	12.4	5.1	4.3	7.7	8.7	11.4	1.1	4.6	2.2	7.0	8.1	16.3	9.9	0.4	10.3	2.5	6.1	6.4	1.8	4.0	2.3	6.2	1.3	1.6	4.0	6.1	5.6	1.5	4.7	14.8	11.5	0.8	2.4	2.1	1.7	7.9	7.1	7.1	1.1	4.2	17.5	15.5	14.5	16.2	3.6	11.0	13.2	12.7	15.2	0.2	0.0	0.0	2.5	9.4	5.5	0.0	11.7	3.8	14.8	1.1	9.6	15.6	4.4	11.0	9.2	0.1	0.0	11.7	0.4	4.2	5.8	23.1	9.1	1.1	0.0	0.1	11.4	0.0	0.0	0.0	8.6	0.0	0.4	0.0	10.1	0.0	15.4	1.8	4.2	9.9	8.3	0.0	0.6	22.4	0.0	7.3	1.3	12.3	5.3	1.8	8.8	0.0	0.0	0.0	3.5	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.6	8.5	6.9	9.4	7.7	8.7	7.0	8.1	6.1	5.6	11.5	7.1	2.4	0.0	0.0	63.6	0.0	0.6	1.1	3.1	4.6	18.7	0.6	3.4	3.5	2.8	3.9	1.8	4.2	4.5	0.0	0.0	7.9	20.8	384.1	37.2	34.1	2.5	0.0	0.0	86.8	0.2	2.6	19.0	0.5	2.7	0.0	3.1	2.9	0.4	0.7	6.7	95.7	0.0	4.1	0.3	1.5	774.5	38.8	1.2	3.6	19.7	2.0	8.3	0.0	106.6	5.1	0.6	0.0	43.6	0.0	0.8	0.0	24.4	19.4	1.5	19.7	18.2	15.8	222.8	12.6	1.2	1.0	1.8	0.5	20.8	0.0	0.3
EYA4	"CMD1J, DFNA10"	ENSG00000112319	"EYA transcriptional coactivator and phosphatase 4"	O95677	6	133240598-133532128	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Cardiomyopathy, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 27.6;tongue: 21.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 46.0;Inhibitory neurons: 139.0;Oligodendrocytes: 79.2;Skeletal myocytes: 26.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 25.4;GAMG: 25.6;HeLa: 74.3;RH-30: 23.8;U-87 MG: 24.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004805, HPA038771, HPA038772"	Enhanced		Approved	Nucleoplasm		No	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-9)"	"unprognostic (1.64e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.27e-4)"	"unprognostic (1.82e-3)"	"unprognostic (6.67e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.51e-2)"	1.1	2.5	2.6	0.1	1.9	0.0	0.4	2.2	1.9	2.6	13.3	0.2	0.2	0.5	1.2	0.4	7.4	0.5	5.8	2.3	1.2	5.0	0.0	1.8	0.1	5.6	7.9	1.2	0.2	0.0	0.8	0.0	4.5	5.7	0.2	0.1	0.2	11.8	27.6	0.0	0.1	0.3	4.5	0.4	0.4	3.0	3.3	6.6	2.1	21.3	0.5	2.2	2.3	4.9	0.0	25.4	2.4	0.0	0.0	0.0	0.0	0.0	20.4	0.5	2.9	0.1	0.1	0.1	19.6	0.0	25.6	0.0	15.4	6.7	0.0	0.0	20.2	2.8	74.3	0.0	0.6	0.0	6.8	5.1	0.0	14.4	4.5	3.4	0.0	0.0	0.0	10.7	8.1	0.0	0.0	0.0	0.0	0.3	1.6	0.3	23.8	0.0	0.0	3.9	3.7	4.1	0.2	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	18.4	7.2	3.4	0.0	24.6	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.9	2.2	1.9	2.3	1.2	5.6	7.9	4.5	4.5	3.3	4.9	0.3	12.8	1.8	2.6	0.0	0.1	0.1	13.3	0.0	0.0	0.0	0.0	14.4	0.0	6.7	46.0	0.0	0.0	0.0	0.1	0.0	0.1	4.4	0.1	0.1	0.5	1.8	0.0	4.8	0.2	0.0	2.9	0.0	0.1	0.0	1.5	0.4	0.1	0.0	0.0	139.0	0.0	8.2	1.0	0.0	2.6	0.6	0.2	0.0	2.8	7.2	0.0	0.0	1.5	79.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	4.8	0.0	0.0	26.2	3.3	7.9	7.1	0.0	0.0	0.0	0.1	1.5	0.0	0.2
FKTN	"FCMD, LGMD2M"	ENSG00000106692	Fukutin	O75072	9	105558122-105653820	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Transferase	"Cardiomyopathy, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 49.4;Inhibitory neurons: 51.6;Oligodendrocyte precursor cells: 40.7;Oligodendrocytes: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA012820	Approved					NA	NA				"Cluster 51: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA012820: AB_1848478"	"unprognostic (3.48e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (9.42e-4)"	"unprognostic (2.41e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.76e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (3.02e-4)"	4.1	5.0	3.4	3.7	4.1	1.1	5.7	3.8	4.1	4.6	3.0	4.6	3.7	5.0	4.9	4.1	4.8	3.6	4.4	3.4	4.1	5.0	4.6	3.3	3.9	3.3	3.6	6.0	7.2	7.4	5.6	4.6	3.4	4.5	5.6	10.0	4.1	4.1	3.8	5.3	4.3	4.2	3.6	4.6	5.6	3.7	3.8	3.3	6.2	5.1	3.6	4.4	4.4	5.2	7.1	5.4	8.3	7.1	13.5	20.3	9.5	13.4	12.5	8.1	9.0	4.6	11.1	5.2	7.2	14.3	7.5	12.3	7.9	10.3	12.3	7.6	5.5	3.9	8.3	3.3	9.7	6.9	3.3	15.9	9.8	11.7	17.6	12.6	8.5	6.6	4.4	6.2	18.4	8.8	6.1	5.1	6.5	7.5	8.2	4.3	17.1	3.6	8.5	2.7	7.7	6.7	9.4	10.4	7.8	7.9	19.3	5.3	10.7	8.9	4.7	18.1	12.4	8.4	10.9	3.4	9.0	7.7	13.0	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.5	0.3	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.1	3.4	4.1	3.8	4.1	3.4	4.1	3.3	3.6	3.4	3.6	3.8	5.2	6.3	6.4	7.7	27.4	5.0	3.2	4.2	5.5	5.7	21.9	6.0	6.1	9.0	8.6	5.7	7.3	8.4	2.4	5.5	4.9	1.9	4.5	2.6	5.2	11.4	5.7	4.2	3.8	49.4	3.3	4.1	10.9	7.7	5.6	2.5	13.5	7.5	5.3	4.4	23.5	51.6	6.4	0.0	3.8	2.1	0.8	6.2	4.1	8.8	13.1	3.4	6.6	5.2	40.7	66.5	3.0	4.3	9.1	3.5	3.9	2.7	3.7	7.3	17.6	6.6	12.9	5.8	12.5	9.1	7.5	4.0	0.8	3.6	10.4	7.5	2.8
GATA4		ENSG00000136574	"GATA binding protein 4"	P43694	8	11676959-11760002	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Atrial septal defect, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 88.6;ovary: 95.4;pancreas: 53.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 41.4;Exocrine glandular cells: 33.7;Gastric mucus-secreting cells: 61.2;Granulosa cells: 158.4;Hepatic stellate cells: 57.8;Late spermatids: 37.0;Leydig cells: 41.3;Peritubular cells: 41.3;Theca cells: 80.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 21.8;testis cancer: 12.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 19.7;HHSteC: 20.9;OE19: 6.2;SH-SY5Y: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013125, HPA073899"	Uncertain		Supported	"Nuclear bodies"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"		"CAB013125: AB_2533804, HPA073899: AB_2686641"	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.68e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.71e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.02e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.67e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"		"unprognostic (1.29e-2)"	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	20.2	0.2	0.0	0.0	2.3	4.0	88.6	0.0	0.0	0.0	36.6	0.2	0.0	0.0	0.0	95.4	53.5	0.0	0.1	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.1	35.2	32.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	1.2	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	19.7	20.9	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	0.2	1.3	0.0	0.0	1.5	20.5	0.0	0.0	0.1	3.9	1.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.4	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	16.1	0.0	0.1	6.1	0.0	0.0	0.1	33.7	0.2	12.0	61.2	0.0	0.0	158.4	57.8	12.1	0.6	0.0	0.1	0.8	0.0	2.8	0.0	37.0	41.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.5	0.0	41.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	5.3	2.4	2.2	0.0	0.0	0.8	0.1	80.1	0.9	0.0
GATA6		ENSG00000141448	"GATA binding protein 6"	Q92908	18	22169589-22202528	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 57.8;ovary: 73.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 97.6;Gastric mucus-secreting cells: 100.9;Granulosa cells: 52.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 26.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	23	"basophil: 4.0"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 54.8;CACO-2: 69.7;hTERT-RPE1: 25.5;OE19: 37.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB011581, HPA066629"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB011581: AB_732529, HPA066629: AB_2685695"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.45e-3)"	"prognostic unfavorable (1.92e-9)"	"unprognostic (8.75e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-2)"	22.2	57.8	0.0	2.5	0.2	0.0	3.8	0.0	0.3	4.9	2.8	11.4	22.8	19.8	1.2	0.8	28.9	11.1	43.9	0.1	0.0	3.0	12.6	14.8	1.9	0.1	0.0	73.0	22.7	0.3	0.6	6.5	0.0	5.5	11.0	0.1	0.8	0.7	0.8	1.5	20.7	9.5	0.2	15.0	49.6	6.3	0.1	0.4	5.3	0.6	0.2	23.0	3.2	0.0	10.1	1.4	0.0	0.0	2.1	1.0	54.8	0.3	0.4	0.8	1.0	69.7	3.8	0.0	3.2	1.2	3.4	10.8	0.4	4.5	1.4	0.0	13.6	0.0	4.3	6.1	14.3	0.6	0.6	0.4	8.9	12.1	9.1	25.5	9.5	0.0	0.5	0.0	0.0	1.5	0.0	0.2	0.1	37.6	9.8	0.0	1.1	0.2	0.4	2.8	0.9	0.1	10.7	6.1	3.0	2.7	1.7	0.0	0.7	1.4	1.6	11.4	1.7	0.0	0.0	0.0	6.2	0.3	9.9	4.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	7.3	44.8	30.2	0.0	0.0	0.9	4.0	4.6	1.8	0.0	3.4	2.7	97.6	30.0	6.1	0.0	0.0	0.9	0.9	50.0	0.0	28.4	44.7	6.3	6.3	11.5	26.0	2.7	0.1	19.6	11.2	24.4	100.9	16.6	5.1	52.9	28.5	11.1	1.6	0.0	0.1	45.8	2.0	0.6	0.9	8.8	3.4	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.2	36.8	27.7	10.1	0.2	4.1	43.3	0.0	3.9	0.0	32.9	0.4	8.6	1.4	1.4	0.9	0.9	1.9	1.3	11.4	47.2	2.9
GATAD1	"FLJ22489, ODAG, RG083M05.2"	ENSG00000157259	"GATA zinc finger domain containing 1"	Q8WUU5	7	92447482-92460075	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 234.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006105, HPA072785"			Enhanced	Nucleoplasm		Yes	No			"Cluster 17: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA006105: AB_1078956, HPA072785: AB_2686556"	"unprognostic (8.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.31e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.65e-3)"	"unprognostic (6.43e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.98e-3)"	22.7	22.1	9.5	7.3	12.8	6.2	22.2	10.1	10.9	26.8	9.7	22.3	11.2	21.4	18.3	14.6	26.5	11.8	16.2	9.6	10.5	21.4	20.1	20.1	8.7	12.1	11.5	33.6	29.4	15.5	23.1	12.4	12.4	23.9	11.3	13.2	18.4	12.4	10.8	14.0	18.6	11.7	10.4	20.2	21.6	10.2	12.0	6.7	26.0	5.7	7.3	22.0	20.2	16.0	12.3	7.5	15.3	16.1	19.7	22.4	12.1	11.9	17.8	12.4	16.9	8.5	18.5	9.1	15.9	8.9	28.9	14.3	10.7	8.1	13.0	15.8	11.3	11.6	8.0	11.6	27.4	14.1	30.0	16.8	19.3	9.5	27.4	22.3	14.2	6.6	24.2	19.0	13.8	17.7	5.5	20.2	20.8	19.9	14.4	7.2	18.1	12.1	13.6	13.4	13.4	21.4	15.7	16.5	23.7	19.0	9.2	18.8	13.0	19.7	14.9	30.0	15.5	15.2	5.5	10.0	16.6	9.0	27.6	2.9	1.1	1.2	0.7	0.7	0.7	0.9	0.5	0.5	0.6	1.4	0.6	0.9	1.0	0.9	0.8	1.2	0.6	0.4	9.5	12.8	10.1	10.9	9.6	10.5	12.1	11.5	12.4	10.4	12.0	16.0	59.0	48.1	64.6	98.9	26.5	13.3	37.8	14.6	26.7	79.0	33.3	35.1	16.3	24.3	26.6	47.8	70.9	25.7	28.8	30.2	3.9	22.4	3.8	46.7	48.3	34.7	16.8	24.6	77.8	22.0	23.4	38.1	30.5	51.6	53.2	115.1	37.1	21.7	24.6	62.2	70.4	33.3	2.0	30.8	23.7	5.0	45.4	40.2	21.4	54.4	25.8	65.3	32.0	108.6	234.9	27.0	30.7	35.0	13.6	45.9	33.2	18.2	36.1	114.1	19.7	54.3	36.7	14.1	10.4	23.6	17.8	20.7	24.7	56.0	31.9	35.7
GDF1		ENSG00000130283	"Growth differentiation factor 1"	P27539	19	18868545-18896158	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Cytokine, Growth factor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 3.7;pituitary gland: 1.5;skeletal muscle: 3.9;testis: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.8;SH-SY5Y: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 38: EFO-21 - Unknown function"																						0.0	0.1	1.5	0.0	2.1	0.0	0.1	1.4	3.6	0.3	0.5	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.6	1.7	1.1	0.0	0.0	0.0	0.0	3.0	2.0	0.4	0.1	0.0	1.5	0.0	2.3	0.2	0.0	0.0	0.1	0.0	3.9	0.0	0.1	0.0	1.9	0.0	0.2	4.9	3.7	0.0	0.1	0.0	0.0	0.3	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.1	1.4	3.6	1.7	1.1	3.0	2.0	2.3	1.9	3.7	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GJA5	CX40	ENSG00000265107	"Gap junction protein alpha 5"	P36382	1	147756199-147773362	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Atrial fibrillation, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 36.7;placenta: 85.4"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 135.3;Extravillous trophoblasts: 345.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SK-BR-3: 133.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB013080, HPA071370"	Enhanced					NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB013080: AB_2533263, HPA071370: "	"unprognostic (1.25e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.88e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.27e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.44e-1)"	"unprognostic (4.41e-2)"	"unprognostic (3.43e-2)"	"unprognostic (8.93e-2)"	18.6	2.2	2.5	6.0	3.4	0.0	10.5	2.4	4.1	5.5	2.6	4.7	3.4	10.8	2.3	4.8	8.2	6.3	36.7	2.4	2.2	17.1	1.2	26.4	1.7	2.8	2.6	4.0	2.6	3.4	0.5	85.4	2.5	4.0	4.1	0.2	1.6	9.4	2.1	1.4	5.9	8.2	2.6	3.9	3.0	2.9	2.7	0.6	5.3	8.9	2.3	7.4	3.8	2.7	1.8	0.0	0.3	0.0	0.0	0.0	5.7	4.4	2.2	2.2	0.5	0.1	0.2	0.0	1.4	0.7	0.0	0.3	0.0	9.3	3.5	0.0	0.3	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.1	13.1	0.0	0.1	0.1	0.2	133.8	0.0	12.2	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.4	2.4	4.1	2.4	2.2	2.8	2.6	2.5	2.6	2.7	2.7	14.3	3.2	4.2	0.0	1.0	0.0	0.0	0.0	0.6	0.0	0.2	1.5	17.7	0.0	0.0	3.7	0.0	135.3	0.1	0.0	0.0	0.0	7.6	0.1	0.3	14.7	0.0	0.0	0.0	0.0	345.3	3.7	0.0	0.1	0.0	19.9	37.9	0.0	15.8	0.0	0.0	0.0	0.0	0.6	0.0	9.8	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	39.5	0.5	11.1	4.3	0.4	0.2	0.3	31.1	0.5	0.1	0.0	0.1
GNAI2	"GIP, GNAI2B"	ENSG00000114353	"G protein subunit alpha i2"	P04899	3	50226292-50259362	"Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 656.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007704	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		4000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA007704: AB_1849230"	"prognostic favorable (1.03e-4)"	"unprognostic (3.89e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.08e-3)"	"unprognostic (6.01e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.38e-1)"	210.2	100.3	155.2	217.9	167.3	367.1	152.8	166.3	181.6	146.0	120.2	142.1	69.9	141.7	66.9	124.4	136.9	152.5	157.1	144.3	184.6	79.4	126.5	214.5	251.3	199.8	170.2	147.7	64.1	66.9	99.2	241.8	194.8	103.6	64.3	35.6	71.9	156.9	69.3	87.0	103.0	154.0	173.6	262.1	73.6	69.6	173.3	160.3	101.3	89.4	170.4	169.7	108.4	193.2	128.2	63.0	186.3	197.6	220.7	277.5	35.5	271.1	399.6	354.9	361.1	70.4	173.2	149.1	119.2	567.0	193.4	100.1	132.8	350.3	222.8	331.2	50.9	364.8	158.0	110.2	219.8	329.2	479.8	270.3	152.9	319.1	129.8	289.6	837.8	124.1	26.1	307.1	357.5	155.7	313.6	433.0	109.7	59.0	302.4	185.0	89.8	219.7	232.6	130.9	48.4	86.1	189.5	57.1	124.4	150.4	94.3	346.1	792.3	330.9	187.5	309.2	274.7	199.4	278.3	127.0	373.6	466.9	398.1	16.6	59.3	113.7	33.7	80.9	20.2	28.8	26.8	34.3	57.3	26.1	20.2	25.8	145.2	23.5	74.5	47.2	34.0	27.3	155.2	167.3	166.3	181.6	144.3	184.6	199.8	170.2	194.8	173.6	173.3	193.2	656.8	41.7	32.1	25.1	119.5	56.7	59.7	32.3	45.5	29.0	61.6	83.8	22.9	55.8	26.6	44.1	14.6	79.5	311.4	11.7	5.9	124.3	203.3	57.8	115.7	340.3	92.2	52.1	12.4	60.5	84.4	101.9	21.9	71.8	89.9	150.0	221.3	79.7	336.0	6.7	14.8	24.6	18.3	342.7	291.7	302.0	90.7	386.1	83.6	58.1	356.6	292.6	151.4	26.7	45.4	160.3	40.9	95.5	104.8	46.1	30.3	24.5	24.4	21.9	52.6	85.3	163.1	16.6	22.6	37.6	62.9	116.4	164.9	156.3	20.5	70.1
GPD1L	KIAA0089	ENSG00000152642	"Glycerol-3-phosphate dehydrogenase 1 like"	Q8N335	3	32105689-32168709	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Brugada syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 158.4;tongue: 253.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 154.1;Distal enterocytes: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 136.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (1.23e-1)"	"unprognostic (3.12e-2)"	"prognostic favorable (7.05e-4)"	"unprognostic (2.63e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (1.35e-5)"	"prognostic favorable (5.71e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.33e-15)"	"unprognostic (1.50e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.31e-3)"	"unprognostic (5.51e-3)"	39.0	44.7	18.2	8.3	20.1	6.9	30.6	17.2	21.2	22.8	27.1	40.1	26.5	11.6	9.8	40.9	19.1	9.2	124.8	21.2	20.5	34.2	2.8	31.3	9.0	19.2	18.6	16.6	21.6	32.8	5.9	20.8	19.3	59.9	36.7	9.8	22.0	41.2	158.4	10.3	29.0	16.6	20.5	12.8	29.7	6.1	18.3	6.8	40.3	253.1	10.2	31.0	12.9	21.9	11.1	10.0	3.5	15.3	49.3	11.9	136.1	8.8	3.1	9.2	7.1	10.7	5.2	19.4	13.2	6.2	11.3	12.6	23.4	9.3	11.6	8.3	21.4	11.3	13.2	16.8	12.4	29.4	39.3	35.5	12.1	8.9	12.5	9.4	16.3	15.7	8.0	6.1	7.3	15.1	12.6	11.0	2.1	27.6	44.8	23.1	15.7	40.0	14.6	66.8	15.1	15.0	6.7	61.1	25.0	4.8	38.7	14.1	8.6	10.5	4.9	16.3	23.6	4.3	2.0	19.3	24.0	22.3	6.0	0.5	2.8	5.7	3.3	3.2	8.0	1.5	4.1	4.0	5.6	1.2	2.5	3.7	1.4	7.4	2.1	4.4	8.8	2.8	18.2	20.1	17.2	21.2	21.2	20.5	19.2	18.6	19.3	20.5	18.3	21.9	10.2	28.9	41.8	1.3	4.1	4.6	5.3	3.5	8.6	4.1	20.3	10.7	154.1	2.8	18.6	9.2	2.1	36.4	10.8	75.2	39.2	2.0	8.0	5.3	4.4	10.5	7.8	6.9	23.1	3.7	6.1	10.5	17.3	9.2	39.3	9.8	13.2	0.7	10.0	1.7	23.7	21.3	26.4	6.3	5.7	20.7	5.9	4.4	8.8	24.4	2.3	32.9	7.2	3.0	11.1	4.3	21.6	12.8	8.7	13.8	33.9	18.4	15.0	3.9	0.0	8.0	8.7	0.8	2.1	32.3	7.0	27.1	10.4	3.3	26.9	8.5
HCN4		ENSG00000138622	"Hyperpolarization activated cyclic nucleotide gated potassium channel 4"	Q9Y3Q4	15	73319859-73368958	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Brugada syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"brain: 8.5;heart muscle: 8.4;testis: 7.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 29.4;Late spermatids: 49.5"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 3.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CACO-2: 1.7;HDLM-2: 1.1;NTERA-2: 4.9;SuSa: 1.2;U-2 OS: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA073174	Approved					NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA073174: "	"unprognostic (2.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.14e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.05e-5)"	"unprognostic (5.56e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (7.95e-2)"	0.0	0.4	3.6	0.0	0.7	0.0	0.0	2.2	1.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	8.4	1.0	2.8	0.0	0.0	0.0	0.0	5.0	4.2	0.0	0.1	0.0	0.5	0.0	4.6	0.1	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.0	2.5	0.0	0.1	7.2	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.7	2.2	1.8	1.0	2.8	5.0	4.2	4.6	2.5	8.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	29.4	0.6	0.0	0.2	1.8	0.0	1.5	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	49.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.3	1.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HLA-DPA1	HLA-DP1A	ENSG00000231389	"Major histocompatibility complex, class II, DP alpha 1"	P20036	6	33064569-33080775	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 319.9;lymphoid tissue: 359.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 1387.3;Kupffer cells: 1794.6;Langerhans cells: 8122.8;Macrophages: 2736.9;monocytes: 2940.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 81.8;intermediate monocyte: 187.4;memory B-cell: 150.4;myeloid DC: 296.0;naive B-cell: 136.5;non-classical monocyte: 124.1;plasmacytoid DC: 82.6"	"Group enriched"	"Detected in all"	7	"B-cells: 150.4;dendritic cells: 296.0;monocytes: 187.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 37.2;HDLM-2: 115.9;REH: 30.3;U-698: 26.1"									HPA017967	Enhanced		Supported	Vesicles		NA	NA		240000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA017967: AB_1853929"	"unprognostic (8.93e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.64e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.82e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.69e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.06e-1)"	180.8	108.0	2.2	33.4	2.0	12.8	138.4	2.7	3.3	76.7	2.5	72.1	20.2	55.3	8.3	43.1	63.0	13.0	62.0	2.0	3.4	99.0	36.8	319.9	51.3	4.9	2.8	24.9	28.6	5.9	58.0	3.4	4.3	64.0	16.1	2.0	59.5	16.2	29.5	66.3	174.4	14.6	4.3	359.6	52.1	13.4	3.1	30.2	76.6	7.3	51.5	58.6	60.0	4.4	0.1	0.0	0.0	0.0	0.8	1.3	1.1	0.4	0.4	0.5	0.0	0.0	4.9	37.2	5.0	0.9	7.1	0.0	0.0	0.0	0.1	115.9	2.5	6.2	0.0	0.0	0.1	0.0	11.6	1.7	0.0	2.2	0.0	0.0	0.6	0.0	0.0	3.3	0.0	0.0	0.1	0.1	0.6	0.0	0.0	30.3	0.0	4.9	0.1	0.0	0.1	0.0	0.0	0.0	2.9	0.0	0.0	1.3	2.6	7.8	0.1	0.1	0.0	5.6	0.9	26.1	12.2	0.2	4.4	2.2	81.8	6.6	21.6	187.4	5.7	150.4	9.6	23.9	296.0	136.5	3.4	15.7	3.0	20.9	124.1	82.6	29.2	136.0	2.2	2.0	2.7	3.3	2.0	3.4	4.9	2.8	4.3	4.3	3.1	4.4	621.8	83.3	404.3	0.3	1387.3	206.7	7.2	12.4	9.1	2.8	41.2	110.4	12.1	64.3	107.3	23.9	0.0	4.2	574.9	10.6	9.8	36.4	2.8	1.2	4.1	337.8	10.2	80.3	0.5	18.8	9.3	53.7	48.4	2.8	64.6	14.3	62.2	7.5	1153.8	5.0	0.9	18.2	12.2	1794.6	8122.8	11.7	18.0	2736.9	302.4	32.8	2940.3	5.1	94.7	0.0	0.1	4.7	5.4	27.4	100.2	10.6	114.0	42.7	129.2	5.0	52.6	14.7	29.8	1.3	4.8	6.0	175.2	6.8	157.8	11.5	28.6	34.4
HLA-DPB1	HLA-DP1B	ENSG00000223865	"Major histocompatibility complex, class II, DP beta 1"	P04440	6	33075990-33089696	"Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 278.7;lymphoid tissue: 409.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 1569.6;Kupffer cells: 2374.2;Langerhans cells: 12627.8;Macrophages: 2453.8;monocytes: 3754.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 285.5"	"Group enriched"	"Detected in all"	10	"B-cells: 227.8;dendritic cells: 285.5;monocytes: 137.5"	"Group enriched"	"Detected in some"	6	"HDLM-2: 65.9;REH: 26.5"									"HPA011078, HPA058509"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA		470000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Cell Junctions"	Nucleoplasm	"HPA011078: AB_1079378, HPA058509: AB_2683737"	"unprognostic (5.44e-3)"	"unprognostic (7.03e-3)"	"unprognostic (9.84e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.77e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.85e-1)"	151.6	101.3	1.0	42.0	1.0	5.8	112.8	3.3	1.3	68.2	0.9	69.4	12.4	50.2	2.9	43.9	55.7	17.2	51.1	0.8	1.8	96.1	38.6	278.7	66.7	1.8	1.3	26.2	32.4	1.0	51.5	0.8	1.8	70.3	2.5	1.5	57.2	6.4	25.1	72.3	176.5	4.7	2.1	409.4	54.1	12.8	1.0	10.9	69.5	1.3	42.2	49.2	56.5	3.0	0.0	0.0	0.1	0.0	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	6.2	0.2	0.0	0.1	0.0	0.0	0.0	65.9	1.9	1.5	0.0	0.0	0.0	0.0	0.5	1.4	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.9	0.0	0.0	26.5	0.1	0.3	0.3	0.0	0.9	0.0	0.0	0.3	0.1	0.4	0.0	0.1	1.8	0.1	0.2	0.0	0.0	7.2	0.3	4.4	1.1	0.0	0.0	0.5	59.6	4.0	14.8	137.5	1.8	226.6	5.1	22.2	285.5	227.8	2.3	11.9	1.6	8.2	60.3	77.5	22.7	107.8	1.0	1.0	3.3	1.3	0.8	1.8	1.8	1.3	1.8	2.1	1.0	3.0	354.8	67.3	330.7	1.3	1569.6	300.5	26.0	5.6	19.4	26.9	54.0	123.6	10.3	67.2	62.3	29.5	16.7	4.8	692.9	7.8	3.9	58.3	3.6	2.0	16.3	297.8	9.6	87.9	1.3	15.6	8.1	62.3	48.4	2.7	61.6	13.6	97.1	8.8	1099.4	8.4	1.6	13.0	10.2	2374.2	12627.8	10.1	27.4	2453.8	323.7	20.6	3754.7	43.3	203.9	2.5	0.2	7.4	10.0	21.1	50.9	28.2	154.7	60.2	54.4	21.9	46.0	21.4	47.5	1.3	7.8	6.4	233.3	9.0	200.7	3.9	23.0	51.7
HLA-DQA1	"CELIAC1, HLA-DQA"	ENSG00000196735	"Major histocompatibility complex, class II, DQ alpha 1"	P01909	6	32628179-32647062	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 333.9;lymphoid tissue: 335.8"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 4114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 666.6"	"Group enriched"	"Detected in all"	19	"B-cells: 287.6;dendritic cells: 666.6;monocytes: 257.6"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 1419.1"									HPA012315	Enhanced					NA	NA		200000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA012315: AB_1853930"	"unprognostic (4.24e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.36e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-1)"	61.7	45.7	2.3	111.0	2.2	7.1	41.6	2.4	2.8	49.9	5.2	76.8	0.1	27.7	32.2	32.1	29.1	127.4	20.8	1.6	5.1	39.6	95.1	333.9	335.8	4.3	2.6	18.6	15.0	2.6	15.2	13.7	2.7	15.1	115.8	1.9	34.8	7.8	7.5	30.0	74.0	19.2	5.4	180.0	103.3	12.2	3.4	234.3	26.0	0.0	322.3	175.9	16.3	11.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	213.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1419.1	0.9	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	4.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	2.4	0.4	0.0	0.1	0.6	0.6	63.2	1.5	156.1	24.4	0.0	0.0	1.9	105.8	0.5	2.4	257.6	1.0	287.6	3.3	16.5	666.6	274.1	0.4	4.3	3.0	8.2	68.3	162.7	21.6	129.0	2.3	2.2	2.4	2.8	1.6	5.1	4.3	2.6	2.7	5.4	3.4	11.1	67.9	12.8	86.3	0.0	972.8	50.2	0.4	4.3	4.6	0.1	9.8	28.6	2.1	7.2	19.4	0.0	2.1	0.8	179.8	0.9	1.9	4.6	0.6	0.5	0.4	97.4	0.0	38.3	0.1	4.6	2.4	14.7	10.7	0.9	50.4	0.8	12.8	0.6	381.0	0.0	0.1	0.4	2.0	518.6	4114.3	1.3	3.1	874.3	71.2	12.2	957.1	1.0	4.1	0.0	0.2	2.1	0.1	0.0	96.1	1.5	1.8	6.5	27.3	2.5	6.6	1.2	5.3	0.0	0.7	2.5	41.6	2.1	56.0	1.2	2.7	7.6
HLA-DQA2	HLA-DXA	ENSG00000237541	"Major histocompatibility complex, class II, DQ alpha 2"	P01906	6	32741391-32747198	"Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 20.8;lymphoid tissue: 27.1"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 1196.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 64: Macrophages - Immune response"		"Cluster 41: Macrophages - Immune response"				"unprognostic (4.06e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.85e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.48e-2)"	10.9	4.5	0.0	0.0	0.0	0.0	7.2	0.0	0.0	3.1	0.0	3.9	0.0	2.1	0.0	3.0	2.8	0.1	2.3	0.0	0.0	5.8	1.7	20.8	0.0	0.0	0.0	0.9	1.2	0.0	2.5	0.0	0.0	2.5	0.0	0.0	3.4	0.0	1.4	8.4	11.6	0.0	0.0	27.1	2.9	0.6	0.0	0.3	3.7	0.0	0.3	3.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.1	3.2	3.6	0.0	179.2	23.5	0.3	1.8	1.2	0.0	2.5	1.3	0.5	0.0	7.5	3.7	0.0	0.2	144.1	0.1	0.0	0.2	0.7	0.1	0.2	20.6	2.4	0.4	0.0	0.0	0.8	1.6	0.0	0.3	0.0	0.8	2.2	0.3	110.0	0.0	0.0	0.0	0.0	78.9	1196.5	2.0	1.2	243.1	24.9	0.0	125.3	0.0	8.2	0.0	0.0	0.2	0.0	0.0	9.5	0.0	0.0	11.2	12.4	0.0	6.6	0.7	1.2	0.1	0.3	0.1	23.3	0.4	13.8	0.0	0.0	0.7
HLA-DQB1	"CELIAC1, HLA-DQB, IDDM1"	ENSG00000179344	"Major histocompatibility complex, class II, DQ beta 1"		6	32659467-32668383	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"lung: 179.1;lymphoid tissue: 301.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 995.1;Langerhans cells: 4144.8;Macrophages: 1090.5;monocytes: 1038.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 153.5;intermediate monocyte: 142.9;memory B-cell: 159.2;myeloid DC: 386.3;naive B-cell: 169.1;plasmacytoid DC: 116.5"	"Group enriched"	"Detected in all"	6	"B-cells: 169.1;dendritic cells: 386.3;monocytes: 153.5"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 599.9"									HPA013667	Enhanced		Supported	"Golgi apparatus,Rods & Rings"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Rods & Rings"	"Golgi apparatus"	"HPA013667: AB_1853932"	"unprognostic (8.60e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (4.48e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.40e-1)"	56.6	23.9	2.2	77.8	2.2	40.0	45.3	2.7	3.1	19.9	3.0	45.8	0.2	18.9	126.9	21.3	22.2	43.6	21.6	2.0	3.6	34.3	37.1	179.1	301.8	4.7	3.8	7.4	14.3	10.6	21.3	10.1	2.9	17.1	39.0	1.7	24.2	11.9	9.6	31.8	78.0	11.2	4.6	139.3	128.0	7.0	3.1	108.2	26.3	0.0	122.3	89.9	16.9	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	93.9	2.2	0.0	0.0	19.2	0.0	19.2	0.0	599.9	13.4	0.0	0.0	0.0	0.0	0.2	7.8	0.0	3.0	0.0	0.0	0.0	0.0	2.9	0.0	1.8	0.0	7.2	0.1	0.9	0.1	0.0	0.0	0.0	0.1	0.2	0.0	1.3	0.0	0.1	1.6	1.1	1.4	0.0	3.3	10.9	0.2	0.0	0.6	0.8	0.4	68.7	2.1	66.0	47.1	0.1	0.0	0.3	153.5	27.9	12.8	142.9	6.6	159.2	6.9	20.0	386.3	169.1	0.4	6.3	11.8	10.4	41.1	116.5	41.1	217.0	2.2	2.2	2.7	3.1	2.0	3.6	4.7	3.8	2.9	4.6	3.1	5.5	162.9	41.7	181.1	0.0	995.1	89.9	8.7	23.1	31.3	5.1	16.8	32.1	3.2	27.1	40.7	18.4	10.4	1.4	188.2	10.3	7.9	38.8	16.5	4.1	1.0	135.3	22.8	37.2	0.2	20.0	3.0	18.8	41.8	5.2	38.5	7.9	25.0	2.3	422.1	0.0	0.8	24.7	12.2	487.3	4144.8	7.5	6.5	1090.5	97.8	8.4	1038.0	1.1	25.7	0.0	0.1	28.3	27.4	9.8	86.9	8.7	417.9	18.5	53.0	2.7	6.6	4.8	9.6	2.7	2.5	18.5	66.3	3.0	84.5	0.9	36.1	49.1
HLA-DRB1	HLA-DR1B	ENSG00000196126	"Major histocompatibility complex, class II, DR beta 1"	P01911	6	32578769-32589848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 581.3;lymphoid tissue: 651.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 2149.9;Langerhans cells: 11630.1;Macrophages: 3622.3;monocytes: 3104.1;Proximal enterocytes: 1849.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 47.5"	"Immune cell enhanced"	"Detected in all"		"myeloid DC: 749.2"	"Group enriched"	"Detected in all"	9	"B-cells: 257.9;dendritic cells: 749.2;monocytes: 371.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 1181.9;HMC-1: 159.7;THP-1: 140.4;U-266/70: 150.3;U-698: 202.5;U-87 MG: 308.9"									"CAB015400, CAB034021, HPA043151"	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"CAB015400: AB_784538, CAB034021: AB_1124844, HPA043151: AB_2678342"	"unprognostic (3.69e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.56e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.28e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.53e-1)"	311.4	162.1	7.2	220.8	7.8	61.3	239.4	6.4	47.5	121.4	11.1	113.5	2.4	90.3	140.6	71.7	119.4	66.9	134.6	6.2	11.4	217.5	100.6	581.3	651.4	6.8	7.1	40.4	50.8	0.0	80.2	13.6	6.9	88.4	135.3	5.2	93.8	0.4	58.3	122.5	353.2	11.1	9.9	516.2	232.3	25.5	9.2	254.3	129.5	0.0	257.4	116.2	91.5	13.4	0.6	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	2.4	17.1	0.0	0.0	1.9	0.0	4.7	0.0	1181.9	12.9	0.1	0.5	0.0	0.0	0.4	159.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	12.3	0.0	28.5	0.4	2.3	0.4	0.0	0.0	4.4	0.4	0.1	0.0	0.0	0.1	0.2	6.5	0.0	26.7	1.5	4.8	140.4	0.1	0.0	0.9	2.1	0.7	150.3	4.4	202.5	308.9	5.8	0.5	2.5	323.0	53.7	12.2	371.3	2.2	225.4	9.0	27.2	749.2	257.9	1.1	12.2	8.9	21.0	223.8	147.6	35.4	411.8	7.2	7.8	6.4	47.5	6.2	11.4	6.8	7.1	6.9	9.9	9.2	13.4	1241.9	147.4	609.1	0.0	2149.9	173.6	14.1	78.2	51.8	2.0	96.0	150.9	30.5	90.1	277.5	141.6	0.0	3.7	484.0	92.2	25.4	272.8	4.6	23.9	4.0	721.5	36.0	120.8	0.0	73.8	7.0	77.9	131.0	21.6	124.0	47.9	179.9	5.0	1417.7	0.0	0.0	92.7	30.5	1755.3	11630.1	12.3	14.9	3622.3	217.1	0.0	3104.1	7.7	55.6	0.0	0.0	89.1	308.9	26.7	120.2	21.0	1849.6	218.2	357.1	10.7	26.3	16.6	47.9	2.4	3.6	27.2	147.9	6.8	245.6	52.5	152.2	125.5
JUP	"CTNNG, DP3, DPIII, PDGB, PKGB"	ENSG00000173801	"Junction plakoglobin"	P14923	17	41754604-41786931	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes, Cardiomyopathy, Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 952.2;skin 1: 932.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 315.9;Pancreatic endocrine cells: 356.2;Squamous epithelial cells: 318.3;Suprabasal keratinocytes: 383.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 13.1;eosinophil: 28.7;intermediate monocyte: 22.6;memory B-cell: 13.5;myeloid DC: 14.5;naive B-cell: 11.7;non-classical monocyte: 43.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 1090.1;OE19: 3919.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002139, HPA032047"	Supported		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		64000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"	Vesicles	"CAB002139: AB_563468, HPA032047: AB_2674124"	"unprognostic (3.96e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-3)"	"unprognostic (9.60e-2)"	"prognostic favorable (2.06e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.49e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.51e-2)"	46.5	16.0	13.6	23.6	21.6	20.7	68.6	20.8	18.9	243.7	25.8	94.9	88.1	57.0	15.3	952.2	69.9	39.8	145.1	14.6	14.3	120.7	70.9	57.1	15.7	20.7	16.2	46.2	59.6	19.9	37.3	51.5	19.6	68.0	49.0	4.7	226.4	41.8	110.8	932.4	95.7	23.1	14.8	22.7	86.3	12.5	16.2	29.6	86.4	62.2	92.0	68.7	432.6	33.6	268.8	217.8	21.7	18.5	0.2	0.1	330.6	15.3	89.2	5.9	5.2	332.6	289.0	5.4	157.8	9.7	7.5	1090.1	31.6	242.4	1.0	0.6	74.2	11.6	165.1	74.4	34.7	7.3	113.6	0.5	538.6	0.9	43.9	64.2	96.1	7.0	99.6	94.0	0.0	342.6	1.9	96.5	42.3	3919.9	36.2	313.5	0.2	202.5	165.8	674.0	52.2	38.6	33.8	652.1	1.9	98.6	545.9	8.0	152.4	0.3	14.8	6.8	5.1	8.2	31.2	5.5	1.5	12.7	2.6	3.9	13.1	28.7	0.0	22.6	0.0	13.5	0.0	0.2	14.5	11.7	0.2	0.1	0.6	0.8	43.8	4.5	0.1	5.7	13.6	21.6	20.8	18.9	14.6	14.3	20.7	16.2	19.6	14.8	16.2	33.6	56.9	60.9	36.8	4.6	10.6	196.9	218.5	104.5	100.2	1.9	87.3	77.0	87.8	48.6	80.9	132.4	4.2	98.9	1.1	315.9	27.4	212.2	28.5	112.6	21.1	55.2	66.8	3.4	0.5	135.4	167.3	25.6	136.1	247.0	11.4	16.5	41.4	34.1	14.4	0.0	1.6	125.0	81.4	7.7	32.7	8.3	5.0	10.9	12.4	2.8	6.3	18.2	0.0	7.1	13.6	356.2	223.7	0.0	3.9	220.1	141.1	35.6	45.7	4.3	6.6	37.4	18.8	2.5	4.5	318.3	383.3	185.7	6.1	3.2	129.2	301.6
KCNA5	"HK2, HPCN1, Kv1.5"	ENSG00000130037	"Potassium voltage-gated channel subfamily A member 5"	P22460	12	5043879-5046788	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"choroid plexus: 52.7;heart muscle: 39.8"	"Cell type enriched"	"Detected in some"	4	"Bipolar cells: 143.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	122	"plasmacytoid DC: 12.2"	"Lineage enriched"	"Detected in single"	122	"dendritic cells: 12.2"	"Cell line enriched"	"Detected in single"	13	"NTERA-2: 4.2"	"Low region specificity"	"Detected in many"							"HPA021516, CAB022562"	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 56: Bipolar cells - Visual perception"			"CAB022562: , HPA021516: AB_2670732"	"unprognostic (3.87e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.08e-3)"	"unprognostic (6.73e-4)"	"unprognostic (1.92e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.08e-2)"	2.2	0.5	3.1	0.2	4.6	0.1	1.4	2.2	3.8	0.8	52.7	3.6	0.3	1.5	0.3	4.9	1.8	0.8	39.8	6.0	7.5	1.1	0.2	2.8	0.2	3.7	6.2	2.4	1.3	0.0	7.1	1.9	2.7	0.6	0.5	7.5	0.3	0.9	3.8	0.5	1.2	0.5	4.3	0.5	3.6	0.2	5.4	0.1	1.3	4.8	0.4	3.6	1.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	3.1	4.6	2.2	3.8	6.0	7.5	3.7	6.2	2.7	4.3	5.4	4.7	0.7	0.0	0.0	0.3	1.6	0.9	0.0	0.0	0.0	143.1	0.0	0.0	20.9	0.0	0.0	0.0	2.1	0.1	10.7	0.0	0.0	0.0	0.0	0.0	0.1	2.9	3.5	0.0	0.3	0.0	0.0	3.7	0.0	0.0	0.0	4.2	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	3.7	0.1	1.9	0.0	1.5	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.0	13.1	3.5	29.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1
KCND3	"KSHIVB, Kv4.3, SCA19, SCA22"	ENSG00000171385	"Potassium voltage-gated channel subfamily D member 3"	Q9UK17	1	111770662-111989668	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Brugada syndrome, Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 46.8;Cardiomyocytes: 38.1;Excitatory neurons: 105.7;Hepatocytes: 37.8;Inhibitory neurons: 88.4;Oligodendrocyte precursor cells: 45.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 8.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 4.8;SCLC-21H: 10.1;U-2 OS: 1.6;WM-115: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029452	Approved					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA029452: AB_10602239"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.44e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.51e-3)"	"unprognostic (6.64e-3)"	4.5	1.5	17.0	4.7	13.8	0.2	3.0	18.1	17.9	2.3	0.0	5.9	0.9	5.3	12.6	4.1	5.1	5.5	8.4	16.2	6.4	1.3	15.4	1.7	0.5	1.0	35.6	0.5	4.5	3.9	3.4	0.5	3.4	11.3	2.4	12.7	1.6	12.0	2.6	7.1	2.2	9.8	0.9	3.2	3.3	2.0	9.2	0.3	1.1	1.7	0.5	5.9	3.2	10.8	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.4	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.2	10.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.0	13.8	18.1	17.9	16.2	6.4	1.0	35.6	3.4	0.9	9.2	10.8	1.1	0.0	9.3	18.3	0.3	7.5	11.9	2.9	0.0	46.8	7.8	1.5	38.1	0.0	1.5	0.0	4.2	0.1	0.4	1.5	0.0	0.8	35.7	0.5	14.5	1.6	0.0	2.7	105.7	23.8	0.2	3.7	0.0	0.7	0.0	0.0	1.8	37.8	0.2	30.3	88.4	0.4	4.1	0.8	1.9	32.3	18.0	0.5	3.6	1.0	0.0	6.2	0.0	45.8	8.7	4.8	1.2	1.9	0.0	21.9	0.1	0.3	0.1	4.8	0.0	0.8	1.7	1.5	1.0	2.0	6.7	0.0	0.5	0.1	2.4	13.4
KCNE1	"IsK, JLNS2, LQT5, minK"	ENSG00000180509	"Potassium voltage-gated channel subfamily E regulatory subunit 1"	P15382	21	34446688-34512210	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"choroid plexus: 13.3;fallopian tube: 10.0;heart muscle: 5.4"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 25.0;Endometrial ciliated cells: 23.8;Kupffer cells: 34.6;Macrophages: 20.3;Respiratory ciliated cells: 54.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.9"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 1.3;CACO-2: 4.0;HBF TERT88: 1.0"	"Not detected"	"Not detected"													NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (8.24e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.30e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.41e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.40e-2)"	0.5	0.1	0.4	0.3	0.3	0.5	0.9	0.4	0.9	0.7	13.3	0.1	0.0	0.3	0.2	0.2	10.0	0.0	5.4	0.5	0.1	1.7	1.1	1.5	0.0	1.0	0.9	0.0	0.0	1.0	0.3	0.1	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.2	1.4	1.0	0.2	1.5	0.9	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	1.3	0.4	4.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.2	0.4	0.3	0.4	0.9	0.5	0.1	1.0	0.9	0.6	1.4	0.9	0.3	0.8	3.2	1.8	0.0	0.6	0.8	0.8	3.3	0.0	1.9	1.0	2.0	6.4	0.0	2.8	0.0	25.0	0.0	0.3	0.8	0.0	0.7	4.8	23.8	0.6	1.9	0.0	2.7	1.4	0.4	0.4	1.2	0.5	4.6	0.0	0.0	1.4	7.3	3.7	0.0	1.6	0.0	2.0	34.6	1.2	2.2	0.3	20.3	0.0	1.9	4.5	0.1	0.0	1.5	2.2	0.5	0.1	0.0	0.1	0.4	0.9	0.2	54.2	1.9	0.0	2.1	1.4	0.9	0.1	0.2	0.3	0.0	0.6	0.0	0.1	1.0
KCNE2	"LQT6, MiRP1"	ENSG00000159197	"Potassium voltage-gated channel subfamily E regulatory subunit 2"	Q9Y6J6	21	34364006-34371381	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"stomach 1: 316.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 35.0;Gastric mucus-secreting cells: 109.1;Late spermatids: 20.1"	"Cancer enriched"	"Detected in some"	6	"stomach cancer: 2.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.6;SCLC-21H: 1.9"	"Region enhanced"	"Detected in many"		"pons and medulla: 29.0"					"HPA029706, HPA051553"	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA029706: AB_2673159, HPA051553: AB_2681532"	"unprognostic (5.29e-4)"	"unprognostic (3.13e-1)"	"unprognostic (6.69e-2)"	"unprognostic (2.65e-5)"	"unprognostic (7.45e-2)"	"unprognostic (7.33e-3)"	"unprognostic (5.77e-3)"	"unprognostic (6.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.81e-2)"	0.5	0.4	1.1	0.3	1.2	0.1	0.4	0.9	1.3	0.6	1.3	1.1	7.1	0.3	0.8	0.4	0.4	0.5	0.4	1.1	1.4	1.6	1.3	0.5	0.1	1.1	1.2	0.5	0.7	0.0	0.5	0.2	1.3	0.5	0.3	0.4	0.3	0.3	0.8	0.3	0.2	0.0	1.1	0.2	316.3	4.1	1.4	0.0	1.0	0.3	0.0	0.6	0.3	1.2	0.3	0.1	0.8	1.5	0.0	0.0	1.0	0.3	0.2	0.0	0.0	0.3	0.4	0.3	0.5	0.0	0.2	0.0	0.1	0.0	0.4	0.4	0.4	0.3	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.1	1.6	0.1	0.6	0.0	0.3	1.1	1.1	0.6	0.2	0.2	0.4	0.1	0.1	1.9	0.1	0.5	0.2	0.5	0.9	0.5	0.4	0.0	0.4	0.2	0.2	0.1	1.6	0.9	0.3	0.1	0.8	0.4	0.0	0.3	0.5	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.1	1.1	1.2	0.9	1.3	1.1	1.4	1.1	1.2	1.3	1.1	1.4	1.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0	2.5	0.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	35.0	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.3	109.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.3	0.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.1	1.1	0.0
KCNE3	"HOKPP, MiRP2"	ENSG00000175538	"Potassium voltage-gated channel subfamily E regulatory subunit 3"	Q9Y6H6	11	74454841-74467729	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Brugada syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 70.5;stomach 1: 56.2"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 41.8;granulocytes: 33.7;Hofbauer cells: 40.6;Kupffer cells: 104.0;Macrophages: 37.8;monocytes: 59.0;Undifferentiated cells: 44.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	48	"basophil: 51.4;classical monocyte: 38.5;eosinophil: 23.4;intermediate monocyte: 41.8;myeloid DC: 18.3;neutrophil: 53.1;non-classical monocyte: 36.6"	"Group enriched"	"Detected in many"	115	"dendritic cells: 18.3;granulocytes: 53.1;monocytes: 41.8"	"Cell line enhanced"	"Detected in some"		"HEL: 70.3;NB-4: 44.7;OE19: 155.3;THP-1: 32.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014849	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"		"HPA014849: AB_1852112"	"unprognostic (1.61e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (4.67e-3)"	"unprognostic (4.89e-4)"	"unprognostic (4.12e-3)"	"unprognostic (2.56e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.45e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-1)"	7.3	2.8	2.8	20.7	2.9	8.2	5.2	2.5	3.6	9.9	7.0	34.9	70.5	8.8	1.9	4.6	9.4	24.6	5.0	3.0	3.0	20.1	5.0	13.8	5.0	3.8	3.6	14.0	10.8	3.6	3.1	12.7	3.6	8.0	47.3	8.1	15.4	3.4	1.3	1.3	40.0	11.1	3.3	12.6	56.2	1.8	4.1	1.9	33.5	3.0	3.2	6.2	4.5	4.9	0.1	0.1	0.1	0.2	8.1	2.1	7.1	0.1	0.0	1.0	0.8	23.0	2.0	0.3	21.3	0.1	0.1	0.3	1.8	0.0	0.7	0.0	0.2	70.3	0.4	4.7	2.9	0.6	12.0	7.1	0.0	0.6	0.0	0.3	0.3	0.1	1.9	0.3	0.8	0.1	0.1	44.7	0.9	155.3	0.1	7.6	0.3	0.5	1.7	0.0	0.0	0.4	0.1	0.0	0.0	5.4	0.1	32.7	0.1	0.1	0.2	0.2	0.1	0.3	0.3	0.4	0.1	12.9	0.1	51.4	38.5	23.4	0.1	41.8	0.2	0.2	0.1	0.1	18.3	0.3	0.1	0.1	53.1	0.2	36.6	0.7	0.0	13.2	2.8	2.9	2.5	3.6	3.0	3.0	3.8	3.6	3.6	3.3	4.1	4.9	4.4	0.0	6.8	0.3	0.7	0.3	0.6	1.1	3.4	0.2	0.2	0.3	0.7	8.6	5.6	1.8	0.0	0.4	0.0	8.6	3.9	0.5	0.1	3.1	3.4	8.9	2.4	2.1	0.2	7.3	7.4	4.5	41.8	5.0	33.7	0.2	5.7	2.0	40.6	0.0	0.3	27.9	4.1	104.0	2.9	0.3	3.7	37.8	0.0	8.4	59.0	22.7	1.0	0.0	0.0	3.3	8.9	2.6	0.2	0.4	8.6	23.4	4.6	1.2	0.0	4.7	0.7	0.0	0.4	2.7	0.1	2.1	1.0	8.8	44.3	0.6
KCNH2	"erg1, HERG, Kv11.1, LQT2"	ENSG00000055118	"Potassium voltage-gated channel subfamily H member 2"	Q12809	7	150944961-150978321	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 42.3;pituitary gland: 43.3"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 217.3;Cardiomyocytes: 83.2;Erythroid cells: 76.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"K-562: 197.7;NB-4: 97.8;SH-SY5Y: 78.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (2.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (9.79e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.52e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (6.08e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.02e-2)"	0.8	3.7	9.8	2.6	8.0	42.3	0.1	13.5	9.0	4.4	4.4	36.1	2.7	16.9	1.7	1.5	7.3	3.2	29.6	5.6	14.8	1.1	0.2	2.0	0.3	23.5	14.7	3.2	3.4	18.1	43.3	1.4	23.0	9.8	1.0	6.7	1.1	8.0	0.2	0.3	8.3	7.8	6.3	1.8	10.9	30.8	17.1	0.4	0.2	0.0	0.1	12.9	2.7	4.1	0.0	0.3	0.9	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	8.0	2.9	0.0	0.2	0.0	3.1	0.0	0.0	0.8	0.4	18.3	0.0	0.0	0.2	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	4.4	197.7	0.0	0.0	0.9	1.6	97.8	1.3	0.2	0.0	0.1	0.1	10.1	0.0	0.0	3.8	78.2	0.0	0.1	0.0	1.1	0.0	1.8	0.6	0.0	1.5	0.0	0.0	5.3	0.2	2.1	0.0	11.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	8.0	13.5	9.0	5.6	14.8	23.5	14.7	23.0	6.3	17.1	4.1	0.0	0.0	0.0	1.6	1.6	0.0	0.2	0.1	0.0	217.3	0.4	0.3	83.2	0.0	0.0	0.0	4.2	0.2	0.0	0.0	0.0	2.1	2.0	0.5	0.8	0.9	16.3	76.4	5.2	0.2	0.9	5.0	0.5	0.1	26.1	6.3	1.4	0.1	0.3	16.8	13.9	0.7	12.2	0.0	0.3	4.8	2.5	0.0	0.0	2.8	0.0	4.5	0.0	5.5	1.7	0.3	0.0	13.2	1.4	0.1	0.2	0.1	0.4	10.3	0.0	1.7	2.6	2.5	5.1	0.0	0.0	0.3	0.9	0.7	0.3	0.4
KCNJ2	"IRK1, Kir2.1, LQT7"	ENSG00000123700	"Potassium inwardly rectifying channel subfamily J member 2"	P63252	17	70168673-70180044	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Atrial fibrillation, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 42.9;parathyroid gland: 36.0"	"Group enriched"	"Detected in many"	4	"Horizontal cells: 240.6;Oligodendrocytes: 164.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 30.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 30.4"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 8.9;HUVEC TERT2: 6.3;REH: 7.5;RH-30: 29.2;U-138 MG: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029109	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 62: Horizontal cells - Visual perception"			"HPA029109: AB_10602913"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.74e-3)"	"unprognostic (6.15e-3)"	"unprognostic (9.60e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.49e-3)"	1.9	0.8	7.2	5.1	19.5	1.9	4.9	13.4	13.1	0.9	0.0	3.9	0.9	0.9	0.6	2.9	6.6	1.4	9.8	5.9	11.8	1.0	1.3	2.1	1.3	18.6	16.2	0.7	0.4	36.0	0.6	6.3	18.2	1.8	3.2	7.6	1.3	1.8	9.7	4.7	1.4	1.0	10.5	7.3	0.8	0.3	14.5	1.8	1.2	8.4	1.5	1.9	1.8	42.9	0.0	0.9	1.8	0.0	1.9	0.5	0.0	0.6	4.5	0.1	0.1	0.0	0.0	0.0	0.4	0.5	1.2	0.5	0.1	0.3	0.1	0.0	0.2	0.0	0.6	0.0	5.4	0.0	0.0	2.0	0.1	2.8	0.3	8.9	6.3	0.0	0.0	0.0	1.9	0.0	0.7	0.0	0.2	0.8	0.2	7.5	29.2	0.0	0.7	0.0	0.4	0.8	0.5	0.1	0.0	3.5	0.3	0.5	0.1	10.6	0.1	0.1	2.4	0.0	0.0	0.1	2.3	0.0	1.5	4.2	3.5	5.6	0.0	6.9	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	30.4	0.0	7.3	0.2	0.0	0.8	7.2	19.5	13.4	13.1	5.9	11.8	18.6	16.2	18.2	10.5	14.5	42.9	12.0	0.0	3.2	0.0	0.6	8.2	4.1	4.9	16.5	43.5	5.8	9.3	19.3	0.0	1.9	1.8	0.0	0.5	0.1	13.5	0.0	0.1	0.3	2.3	0.2	16.0	10.7	0.4	3.8	0.0	0.4	1.7	4.1	1.6	0.0	0.1	3.3	0.1	6.8	240.6	16.2	2.7	0.0	36.9	7.4	0.0	1.5	7.8	3.6	2.8	8.2	5.8	0.0	1.5	164.7	0.0	12.3	1.2	0.0	2.2	0.9	0.1	4.9	5.2	0.0	3.9	2.6	0.1	0.9	6.9	3.3	1.4	0.8	0.2	8.5	0.3
KCNJ5	"CIR, GIRK4, KATP1, Kir3.4, LQT13"	ENSG00000120457	"Potassium inwardly rectifying channel subfamily J member 5"	P48544	11	128891356-128921163	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cancer-related genes, Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 64.3;pancreas: 20.4"	"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 48.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"HBEC3-KT: 13.3"	"Group enriched"	"Detected in many"	6	"basal ganglia: 2.9;hypothalamus: 6.8;midbrain: 1.9;thalamus: 3.6"	"Low region specificity"	"Detected in all"			"HPA014722, HPA017353, CAB022569"	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"			"CAB022569: , HPA014722: AB_1852133, HPA017353: AB_1852135"	"unprognostic (2.01e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.56e-3)"	"unprognostic (5.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.54e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.23e-2)"	1.5	64.3	1.2	0.6	0.9	0.4	0.9	0.6	2.0	1.3	0.2	0.8	0.8	0.3	0.9	1.0	0.9	2.2	8.5	0.7	3.2	5.4	0.4	5.9	1.6	3.7	1.7	0.9	20.4	1.3	11.9	7.3	2.7	1.3	0.7	1.0	0.9	9.6	0.4	0.4	0.5	0.6	1.7	13.6	2.3	1.1	7.9	5.8	0.5	0.4	0.5	1.5	0.4	3.9	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.1	0.3	13.3	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	1.2	0.9	0.6	2.0	0.7	3.2	3.7	1.7	2.7	1.7	7.9	3.9	0.2	0.0	10.0	0.3	0.2	1.5	2.2	4.7	0.0	2.7	0.2	1.4	7.6	0.0	0.3	1.8	0.0	0.8	0.1	0.0	0.0	0.1	2.3	0.2	0.2	0.6	0.0	0.0	0.2	3.9	0.7	1.1	0.0	0.3	0.0	0.2	0.4	0.1	48.3	1.7	3.1	0.0	0.0	2.2	2.9	7.8	0.9	10.9	3.6	3.7	1.2	0.3	3.1	0.5	0.1	0.8	0.0	0.7	0.3	0.6	0.0	0.1	0.3	1.4	0.0	0.9	0.2	0.9	0.5	0.5	1.7	1.2	0.6	2.3	0.0	0.6
KCNQ1	"JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1"	ENSG00000053918	"Potassium voltage-gated channel subfamily Q member 1"	P51787	11	2444684-2849105	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, Deafness, Diabetes mellitus, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 197.1;stomach 1: 98.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 47.6;Microglial cells: 71.2;Undifferentiated cells: 57.8"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 42.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 33.4;OE19: 41.4;RPMI-8226: 23.2;U-266/70: 11.5;U-937: 13.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB018656, HPA048553, HPA071107"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"	"Plasma membrane"	"CAB018656: AB_2131551, HPA048553: AB_2680438, HPA071107: "	"unprognostic (6.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.39e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.46e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.07e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.46e-3)"	"prognostic favorable (9.85e-4)"	"unprognostic (3.99e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.27e-2)"	5.4	197.1	2.1	9.0	2.4	14.2	3.0	2.4	2.6	16.5	5.7	22.6	47.8	2.9	14.1	2.9	8.9	19.5	28.4	2.6	2.6	25.3	1.8	15.9	5.0	4.1	3.1	1.4	61.2	21.4	5.5	7.6	3.9	6.1	15.2	0.7	20.0	50.2	1.0	1.2	39.7	3.1	4.0	8.2	98.9	1.6	4.2	3.6	71.6	1.6	2.9	14.7	1.6	4.4	0.0	0.1	0.0	5.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	2.6	1.9	5.2	0.0	0.4	0.1	0.7	0.0	0.0	0.4	1.3	0.0	3.7	0.4	0.3	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.7	0.0	0.7	1.3	41.4	0.2	0.1	0.0	23.2	8.0	2.7	0.7	5.6	0.7	0.0	0.0	0.5	0.2	10.3	0.0	0.0	0.3	0.2	0.0	11.5	0.0	0.0	0.0	13.4	0.0	0.7	3.1	3.1	0.0	1.8	0.0	0.8	0.4	0.1	3.8	0.3	1.0	1.2	3.3	0.0	2.8	1.3	0.3	1.0	2.1	2.4	2.4	2.6	2.6	2.6	4.1	3.1	3.9	4.0	4.2	4.4	7.1	3.2	12.9	0.3	8.4	0.6	8.0	4.2	0.0	1.7	6.1	1.8	18.6	14.3	7.1	29.5	0.0	1.1	0.3	34.0	15.6	23.2	2.0	3.3	0.4	6.3	6.6	0.4	13.7	21.7	1.4	1.0	23.4	4.9	19.7	47.6	9.3	1.1	17.3	0.0	20.0	26.1	8.2	25.4	15.9	0.9	0.3	19.6	1.8	71.2	11.0	0.5	1.0	43.7	34.9	15.3	20.2	0.0	6.4	5.2	30.9	2.0	4.4	0.5	6.6	0.4	1.7	0.2	0.2	0.1	1.0	2.1	4.0	16.6	57.8	20.4
LAMA4	LAMA3	ENSG00000112769	"Laminin subunit alpha 4"	Q16363	6	112107931-112254939	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.7;Early spermatids: 114.7;Extravillous trophoblasts: 119.1;Fibroblasts: 149.2;Leydig cells: 166.5;Microglial cells: 124.6;Oligodendrocyte precursor cells: 160.4;Theca cells: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 330.5;ASC TERT1: 512.5;HSkMC: 405.5;hTERT-RPE1: 256.0;HUVEC TERT2: 441.3;TIME: 404.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015693, CAB078156"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		320000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"CAB078156: AB_2665814, HPA015693: AB_1852687"	"unprognostic (1.87e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.52e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (4.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.15e-2)"	116.2	9.4	17.6	34.0	17.1	0.5	59.9	11.7	12.9	77.0	12.6	82.6	17.2	77.5	18.5	35.6	115.2	37.3	51.2	12.3	17.9	9.9	4.4	80.8	11.5	12.7	16.3	23.2	4.9	8.6	13.6	68.0	14.7	35.4	34.0	1.3	38.4	40.7	10.6	17.7	34.5	107.8	11.4	1.5	36.7	18.7	22.6	5.0	23.2	18.6	8.9	65.1	40.3	11.4	0.3	0.1	18.8	0.6	330.5	512.5	0.3	91.4	55.8	8.9	1.4	0.0	36.1	0.0	58.0	154.9	19.8	0.3	4.0	0.6	1.5	0.3	46.4	0.0	44.4	0.0	69.6	0.1	0.3	405.5	0.1	64.9	0.2	256.0	441.3	0.0	0.4	0.4	1.7	0.0	0.1	0.3	1.1	0.0	15.1	0.2	0.2	0.3	134.0	2.8	0.4	2.1	14.2	0.4	68.5	1.5	0.4	0.2	404.9	145.1	7.6	160.6	29.1	0.0	0.3	0.3	33.5	0.2	191.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	17.1	11.7	12.9	12.3	17.9	12.7	16.3	14.7	11.4	22.6	11.4	115.7	3.2	4.5	45.4	0.1	22.7	1.4	2.9	8.6	1.6	5.4	9.4	53.3	2.8	10.4	3.7	0.0	1.0	0.6	0.0	3.9	0.7	114.7	6.2	24.8	103.5	0.0	2.7	27.4	0.7	119.1	149.2	3.6	10.5	1.3	3.5	36.0	35.3	3.0	0.0	6.3	0.8	20.3	1.6	20.8	47.0	166.5	2.0	56.9	124.6	0.6	0.0	0.0	160.4	2.0	0.7	0.0	81.3	1.5	1.5	0.0	0.1	1.7	0.5	65.7	5.4	98.2	1.3	1.2	5.0	18.6	3.0	2.7	117.4	0.0	12.9
LDB3	"CMD1C, KIAA0613, PDLIM6, ZASP"	ENSG00000122367	"LIM domain binding 3"	O75112	10	86668507-86736072	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	26	"heart muscle: 1423.0;skeletal muscle: 2945.6;tongue: 1809.4"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 1825.0"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.7;melanoma: 2.5;prostate cancer: 3.6;stomach cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 3.0;hTERT-RPE1: 3.3;SCLC-21H: 4.9;SK-MEL-30: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048955	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA		750000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA048955: AB_2680568"	"unprognostic (1.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.72e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-1)"	11.1	1.4	12.8	2.8	39.6	0.4	6.5	29.8	29.0	10.1	0.1	36.2	2.4	15.1	4.9	54.5	17.3	3.1	1423.0	14.7	23.3	2.0	0.8	5.1	0.5	55.5	36.9	6.4	1.3	0.5	2.4	2.7	46.2	38.1	5.3	0.7	20.8	25.2	2945.6	4.8	8.8	23.7	26.4	0.6	9.0	4.7	38.4	0.7	5.2	1809.4	0.3	7.0	10.3	78.4	0.1	0.1	0.2	1.7	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.5	0.4	0.4	0.7	0.0	0.0	0.0	0.9	3.0	0.2	0.0	0.0	3.3	0.0	0.3	0.1	1.0	0.0	0.8	0.2	0.1	0.2	0.2	0.2	0.0	1.1	0.0	0.0	0.6	4.9	0.9	0.2	0.1	2.4	0.7	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.3	0.2	0.4	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.8	39.6	29.8	29.0	14.7	23.3	55.5	36.9	46.2	26.4	38.4	78.4	1.5	0.0	0.0	1.0	0.0	1.0	0.5	0.2	0.0	1.5	0.2	0.3	1825.0	0.0	0.2	1.8	0.0	0.1	0.0	0.0	0.0	0.0	23.4	0.1	0.4	15.5	0.0	0.0	4.5	1.1	0.0	31.5	0.0	0.2	0.0	0.9	0.0	0.0	0.1	0.0	2.6	0.0	4.1	0.0	1.2	19.6	11.1	0.5	1.8	1.9	0.0	0.7	0.0	1.5	245.1	0.1	0.0	6.8	0.0	0.3	0.0	0.1	0.1	4.1	39.5	48.0	54.9	1.0	1.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2
LMNA	"CMD1A, HGPS, LGMD1B, LMN1, LMNL1, MADA, PRO1"	ENSG00000160789	"Lamin A/C"	P02545	1	156082573-156140081	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Cardiomyopathy, Charcot-Marie-Tooth disease, Congenital muscular dystrophy, Disease variant, Emery-Dreifuss muscular dystrophy, Limb-girdle muscular dystrophy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 1533.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 85.1;T-reg: 83.2"	"Group enriched"	"Detected in all"	8	"dendritic cells: 85.1;granulocytes: 23.9;T-cells: 83.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004022, HPA006523, HPA006660"	Supported		Supported	"Nuclear speckles"		NA	NA		5700000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"		"CAB004022: AB_2136278, HPA006523: , HPA006660: AB_1079231"	"unprognostic (2.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.23e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.90e-2)"	"unprognostic (5.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.44e-2)"	280.2	174.8	17.6	64.9	27.1	58.1	231.5	24.1	20.6	221.7	33.0	183.3	72.8	271.4	14.5	256.2	173.8	92.1	221.7	15.8	23.1	120.9	93.2	188.5	18.2	30.3	25.2	178.2	81.8	21.3	76.9	53.0	26.1	125.3	38.2	4.7	176.1	42.8	190.0	364.3	136.8	78.8	21.0	84.1	160.6	61.9	30.9	15.3	147.4	23.8	22.9	168.7	217.6	41.8	518.8	269.7	26.2	72.4	119.5	238.7	169.4	607.3	379.6	221.3	146.8	68.3	311.9	2.8	338.7	417.9	94.6	515.4	31.4	227.8	70.3	188.6	50.8	175.4	168.4	130.8	124.0	25.7	412.9	133.0	92.0	154.8	134.7	120.2	207.5	0.7	82.8	21.9	205.8	193.1	1.0	67.8	32.1	202.9	706.0	1.6	195.9	137.7	128.9	105.6	33.8	114.9	414.3	154.2	427.4	56.2	230.1	74.2	727.9	241.6	233.0	389.1	393.3	39.5	10.5	4.9	449.2	24.8	760.4	23.9	8.3	0.4	2.8	2.1	2.5	2.4	17.8	7.3	85.1	0.2	0.2	0.7	2.1	3.7	0.2	0.3	83.2	14.6	17.6	27.1	24.1	20.6	15.8	23.1	30.3	25.2	26.1	21.0	30.9	41.8	353.5	262.8	350.0	16.0	179.1	610.5	1235.3	446.2	531.6	7.2	542.5	374.9	94.1	191.6	320.3	161.8	47.9	478.8	239.8	614.1	109.5	429.3	38.6	215.4	209.4	386.0	431.5	70.4	9.9	360.2	387.8	622.1	505.1	270.5	1181.8	145.5	277.7	103.1	343.0	13.5	15.1	601.2	177.0	60.6	1533.4	45.4	288.6	409.0	859.2	10.3	20.4	37.2	3.1	17.1	20.1	513.0	384.1	287.3	331.3	340.6	262.6	125.0	170.5	17.8	203.8	1028.4	766.8	107.4	42.2	404.1	602.4	680.9	472.3	111.6	513.8	942.6
MIB1	"DIP-1, KIAA1323, MIB, ZZANK2, ZZZ6"	ENSG00000101752	"Mindbomb E3 ubiquitin protein ligase 1"	Q86YT6	18	21704957-21870953	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"REH: 121.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019100, CAB037044"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Vesicles	"CAB037044: AB_1841007, HPA019100: AB_1853934"	"unprognostic (1.38e-1)"	"unprognostic (6.92e-2)"	"unprognostic (7.29e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.66e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.70e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.91e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.85e-2)"	8.1	6.3	9.1	6.0	9.1	4.9	11.2	9.2	8.5	11.0	8.0	7.1	5.1	13.0	9.5	8.0	7.1	8.6	6.0	8.4	9.2	11.1	10.4	7.2	7.6	9.5	10.2	11.7	8.1	9.8	5.2	11.0	8.6	10.1	7.0	8.3	8.4	8.5	5.8	9.1	5.2	10.2	10.1	7.2	7.6	8.7	10.3	11.5	13.6	7.0	7.9	8.4	8.2	9.6	19.9	7.6	36.4	25.8	19.5	23.0	9.0	15.6	17.2	10.8	15.6	11.3	7.1	16.9	14.1	21.4	11.8	13.2	21.4	21.0	24.4	22.4	10.4	18.8	9.7	15.9	15.8	38.3	7.8	14.8	23.0	12.6	32.0	16.0	27.8	6.6	26.5	47.5	17.2	9.5	18.9	14.7	9.5	12.2	10.2	121.1	30.3	42.5	18.7	16.9	12.1	30.1	26.8	12.4	13.9	18.6	8.8	25.1	23.9	27.8	14.2	11.7	21.1	25.6	9.5	25.4	11.8	24.1	16.9	0.7	0.3	0.1	0.2	0.1	0.2	0.2	0.3	0.2	0.1	0.1	0.2	0.1	0.3	0.5	0.1	0.2	0.4	0.1	9.1	9.1	9.2	8.5	8.4	9.2	9.5	10.2	8.6	10.1	10.3	9.6	35.7	48.1	22.7	68.2	11.9	21.9	15.1	19.8	24.5	28.8	24.1	19.7	18.1	25.8	31.8	16.5	25.0	13.3	18.2	20.8	3.9	13.4	7.0	29.0	59.2	30.8	24.0	23.1	106.7	12.9	7.5	33.1	10.2	32.4	14.5	16.8	24.3	30.0	12.9	15.2	92.6	17.1	26.4	17.2	16.2	5.6	20.5	14.2	26.6	67.5	19.4	17.7	15.5	121.2	109.6	18.8	7.0	24.8	18.1	48.5	8.7	15.9	30.6	14.5	0.0	35.4	26.9	26.2	12.0	23.4	24.6	25.3	14.5	21.8	10.4	25.3
MYBPC3	"CMH4, cMyBP-C, FHC"	ENSG00000134571	"Myosin binding protein C3"	Q14896	11	47331406-47352702	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	584	"heart muscle: 1725.4"	"Cell type enriched"	"Detected in some"	42	"Cardiomyocytes: 1876.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"U-937: 6.4"	"Region enriched"	"Detected in some"	33	"cerebellum: 34.4"	"Low region specificity"	"Detected in many"			"HPA040147, HPA043898"	Enhanced					NA	NA		21000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA040147: AB_2676861, HPA043898: AB_2678720"	"unprognostic (1.06e-1)"	"unprognostic (1.47e-6)"	"unprognostic (2.17e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.40e-4)"	"unprognostic (7.47e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.21e-2)"	0.4	2.9	0.0	0.7	0.0	1.5	0.7	0.2	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.4	1725.4	0.0	0.0	0.3	0.3	2.0	0.5	0.2	0.1	0.1	0.7	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.6	0.0	0.4	0.2	0.3	0.1	0.0	2.8	2.8	1.4	0.0	0.0	0.3	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.9	0.0	1.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1876.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	28.3	0.0	0.0	14.3	0.0	0.0	0.2	0.0	0.0	43.9	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.2	0.8	0.0	0.8	0.0	19.2	0.3	0.7	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.1	0.9	0.0	0.0	0.3	0.0	17.4	0.6	0.0
MYH6		ENSG00000197616	"Myosin heavy chain 6"	P13533	14	23381982-23408273	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Atrial septal defect, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"heart muscle: 2882.7"	"Cell type enriched"	"Detected in some"	17	"Cardiomyocytes: 8051.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	23	"NTERA-2: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001239, HPA001349, CAB075723, CAB075724, CAB075725"	Enhanced		Uncertain	"Focal adhesion sites"		NA	NA		25000000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites"		"CAB075723: AB_2665728, CAB075724: AB_2665729, CAB075725: AB_2665730, HPA001239: AB_1079438, HPA001349: AB_1079437"	"unprognostic (2.09e-2)"	"unprognostic (8.53e-4)"		"unprognostic (1.80e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.09e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.34e-3)"		"unprognostic (6.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-2)"	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	2882.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.9	5.8	0.0	0.0	0.5	0.1	0.9	0.0	0.0	1.9	0.0	53.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	50.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8051.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	31.7	0.0	2.7	0.1	0.0	0.0	449.6	0.0	0.0	0.0	0.3	1.1	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	60.3	0.1	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MYH7	"CMD1S, CMH1, MPD1"	ENSG00000092054	"Myosin heavy chain 7"	P12883	14	23412740-23435660	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	71	"heart muscle: 7569.2;skeletal muscle: 14554.3;tongue: 5378.8"	"Cell type enriched"	"Detected in some"	127	"Cardiomyocytes: 10295.8"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 12.2;prostate cancer: 15.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	31	"HSkMC: 11.4"	"Low region specificity"	"Detected in many"							"HPA001239, HPA001349, CAB015384"	Enhanced		Uncertain	"Focal adhesion sites"		NA	NA		43000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites"		"CAB015384: AB_2147279, HPA001239: AB_1079438, HPA001349: AB_1079437"	"unprognostic (6.49e-2)"	"unprognostic (8.27e-5)"	"unprognostic (1.56e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.30e-1)"	"unprognostic (7.33e-3)"		"unprognostic (8.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.28e-2)"	2.0	1.3	1.4	0.0	1.9	0.1	2.5	0.1	1.1	0.3	1.4	1.2	0.5	0.4	0.0	129.2	0.1	1.1	7569.2	1.2	2.9	0.9	1.4	3.2	1.5	0.8	1.6	0.7	7.8	0.0	1.5	0.0	0.9	76.8	0.0	0.0	37.0	0.0	14554.3	4.8	0.9	0.0	0.9	0.5	0.9	1.4	3.2	0.1	1.8	5378.8	0.1	0.2	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.9	0.1	1.1	1.2	2.9	0.8	1.6	0.9	0.9	3.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10295.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	80.9	0.0	0.0	0.2	3.1	0.0	70.5	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.7	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	3.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	52.2	51.2	0.1	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
MYL2	CMH10	ENSG00000111245	"Myosin light chain 2"	P10916	12	110910819-110921443	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	72	"heart muscle: 27910.5;skeletal muscle: 28967.7;tongue: 19823.2"	"Cell type enriched"	"Detected in some"	80	"Cardiomyocytes: 27611.5"	"Group enriched"	"Detected in some"	46	"head and neck cancer: 31.5;prostate cancer: 25.5"	"Region enriched"	"Detected in some"	6	"hypothalamus: 6.0"	"Group enriched"	"Detected in some"	12	"memory B-cell: 1.1;naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.2;HSkMC: 8.8;U-2 OS: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA019763, HPA039262"	Supported		Uncertain	Microtubules		NA	NA		180000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Microtubules		"HPA019763: AB_1854243, HPA039262: AB_2676418"	"unprognostic (2.07e-2)"	"unprognostic (1.37e-1)"		"unprognostic (1.39e-1)"		"prognostic unfavorable (2.60e-4)"		"unprognostic (1.32e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-1)"		"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.55e-1)"		7.3	4.5	0.0	0.1	0.0	0.7	29.4	0.0	0.0	1.5	0.0	4.7	0.6	2.2	0.0	357.0	0.5	9.5	27910.5	0.0	6.0	3.0	5.4	5.0	15.2	0.6	1.0	2.4	5.8	0.0	2.5	0.1	0.3	249.8	0.1	0.0	108.7	0.2	28967.7	19.3	3.2	0.3	0.0	2.1	3.5	2.1	0.0	1.0	13.3	19823.2	1.1	2.2	4.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	4.2	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	17.7	0.0	0.1	0.0	0.0	1.7	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.6	1.0	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	27611.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	235.7	0.0	0.0	0.0	0.0	0.0	53.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	4.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	342.2	138.8	0.1	0.1	0.0	0.0	0.0	3.3	0.0	0.1	0.0
MYL3	"CMH8, MLC1SB, MLC1V, VLC1"	ENSG00000160808	"Myosin light chain 3"	P08590	3	46835111-46882172	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 9155.0;skeletal muscle: 5135.3;tongue: 2074.2"	"Cell type enriched"	"Detected in some"	53	"Cardiomyocytes: 3626.2"	"Group enriched"	"Detected in many"	4	"head and neck cancer: 3.0;prostate cancer: 3.4;renal cancer: 8.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.6;HSkMC: 8.7;RPTEC TERT1: 34.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA016564, CAB018662, HPA046859, HPA063034"	Enhanced		Approved	Nucleoli,Mitochondria		NA	NA		7300000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoli, Mitochondria"		"CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: AB_2679842, HPA063034: AB_2684927"	"unprognostic (3.11e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.67e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.88e-2)"	"prognostic favorable (1.22e-8)"	"unprognostic (1.16e-3)"	"unprognostic (9.45e-3)"	"unprognostic (7.18e-5)"	"unprognostic (2.53e-3)"	5.8	4.1	11.3	0.9	11.1	1.5	8.9	11.4	14.8	6.7	8.4	2.5	1.6	3.3	3.4	157.0	4.2	3.6	9155.0	11.0	12.8	50.3	4.1	5.7	3.3	15.2	13.0	5.2	2.7	1.3	1.7	4.7	12.1	25.1	0.8	1.9	19.6	1.5	5135.3	4.0	2.3	2.0	13.2	7.9	2.1	2.3	12.6	0.7	2.4	2074.2	0.5	2.4	4.7	13.2	0.5	0.7	0.4	0.3	4.4	1.5	3.6	0.7	0.4	0.4	0.6	8.6	0.8	1.6	1.4	0.1	0.2	0.5	0.4	0.1	0.7	0.3	0.1	0.8	2.6	0.3	0.7	0.9	0.8	8.7	0.2	0.3	0.1	0.2	0.1	0.5	0.4	1.2	0.2	1.2	0.3	0.5	1.0	0.4	0.4	0.9	0.3	0.1	34.2	1.3	0.6	0.4	0.3	0.7	0.1	0.7	0.3	0.5	0.2	1.0	0.8	0.6	0.3	0.5	0.4	0.7	0.3	0.8	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.4	0.1	0.1	0.3	0.0	0.1	0.4	0.0	0.0	11.3	11.1	11.4	14.8	11.0	12.8	15.2	13.0	12.1	13.2	12.6	13.2	0.7	0.0	0.0	1.0	0.0	0.8	0.2	0.0	0.0	0.2	2.3	0.1	3626.2	0.0	0.0	1.8	0.0	0.4	0.0	0.0	54.8	0.0	2.4	0.1	2.2	32.8	0.0	0.0	0.1	0.0	16.4	23.7	0.0	0.0	0.0	0.0	1.1	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.6	12.8	1.2	0.7	0.0	0.0	0.0	2.8	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	68.1	0.0	0.4	6.6	27.9	20.4	0.2	0.5	0.0	0.4	0.8	0.4	0.1	0.0	0.0
MYL4	"ALC1, AMLC, GT1, PRO1957"	ENSG00000198336	"Myosin light chain 4"	P12829	17	47200446-47223679	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Atrial fibrillation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	47	"heart muscle: 6347.0"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 2426.3"	"Cancer enriched"	"Detected in some"	5	"thyroid cancer: 11.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"plasmacytoid DC: 1.8"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 1.8"	"Cell line enriched"	"Detected in some"	4	"HEL: 552.8"	"Group enriched"	"Detected in all"	6	"amygdala: 25.8;cerebral cortex: 88.4;hippocampal formation: 25.2;white matter: 50.9"	"Not detected"	"Not detected"			"HPA046859, HPA051884, HPA063034"	Enhanced		Approved	"Plasma membrane"		NA	NA		3100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"		"HPA046859: AB_2679842, HPA051884: AB_2681651, HPA063034: AB_2684927"	"unprognostic (2.43e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.00e-6)"	"unprognostic (1.92e-4)"	"unprognostic (2.54e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.50e-1)"	2.1	0.5	0.2	0.4	0.3	134.6	2.7	0.2	0.4	0.4	0.4	0.8	0.8	0.8	0.0	0.6	0.5	1.0	6347.0	0.3	0.4	1.3	1.4	9.4	0.9	0.3	0.3	0.8	8.6	0.3	0.5	9.1	0.4	1.1	0.3	42.2	3.0	0.2	3.5	1.2	1.3	0.8	0.2	3.1	3.4	15.5	0.3	2.4	11.0	6.4	0.4	0.9	0.8	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.9	0.3	0.0	0.2	0.0	0.9	0.1	1.6	0.9	0.0	0.4	0.0	0.1	0.0	0.0	3.0	0.2	552.8	0.1	0.0	0.0	0.0	0.3	21.2	0.0	0.3	0.1	0.0	1.0	1.4	133.3	0.3	0.2	0.0	10.0	0.1	0.3	0.0	0.4	0.3	12.9	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	24.3	0.0	0.2	4.5	0.0	0.3	0.1	0.0	0.3	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.2	0.3	0.2	0.4	0.3	0.4	0.3	0.3	0.4	0.2	0.3	0.4	3.2	3.2	0.0	0.0	0.7	0.8	0.0	0.0	0.0	5.5	0.0	0.0	2426.3	0.0	0.0	0.0	64.6	0.5	2.7	0.1	0.0	0.1	23.3	0.1	0.0	23.2	0.0	412.8	0.1	0.0	3.9	150.7	1.5	0.1	0.0	0.3	1.8	0.5	1.9	1.7	0.0	0.8	0.0	0.6	0.6	54.6	3.4	34.0	12.4	0.0	1.5	7.9	4.1	0.0	0.1	0.1	0.0	1.5	0.8	0.0	10.9	0.2	0.0	24.4	0.0	0.6	36.5	9.9	0.5	0.0	0.9	1.4	0.3	0.2	1.0	0.0
MYPN	MYOP	ENSG00000138347	Myopalladin	Q86TC9	10	68106117-68212017	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Cardiomyopathy, Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 64.1;skeletal muscle: 283.6;tongue: 172.8"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 114.2"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 0.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 1.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ: 39.8;fHDF/TERT166: 112.3;HBF TERT88: 25.6;LHCN-M2: 47.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA036299, HPA061494"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Vesicles"	Cytosol	"HPA036299: , HPA061494: AB_2684539"	"unprognostic (4.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.14e-3)"	"unprognostic (8.62e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.94e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.88e-8)"	"unprognostic (4.63e-5)"	"unprognostic (9.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.47e-1)"	0.1	0.3	0.2	0.2	0.1	0.6	0.1	0.5	0.2	0.0	0.0	0.3	0.1	0.1	0.1	2.2	0.0	0.1	64.1	0.8	0.8	0.0	0.0	0.0	0.2	0.6	0.2	0.1	0.6	0.0	0.0	0.1	0.1	1.7	0.1	1.7	2.7	0.0	283.6	0.1	0.1	0.2	0.0	0.1	0.8	0.9	0.0	0.1	0.0	172.8	0.0	0.1	0.0	0.3	2.9	1.3	0.0	0.0	0.7	4.1	0.1	39.8	19.7	14.4	5.4	0.0	0.1	0.1	0.0	112.3	20.5	0.7	0.0	0.2	25.6	0.4	0.0	0.0	14.6	0.0	0.3	0.0	0.1	1.6	0.0	7.9	0.9	3.6	0.4	0.0	0.0	0.2	47.6	8.6	0.0	0.1	0.0	0.0	1.3	0.0	2.2	0.0	0.1	0.1	0.1	0.0	5.7	0.9	0.2	0.1	0.0	0.0	1.1	0.7	0.2	4.1	0.1	0.1	0.0	0.0	4.6	0.1	4.2	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.2	0.8	0.8	0.6	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.2	0.0	114.2	0.0	0.0	0.0	25.0	0.0	0.0	1.8	0.0	0.0	1.0	1.5	0.1	0.7	0.0	0.0	0.5	0.2	0.0	1.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.4	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.1
NEXN	"NELIN, nexilin"	ENSG00000162614	"Nexilin F-actin binding protein"	Q0ZGT2	1	77888513-77943895	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 404.8;skeletal muscle: 676.9;tongue: 548.9"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 2329.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 152.2;LHCN-M2: 135.1;RH-30: 108.5"	"Region enhanced"	"Detected in all"		"basal ganglia: 40.4"	"Group enriched"	"Detected in all"	4	"basal ganglia: 9.0;midbrain: 13.4;pons: 10.0;thalamus: 25.2"	"HPA011185, HPA011904"	Approved		Supported	"Plasma membrane,Actin filaments"		NA	NA		2900000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Actin filaments"		"HPA011185: AB_1854409, HPA011904: "	"unprognostic (9.73e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.68e-2)"	42.8	22.3	2.3	24.5	3.1	0.6	16.2	1.7	1.6	21.9	2.5	89.2	10.2	79.0	10.7	49.4	47.5	28.7	404.8	1.3	1.8	8.0	5.6	25.2	5.6	1.4	3.3	15.2	10.0	1.5	1.4	10.6	1.5	62.5	15.7	0.6	11.5	69.8	676.9	6.8	26.7	70.6	1.2	8.6	44.1	5.7	4.7	2.1	10.3	548.9	1.8	49.7	19.5	1.7	26.0	1.5	4.5	0.2	79.5	75.3	12.3	152.2	65.5	29.8	20.2	4.6	0.2	0.0	8.6	54.7	34.4	3.4	3.3	14.3	53.3	0.7	3.4	6.2	7.5	1.5	59.3	1.3	0.2	56.6	3.3	40.7	23.8	65.2	22.8	6.0	0.3	0.0	135.1	0.0	29.9	1.8	23.8	0.0	18.6	24.3	108.5	0.2	35.5	1.2	0.1	1.1	13.3	0.0	1.0	29.9	0.0	3.5	23.4	71.7	53.6	31.2	76.1	0.2	0.2	0.1	4.0	2.8	0.2	0.0	1.7	0.0	0.2	1.0	0.0	0.7	0.1	0.2	0.9	0.5	0.3	0.1	1.4	0.3	0.8	0.6	0.0	3.6	2.3	3.1	1.7	1.6	1.3	1.8	1.4	3.3	1.5	1.2	4.7	1.7	8.3	105.8	4.9	11.4	2.1	1.8	0.9	4.6	1.2	2.7	1.4	33.1	2329.6	0.0	5.4	0.0	4.2	0.8	4.1	0.4	1.9	15.3	24.0	2.6	24.2	17.4	0.0	1.7	26.6	32.4	4.0	93.2	1.1	3.2	1.3	29.7	38.6	1.5	1.2	1.7	27.6	0.5	0.0	4.4	2.2	9.0	73.3	44.9	0.0	16.9	5.8	0.7	0.0	24.6	27.3	21.8	0.1	346.1	0.3	1.3	5.3	0.7	0.4	3.8	216.9	70.4	177.2	0.7	3.6	0.8	0.9	0.3	2.3	13.0	2.1	0.4
NKX2-5	"CSX, CSX1, NKX2.5, NKX2E, NKX4-1"	ENSG00000183072	"NK2 homeobox 5"	P52952	5	173232109-173235311	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Atrial septal defect, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"heart muscle: 229.0"	"Cell type enriched"	"Detected in some"	26	"Cardiomyocytes: 68.4"	"Cancer enhanced"	"Detected in many"		"glioma: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 32.9;NTERA-2: 11.4;SK-MEL-30: 15.2;U-2 OS: 25.4;U-251 MG: 20.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065034			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA065034: AB_2685409"	"unprognostic (3.81e-1)"	"unprognostic (8.53e-2)"		"unprognostic (2.62e-2)"	"unprognostic (9.57e-3)"	"unprognostic (3.22e-3)"		"unprognostic (6.63e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.31e-1)"			"unprognostic (5.80e-2)"	"unprognostic (2.19e-1)"		"unprognostic (1.77e-2)"	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	229.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	34.9	0.0	0.1	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	5.0	1.7	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	7.6	32.9	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.2	0.2	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.1	0.5	6.3	0.0	15.2	4.2	0.0	0.1	0.0	5.9	25.4	7.8	20.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	68.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.1	0.0	0.1	0.1	0.0	0.7	0.0	0.0
NKX2-6	"CSX2, NKX4-2"	ENSG00000180053	"NK2 homeobox 6"	A6NCS4	8	23701740-23706756	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"salivary gland: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTEC/SVTERT24-B: 5.6;JURKAT: 2.1;LHCN-M2: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA025288			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA025288: "												"unprognostic (1.86e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	2.1	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPPA	"ANP, PND"	ENSG00000175206	"Natriuretic peptide A"	P01160	1	11845709-11848345	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hormone, Vasoactive, Vasodilator"	"Atrial fibrillation, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	873	"heart muscle: 60060.6"	"Cell type enriched"	"Detected in some"	23	"Cardiomyocytes: 62235.0"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 9.6;SH-SY5Y: 9.5"	"Region enriched"	"Detected in some"	7	"olfactory bulb: 22.8"	"Low region specificity"	"Detected in all"			"HPA058269, HPA064007"	Enhanced				"Secreted to blood"	NA	NA		1200000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA058269: AB_2683660, HPA064007: "	"unprognostic (1.27e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.93e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.70e-2)"	8.3	3.0	1.7	0.7	2.1	0.6	18.0	1.8	2.4	1.2	2.3	5.0	0.2	3.3	12.9	2.8	1.3	0.9	60060.6	2.2	1.5	2.6	5.0	58.1	1.2	1.7	1.5	12.1	68.7	0.9	3.9	5.9	1.4	5.1	0.0	0.4	28.5	0.0	8.9	5.8	6.1	0.7	1.3	3.1	3.6	3.9	1.7	0.5	7.1	0.0	0.0	1.2	3.9	2.0	0.5	0.2	0.3	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.9	0.6	0.8	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.2	0.4	1.0	0.3	1.8	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	1.2	0.0	0.3	0.3	1.0	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.6	9.6	9.5	0.0	0.0	0.5	0.3	0.3	0.1	0.0	0.4	0.7	0.6	0.1	0.4	0.8	1.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	2.1	1.8	2.4	2.2	1.5	1.7	1.5	1.4	1.3	1.7	2.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62235.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	339.1	0.0	0.0	0.3	0.0	0.0	2684.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	636.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NUP155	"KIAA0791, N155"	ENSG00000113569	"Nucleoporin 155"	O75694	5	37288137-37371106	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Atrial fibrillation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 70.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.6;Late spermatids: 104.5;Spermatocytes: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037775	Enhanced		Enhanced	"Nuclear membrane"	"Intracellular and membrane"	NA	NA		28000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"		"HPA037775: AB_10671885"	"unprognostic (1.10e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (1.35e-6)"	"unprognostic (2.18e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	5.3	3.4	1.9	6.7	2.7	15.2	7.4	5.1	2.5	5.2	3.3	5.6	4.9	6.0	2.7	6.5	5.2	4.0	4.0	2.1	2.5	4.6	5.7	4.2	8.3	2.5	2.4	6.3	4.8	8.1	2.1	8.1	2.9	5.2	6.9	6.6	4.4	4.2	4.3	5.1	4.5	6.6	2.5	5.7	5.0	70.8	2.8	12.6	6.1	5.9	9.8	5.7	3.5	4.0	40.6	31.7	33.7	50.0	10.3	15.1	120.8	32.2	16.9	43.1	31.4	46.9	32.5	46.0	14.4	20.9	46.7	32.2	57.5	31.7	67.0	30.4	32.3	35.8	109.6	21.9	13.0	60.0	24.0	11.1	13.0	66.5	33.5	11.8	23.2	20.4	65.8	23.8	29.0	19.9	32.4	16.3	32.0	24.8	28.4	38.3	106.1	36.5	9.7	38.5	40.6	27.8	74.0	31.4	18.1	23.8	38.8	23.5	20.2	51.5	42.9	39.3	49.5	26.8	47.9	60.0	24.1	53.0	39.9	4.3	2.0	3.5	3.3	4.2	5.6	3.9	3.1	2.9	2.9	2.9	3.0	3.5	0.6	4.5	3.1	2.0	2.4	2.7	1.9	2.7	5.1	2.5	2.1	2.5	2.5	2.4	2.9	2.5	2.8	4.0	11.1	3.2	6.8	11.8	15.5	10.5	6.5	6.5	10.8	8.0	8.0	5.0	11.0	2.8	9.6	3.7	6.2	14.3	9.8	5.2	0.0	6.0	64.6	6.9	11.0	9.6	1.2	10.7	12.4	6.1	20.4	9.0	9.2	7.1	5.1	15.1	13.9	9.7	7.9	5.0	12.6	8.7	12.2	8.9	8.0	104.5	11.1	7.0	0.0	7.5	5.7	3.9	8.2	15.1	16.7	8.2	3.8	10.1	12.7	7.6	3.9	4.1	11.4	14.5	0.0	11.5	10.5	48.2	21.1	10.8	11.6	7.5	9.9	10.6	11.3	4.9
PKP2		ENSG00000057294	"Plakophilin 2"	Q99959	12	32790755-32896777	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 188.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 393.9;Distal enterocytes: 105.5;Extravillous trophoblasts: 185.9;Undifferentiated cells: 135.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 8.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 198.8;OE19: 72.7;SuSa: 149.0"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 20.2"	"Low region specificity"	"Detected in all"			"HPA014314, CAB037336, HPA056908"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Cell Junctions"	Nucleoplasm	"CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-2)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.76e-2)"	5.5	2.6	1.6	6.5	2.0	5.8	11.2	3.1	3.8	20.3	8.2	49.8	23.6	5.0	3.9	5.3	73.0	7.4	188.2	8.7	1.0	7.8	25.9	1.3	4.5	1.4	0.3	15.1	16.4	33.6	9.9	20.5	0.6	9.1	45.2	2.6	58.5	6.9	6.0	2.9	26.5	5.5	0.7	2.0	17.8	6.4	1.6	12.4	0.3	1.7	10.6	5.3	3.4	1.6	56.5	10.8	0.4	0.3	0.2	0.0	0.5	0.0	0.0	0.2	0.1	198.8	49.6	0.0	32.9	0.0	7.1	48.8	6.8	43.3	0.0	0.2	15.7	0.3	2.3	52.6	29.5	3.1	0.6	0.2	40.2	0.1	46.2	21.4	1.8	0.1	10.4	15.3	4.8	14.9	0.2	0.4	29.7	72.7	9.5	0.0	23.6	16.8	14.3	26.3	5.9	5.3	2.3	11.4	0.1	149.0	24.7	0.7	0.3	0.1	21.1	0.0	13.5	12.6	0.2	0.4	0.1	0.2	2.6	5.8	0.9	8.1	0.2	1.1	0.6	0.1	0.4	0.3	2.9	0.3	0.5	0.3	0.6	1.0	1.7	0.5	0.4	0.4	1.6	2.0	3.1	3.8	8.7	1.0	1.4	0.3	0.6	0.7	1.6	1.6	0.4	0.0	0.0	0.3	2.2	7.0	48.1	20.7	32.5	3.2	22.1	13.1	393.9	21.5	17.7	1.8	4.2	57.9	0.9	105.5	3.9	12.7	4.0	61.2	11.6	3.7	27.1	2.1	1.3	10.1	185.9	12.9	43.3	52.1	4.5	23.2	5.0	46.0	8.6	1.7	58.8	67.0	26.4	17.0	20.4	1.8	11.8	28.6	10.6	4.7	1.4	14.3	0.0	2.0	1.0	23.6	65.5	2.2	1.6	32.8	30.8	11.0	14.2	1.1	0.0	13.0	9.8	6.9	5.7	12.1	3.3	41.5	2.7	1.0	135.6	28.2
PLN	"CMD1P, PLB"	ENSG00000198523	Phospholamban	P26678	6	118548296-118561716	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 1563.4;skeletal muscle: 507.3"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 2452.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"CAB005597, HPA026900"	Enhanced					NA	NA				"Cluster 38: Heart - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB005597: AB_2252716, HPA026900: AB_1855314"	"unprognostic (2.49e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.96e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.35e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.98e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (5.59e-4)"	40.1	12.3	1.5	12.3	3.0	0.6	15.9	2.9	4.0	31.7	2.0	148.7	13.6	121.7	21.8	43.9	81.9	92.2	1563.4	1.6	1.6	15.0	1.2	15.4	2.7	1.8	2.0	20.4	3.2	1.3	1.5	0.3	1.8	35.1	24.4	0.2	5.3	37.0	507.3	8.3	41.6	128.4	1.5	3.0	34.1	4.3	2.2	1.0	12.7	230.2	0.9	44.1	22.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.0	2.9	4.0	1.6	1.6	1.8	2.0	1.8	1.5	2.2	2.0	4.5	0.0	0.0	0.3	0.2	4.2	0.2	0.0	1.2	1.8	0.4	0.6	2452.8	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	108.2	0.2	0.7	21.4	0.0	0.0	1.0	0.0	0.0	49.1	0.5	0.1	0.0	0.1	0.7	0.1	0.1	0.0	0.9	0.0	0.0	0.0	4.7	25.0	0.9	0.4	3.6	1.0	0.0	0.0	0.0	2.0	1.1	0.1	0.0	11.7	0.0	0.7	0.0	0.0	0.0	0.3	276.1	16.7	248.0	9.2	0.8	0.3	1.6	0.0	0.8	0.0	0.0	0.4
PPCS	FLJ11838	ENSG00000127125	"Phosphopantothenoylcysteine synthetase"	Q9HAB8	1	42456117-42473385	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 397.2;Proximal tubular cells: 316.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031361, HPA031363"	Approved		Approved	Mitochondria		NA	NA		17000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA031361: AB_10602150, HPA031363: AB_2673844"	"unprognostic (1.49e-1)"	"unprognostic (6.71e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.84e-3)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (5.96e-5)"	"unprognostic (2.71e-1)"	"unprognostic (7.79e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.41e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.30e-2)"	51.0	62.7	28.2	34.6	29.3	27.1	65.0	29.8	34.6	44.2	36.8	63.5	58.0	35.8	71.0	48.4	31.7	43.1	42.5	28.6	32.0	88.1	99.6	39.8	43.5	30.1	28.8	30.2	66.9	59.8	27.8	38.0	29.1	52.3	58.0	22.4	59.3	44.2	45.9	47.0	56.4	29.0	31.6	42.2	64.7	15.0	29.9	27.8	64.8	40.4	38.2	43.3	40.1	32.9	83.4	34.3	17.2	28.8	52.3	55.0	72.1	40.7	43.3	49.1	44.2	30.7	93.3	22.6	80.7	46.2	30.3	48.8	11.5	62.5	40.3	66.2	35.1	39.9	34.7	31.3	72.5	39.9	69.4	48.8	98.9	35.8	62.4	58.2	48.3	29.9	16.9	17.0	50.5	47.3	20.4	40.1	22.6	70.0	49.8	22.6	18.8	45.3	106.2	70.7	23.0	25.0	47.9	113.2	129.4	50.2	56.7	167.8	31.1	28.2	41.1	42.9	46.5	58.6	37.3	17.5	12.6	44.4	61.0	298.8	231.5	325.6	114.5	245.4	135.2	171.5	141.1	128.0	195.9	182.4	149.5	132.9	159.5	185.6	237.2	135.8	160.9	262.8	28.2	29.3	29.8	34.6	28.6	32.0	30.1	28.8	29.1	31.6	29.9	32.9	61.0	57.7	84.1	5.9	62.6	23.3	42.3	99.4	42.7	12.1	91.3	100.2	104.3	84.4	90.8	64.4	6.2	172.2	52.6	129.2	397.2	96.5	3.5	66.7	43.9	48.7	31.3	29.0	7.4	136.8	131.0	52.9	61.7	59.3	57.0	52.8	44.6	120.1	107.4	11.8	7.0	124.9	103.7	84.4	44.3	4.6	60.6	76.3	81.8	6.5	127.0	64.8	79.3	8.0	8.7	98.5	125.2	63.6	41.8	51.7	159.7	316.3	63.2	28.0	26.3	26.2	48.9	10.3	20.8	66.3	36.2	134.6	62.5	103.2	101.2	60.1
PRDM16	"KIAA1675, KMT8F, MEL1, MGC166915, PFM13"	ENSG00000142611	"PR/SET domain 16"	Q9HAZ2	1	3069168-3438621	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 16.2"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 173.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	16	"NK-cell: 2.4"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.8;HHSteC: 2.0;hTERT-RPE1: 6.7;MCF7: 1.6;OE19: 3.5"	"Region enriched"	"Detected in many"	5	"basal ganglia: 15.7"	"Low region specificity"	"Detected in many"			"HPA050343, HPA060467"			Supported	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA050343: AB_2681099, HPA060467: AB_2684287"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.07e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.80e-6)"	"unprognostic (2.14e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (4.06e-2)"	1.6	0.2	3.7	0.5	4.8	0.0	1.1	0.1	4.1	1.3	16.2	1.1	7.4	1.0	2.1	0.3	1.4	1.1	5.4	2.8	0.6	6.8	0.2	2.5	0.5	0.5	1.7	1.5	5.8	0.9	0.6	0.1	0.9	0.7	0.2	0.0	0.4	2.2	0.4	0.5	2.6	0.2	0.0	2.1	9.3	0.7	4.1	0.1	8.0	0.6	0.3	0.9	1.1	1.5	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.3	0.0	0.2	0.0	0.2	0.0	1.3	0.0	0.0	0.1	1.8	0.0	0.0	0.3	2.0	0.0	0.7	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	3.7	4.8	0.1	4.1	2.8	0.6	0.5	1.7	0.9	0.0	4.1	1.5	4.5	35.3	10.5	173.7	0.1	0.6	0.3	2.1	0.6	0.1	0.2	0.3	5.2	22.8	6.3	7.3	0.0	0.0	0.1	0.2	5.9	10.0	0.3	0.2	0.0	2.1	5.4	0.8	1.2	4.9	4.2	0.6	30.5	0.4	0.0	0.3	0.0	0.0	0.0	1.7	1.0	0.9	0.0	0.0	0.4	0.2	1.5	0.1	0.0	14.0	0.0	1.4	0.0	6.6	1.8	7.1	0.8	1.9	0.1	0.8	0.5	0.2	1.9	0.3	0.0	3.3	9.0	0.3	1.8	0.2	0.0	0.0	0.4	0.0	1.5	0.2
PRKAG2	"AAKG, AAKG2, CMH6, H91620p, WPWS"	ENSG00000106617	"Protein kinase AMP-activated non-catalytic subunit gamma 2"	Q9UGJ0	7	151556124-151877125	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"Cardiomyopathy, Disease variant, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 143.0"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 208.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 178.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004246, CAB018641"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB018641: AB_2170355, HPA004246: AB_1078151"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.33e-3)"	"unprognostic (7.13e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.52e-1)"	27.1	7.7	21.7	12.8	20.3	8.1	18.4	16.7	22.8	16.2	11.1	25.8	24.4	19.8	14.3	16.2	17.9	12.8	143.0	23.7	21.1	22.5	36.1	14.2	11.6	19.3	17.4	10.9	10.9	9.2	9.5	16.1	19.7	25.3	18.9	2.9	15.0	19.5	15.0	13.5	26.2	16.5	15.8	17.6	26.7	12.8	18.5	7.9	16.6	21.7	9.8	47.9	17.5	19.6	46.6	13.6	9.1	10.6	36.4	28.6	14.4	21.5	19.5	22.7	22.3	8.6	52.5	0.0	34.0	28.9	178.2	13.9	5.7	22.4	30.0	15.8	6.2	11.5	1.8	0.9	60.8	8.5	11.4	16.5	49.7	21.8	21.0	34.1	40.2	14.9	4.1	5.6	66.2	17.2	3.5	6.7	9.7	18.8	37.5	5.6	6.9	9.7	39.2	10.9	38.5	6.7	10.7	19.9	10.0	22.9	4.0	13.6	52.8	5.0	4.3	2.8	13.1	3.5	5.1	0.0	63.5	29.8	45.9	26.2	9.3	10.9	5.3	7.0	4.1	9.6	4.9	4.8	6.5	4.0	4.8	7.3	11.1	4.4	6.4	6.0	2.9	5.3	21.7	20.3	16.7	22.8	23.7	21.1	19.3	17.4	19.7	15.8	18.5	19.6	19.2	6.4	19.8	37.5	24.8	10.6	39.9	25.0	19.9	22.3	20.6	14.5	122.3	8.6	22.9	46.0	8.4	3.9	43.8	29.5	64.6	14.1	49.3	75.1	16.9	20.4	13.1	3.8	208.5	22.7	31.2	24.9	21.9	98.1	22.2	4.6	18.9	76.8	17.7	3.3	85.2	34.5	105.8	57.2	48.2	35.8	7.5	50.9	16.0	73.1	62.9	14.7	37.0	39.2	4.4	27.5	21.9	7.9	23.4	45.7	77.7	19.7	14.2	6.1	13.1	6.9	27.3	4.0	32.3	12.8	10.9	50.6	27.3	5.0	28.0	45.2
PSEN1	"AD3, FAD, PS1, S182"	ENSG00000080815	"Presenilin 1"	P49768	14	73136418-73223691	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell adhesion, Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Oligodendrocytes: 395.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006844, HPA030760, HPA067496"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Nucleoplasm, Cell Junctions"	"CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853"	"unprognostic (1.67e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.39e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.84e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.65e-1)"	"unprognostic (8.99e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.52e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.85e-1)"	25.1	22.6	44.3	26.5	80.7	39.6	28.2	62.4	56.0	28.1	48.9	49.5	50.2	25.3	26.9	35.2	22.9	31.7	18.0	47.4	51.6	35.5	31.9	32.1	22.4	73.0	63.8	22.0	22.9	35.1	11.6	43.1	71.5	24.3	46.3	23.4	22.9	23.4	18.4	38.2	49.0	27.1	55.7	22.6	31.0	32.5	60.8	26.2	36.9	23.3	30.7	35.0	19.2	119.1	37.1	55.9	50.6	20.0	68.9	49.9	46.7	52.5	60.1	52.6	66.7	69.9	88.9	23.7	34.1	50.5	43.0	94.9	43.2	40.1	57.3	54.6	26.7	27.1	35.1	34.4	63.8	27.7	50.7	50.4	71.9	44.3	54.4	48.5	43.2	26.2	31.0	46.6	50.0	72.8	21.0	35.7	22.0	64.5	40.4	26.4	42.7	30.2	73.7	76.5	28.1	38.3	57.4	53.0	47.1	45.4	66.3	60.7	45.7	53.1	43.5	44.1	25.3	30.3	47.9	23.7	44.9	32.8	33.3	126.8	94.5	96.3	23.1	106.0	22.6	23.1	22.3	19.0	83.4	31.8	20.7	20.1	129.3	42.8	125.0	43.6	37.0	70.3	44.3	80.7	62.4	56.0	47.4	51.6	73.0	63.8	71.5	55.7	60.8	119.1	22.2	28.9	30.5	35.9	25.8	28.6	24.6	24.7	12.0	17.1	25.0	17.7	12.5	15.7	30.2	23.9	39.6	27.1	30.7	79.1	5.9	27.1	22.9	26.3	26.4	22.3	16.2	12.0	38.9	26.7	29.2	23.7	32.1	47.4	18.3	29.6	15.7	24.6	30.5	13.5	40.2	39.5	24.4	50.5	40.8	12.9	16.4	52.3	16.0	39.4	51.8	13.8	14.4	48.7	395.8	38.2	58.8	15.4	23.6	38.8	76.2	13.0	29.0	28.0	26.3	20.0	19.0	40.2	14.4	20.4	33.0	49.9	21.6	18.6	41.3	51.5
PSEN2	"AD3L, AD4, PS2, STM2"	ENSG00000143801	"Presenilin 2"	P49810	1	226870184-226927726	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cardiomyopathy, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ionocytes: 36.7;Syncytiotrophoblasts: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (3.40e-2)"	"unprognostic (4.73e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.86e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (8.25e-3)"	"unprognostic (8.53e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	11.2	19.8	9.7	7.5	9.8	1.6	10.6	12.5	10.7	9.7	10.7	15.2	10.5	15.9	9.0	10.3	13.4	8.3	14.0	9.4	10.6	13.5	12.6	11.5	8.0	9.8	10.9	12.8	45.5	18.1	17.1	9.0	10.8	14.9	8.1	7.4	13.0	13.6	26.5	10.1	13.8	10.4	8.5	15.6	11.5	13.5	10.7	3.3	9.5	16.7	5.0	13.5	9.7	9.7	14.1	24.5	7.2	21.9	10.0	3.5	10.2	12.4	26.5	16.9	12.9	13.8	21.5	1.0	17.0	16.8	10.5	7.9	12.1	11.9	6.7	13.6	20.7	8.7	10.5	12.0	15.4	7.5	15.7	9.1	13.9	18.9	10.4	11.2	6.9	0.7	18.1	6.4	10.0	14.7	0.4	8.2	20.5	22.0	16.0	0.4	22.6	26.4	15.9	13.4	11.3	18.3	9.7	30.6	51.6	18.4	26.5	13.1	8.5	11.2	8.9	9.9	15.2	25.6	45.0	0.9	21.5	2.5	15.7	37.4	8.7	18.4	4.5	9.7	5.1	7.4	1.5	4.6	11.4	3.1	0.7	2.0	1.6	20.0	30.2	0.8	2.4	5.2	9.7	9.8	12.5	10.7	9.4	10.6	9.8	10.9	10.8	8.5	10.7	9.7	11.0	16.0	10.8	2.6	3.9	1.7	4.5	4.0	1.8	6.2	6.6	4.1	12.9	15.7	4.7	5.5	0.0	15.9	1.3	5.9	1.9	13.0	2.5	4.5	3.0	10.0	6.0	6.1	4.2	18.0	4.1	5.9	7.7	5.2	14.5	10.1	19.2	8.4	17.2	16.8	4.5	5.1	36.7	7.2	6.5	1.3	7.2	8.2	33.8	5.6	18.9	21.2	2.1	2.5	1.5	15.2	7.8	13.2	9.9	5.3	13.8	7.2	4.9	5.8	6.6	9.4	10.6	1.5	6.1	3.8	1.8	45.8	2.9	6.6	4.3	4.6
RAF1	"c-Raf, CRAF, Raf-1"	ENSG00000132155	"Raf-1 proto-oncogene, serine/threonine kinase"	P04049	3	12583601-12664125	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 175.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 175.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002639, HPA002640, CAB019291"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cytosol"		"CAB019291: , HPA002639: , HPA002640: AB_1856047"	"unprognostic (6.33e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.17e-3)"	"unprognostic (6.51e-3)"	"unprognostic (7.66e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-2)"	42.4	34.2	36.7	33.8	37.9	77.4	39.2	42.6	37.4	47.6	40.4	46.8	40.5	45.6	34.0	55.5	43.2	31.0	89.6	36.9	35.8	46.7	68.9	44.7	36.3	38.3	36.9	52.0	50.6	63.6	28.3	39.1	37.0	41.9	42.0	37.4	39.6	38.0	194.9	56.0	43.4	45.5	36.7	48.3	55.5	26.8	38.1	52.8	48.8	122.5	47.7	46.1	46.2	39.8	49.9	57.9	85.5	66.6	74.3	59.6	168.0	73.9	129.1	100.1	112.5	46.6	41.3	52.7	34.6	120.1	51.6	31.9	93.4	67.5	103.8	91.4	70.2	72.0	69.4	42.9	74.2	70.1	64.7	55.3	67.8	102.3	82.0	67.6	73.1	78.2	52.6	136.0	98.3	88.6	91.1	47.8	86.5	64.0	76.4	72.6	75.7	66.4	60.9	76.9	26.1	56.2	61.1	59.8	40.9	66.1	99.1	91.5	51.1	65.6	62.5	55.7	85.0	103.3	178.4	112.3	57.2	80.4	73.9	40.4	32.7	62.5	22.3	32.6	22.5	19.5	21.9	22.3	30.3	20.4	21.9	22.8	175.1	29.8	34.2	13.5	28.3	28.2	36.7	37.9	42.6	37.4	36.9	35.8	38.3	36.9	37.0	36.7	38.1	39.8	28.5	22.4	37.6	47.7	36.1	34.4	35.2	22.1	27.9	56.7	27.5	22.6	29.0	35.8	25.7	27.6	66.7	40.0	41.5	31.3	13.7	25.6	8.8	33.2	37.1	32.7	29.3	46.7	46.1	37.0	46.8	32.3	27.5	43.8	34.2	78.7	36.0	41.2	28.6	43.7	52.9	31.0	30.5	39.3	43.4	4.6	39.1	34.7	26.6	44.0	49.5	31.9	51.5	65.4	64.0	35.5	29.9	41.3	43.3	46.9	47.3	20.1	31.2	81.9	32.9	56.2	39.1	28.3	33.6	31.8	43.5	62.3	40.8	35.6	31.2	47.1
RBM20		ENSG00000203867	"RNA binding motif protein 20"	Q5T481	10	110644336-110839468	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.8;pancreas: 20.2"	"Cell type enriched"	"Detected in many"	8	"Cardiomyocytes: 151.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 6.0;HEL: 5.2;K-562: 5.0;RH-30: 16.2;SH-SY5Y: 15.0;SuSa: 4.9;T-47d: 9.2"	"Low region specificity"	"Detected in single"							"HPA035806, HPA070358"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytokinetic bridge"		Yes	No				"Cluster 38: Heart - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Golgi apparatus"	"Nucleoli, Cytokinetic bridge"	"HPA035806: AB_10672097, HPA070358: "	"unprognostic (2.43e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.75e-2)"	"unprognostic (5.47e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.78e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.46e-2)"	1.5	0.1	0.8	0.2	2.6	0.1	2.5	0.4	0.8	1.5	1.8	4.1	0.1	2.9	0.6	5.6	2.6	0.4	40.8	0.8	0.4	0.7	0.1	0.9	0.1	0.8	0.9	2.7	20.2	1.2	1.7	1.6	0.6	1.3	0.4	1.2	7.3	0.7	15.6	1.2	0.8	2.2	0.5	0.1	1.0	0.8	0.8	0.5	1.0	3.8	0.6	1.0	5.5	0.7	0.0	1.6	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.1	0.0	0.0	2.5	6.0	5.2	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.4	0.0	16.2	0.0	0.0	0.0	0.1	15.0	0.1	0.0	0.6	4.9	9.2	0.0	0.0	0.3	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.6	0.4	0.8	0.8	0.4	0.8	0.9	0.6	0.5	0.8	0.7	0.3	0.0	0.0	0.7	0.2	0.1	0.2	0.4	1.2	1.4	0.8	0.5	151.5	0.0	0.1	0.0	2.1	1.6	0.0	0.7	1.9	0.0	0.8	0.5	1.2	1.5	0.0	0.0	14.8	0.2	0.2	3.3	0.0	0.1	0.0	14.6	1.4	0.0	0.1	0.0	15.4	0.7	2.0	0.0	0.0	0.8	4.4	0.0	0.0	17.8	0.0	0.1	0.0	1.5	0.6	0.0	0.1	13.5	1.0	0.0	2.0	1.5	12.4	2.7	6.6	3.7	5.4	0.5	0.8	3.7	0.0	3.1	0.2	1.7	0.2	0.3
RYR2	"ARVC2, ARVD2, VTSIP"	ENSG00000198626	"Ryanodine receptor 2"	Q92736	1	237042184-237833988	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 132.0"	"Group enriched"	"Detected in many"	10	"Cardiomyocytes: 2180.6;Excitatory neurons: 1320.5;Inhibitory neurons: 790.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.7;HEK 293: 8.5;K-562: 2.3;NB-4: 2.7;NTERA-2: 3.1;U-937: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020028	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA020028: AB_1856528"	"unprognostic (5.23e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.02e-4)"	"unprognostic (6.26e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"	0.7	0.7	9.1	0.8	15.9	0.0	0.6	8.7	24.0	1.5	0.0	2.0	0.2	0.7	0.4	2.9	0.7	1.9	132.0	10.5	0.0	0.1	0.1	1.8	0.1	0.0	0.0	2.9	8.4	0.0	1.8	1.2	0.0	2.9	0.5	6.5	0.5	1.7	0.1	0.3	0.5	0.7	0.0	1.3	1.5	1.1	0.0	0.1	4.4	0.3	0.0	1.2	0.4	13.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.9	0.3	0.0	0.0	7.7	8.5	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	2.3	0.4	0.0	0.0	0.0	2.7	3.1	0.6	0.3	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	9.1	15.9	8.7	24.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.2	0.0	0.5	17.0	0.0	0.4	0.0	0.0	0.0	74.2	0.3	0.1	2180.6	0.0	1.3	1.8	10.4	0.1	0.1	0.0	0.0	0.0	21.1	0.2	3.4	10.6	3.5	0.0	1320.5	2.9	0.1	53.6	0.0	0.5	0.0	0.5	1.1	0.0	0.1	1.7	790.6	0.0	0.0	0.0	0.2	15.3	1.2	1.3	8.8	48.7	0.0	1.3	0.0	29.7	140.6	0.4	0.0	0.0	0.1	0.0	1.0	0.2	0.7	5.3	0.0	0.5	21.6	5.8	2.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0
SCN1B		ENSG00000105711	"Sodium voltage-gated channel beta subunit 1"	Q07699	19	35030470-35040449	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 256.5;skeletal muscle: 572.0;tongue: 227.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 67.9;Excitatory neurons: 50.4;Hofbauer cells: 31.3;Inhibitory neurons: 48.3;Kupffer cells: 35.1;Macrophages: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 17.5;EFO-21: 12.7;TIME: 26.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 349.1"						"Secreted in other tissues"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"				"unprognostic (8.18e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.34e-2)"	"unprognostic (4.72e-3)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.05e-2)"	"unprognostic (9.68e-3)"	"unprognostic (5.81e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.78e-2)"	20.2	13.6	48.2	3.3	53.0	2.3	16.3	95.8	256.5	15.5	7.7	9.7	1.9	9.4	2.2	8.6	21.7	4.8	95.4	45.0	97.2	8.3	8.5	11.1	3.0	120.4	67.0	7.8	12.3	18.2	17.4	5.3	115.7	8.7	2.7	10.7	15.4	3.6	572.0	6.3	8.0	4.5	52.2	19.8	8.4	2.8	153.5	1.3	11.1	227.8	0.8	13.4	10.5	113.6	0.4	17.5	0.2	1.0	5.2	7.8	0.1	7.1	6.1	3.4	0.9	0.7	0.2	0.2	12.7	7.1	3.0	0.3	1.1	0.7	1.6	0.2	0.8	0.2	2.5	4.5	6.9	0.1	0.1	2.5	0.1	0.4	0.2	6.8	11.6	0.2	0.4	0.1	2.2	1.7	0.2	0.2	0.8	1.6	5.1	0.9	1.8	0.2	0.5	0.1	8.1	4.3	0.9	0.1	1.4	0.6	1.6	0.4	26.1	6.7	6.6	0.3	4.6	0.3	0.5	1.0	4.0	0.8	4.8	0.7	0.2	0.1	0.3	0.1	0.6	0.1	0.1	0.1	0.6	0.2	0.1	0.1	0.7	0.2	0.1	0.1	0.3	0.7	48.2	53.0	95.8	256.5	45.0	97.2	120.4	67.0	115.7	52.2	153.5	113.6	12.8	0.0	3.3	11.8	1.1	1.8	0.8	1.6	0.0	67.9	1.6	7.7	20.3	0.0	0.6	0.0	2.1	0.4	2.9	0.0	9.8	0.3	0.3	2.0	2.0	9.7	0.0	0.4	50.4	2.6	0.6	9.9	2.0	1.8	2.5	0.1	20.7	1.2	31.3	8.4	48.3	1.6	0.0	35.1	3.7	0.0	7.5	29.5	3.6	15.9	3.0	13.3	0.0	6.0	18.5	0.7	0.1	2.2	2.7	1.1	0.1	2.5	1.0	22.8	0.0	25.3	3.6	0.2	0.7	0.1	1.1	1.0	2.0	0.1	0.8	0.3
SCN2B		ENSG00000149575	"Sodium voltage-gated channel beta subunit 2"	O60939	11	118162806-118176639	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.0;heart muscle: 12.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.8;Cardiomyocytes: 16.8;Excitatory neurons: 21.9;Horizontal cells: 13.5;Inhibitory neurons: 32.0;Oligodendrocytes: 7.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3;thyroid cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (9.01e-2)"	"unprognostic (3.50e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.71e-4)"	"unprognostic (5.17e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.35e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.88e-3)"	0.6	1.5	19.1	0.3	20.7	0.0	0.7	14.9	34.0	1.4	0.0	1.7	0.6	1.6	1.3	1.8	1.3	1.3	12.8	20.9	12.3	0.4	0.0	1.1	0.0	5.7	13.3	1.3	0.1	0.0	0.8	0.0	9.1	1.0	0.7	3.7	0.5	1.2	7.3	0.2	1.1	1.9	4.9	0.1	0.3	0.2	19.5	1.8	0.7	7.5	0.0	0.3	0.4	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	19.1	20.7	14.9	34.0	20.9	12.3	5.7	13.3	9.1	4.9	19.5	22.1	0.1	0.0	0.0	3.9	0.0	0.4	0.6	0.7	1.8	8.8	0.1	2.0	16.8	0.0	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.5	0.2	0.0	0.0	21.9	0.0	0.0	1.6	0.0	0.3	0.0	0.2	0.0	0.0	0.1	13.5	32.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	1.9	0.0	0.9	0.0	2.5	7.4	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.1	1.9	0.0	0.9	0.8	0.1	0.6	0.0	0.1	0.0	0.1	0.5	0.0	0.3
SCN3B	HSA243396	ENSG00000166257	"Sodium voltage-gated channel beta subunit 3"	Q9NY72	11	123629187-123655244	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.2;pituitary gland: 28.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 31.6;Excitatory neurons: 58.8;Horizontal cells: 20.2;Inhibitory neurons: 35.7;Late spermatids: 31.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"	"Group enriched"	"Detected in many"	8	"amygdala: 34.3;basal ganglia: 40.6;cerebral cortex: 49.7;hippocampal formation: 54.2;white matter: 15.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.8;GAMG: 1.8;hTCEpi: 5.8;RH-30: 2.0;SCLC-21H: 5.5;SH-SY5Y: 4.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"hippocampal formation: 166.1"	HPA041707			Approved	"Intermediate filaments,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Intermediate filaments"	Cytosol	"HPA041707: AB_2732493"	"unprognostic (1.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (8.13e-4)"	"unprognostic (3.93e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.29e-3)"	"unprognostic (5.64e-2)"	"unprognostic (3.34e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.13e-2)"	"unprognostic (9.16e-4)"	"unprognostic (4.01e-1)"	"unprognostic (1.89e-4)"	"unprognostic (2.01e-2)"	"unprognostic (9.01e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.43e-2)"	1.9	8.4	34.3	0.6	40.6	0.4	1.8	0.0	49.7	1.0	0.0	1.4	0.8	1.5	0.7	0.7	1.2	0.5	1.4	54.2	2.4	1.4	0.1	1.0	0.3	0.0	4.7	1.0	1.1	4.4	28.0	0.1	0.5	0.8	0.8	10.0	0.7	0.5	14.1	1.5	1.3	1.4	0.9	0.5	0.7	2.2	0.9	0.2	4.1	3.3	0.2	0.8	1.0	15.3	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.9	0.1	1.8	0.0	0.6	0.0	0.0	0.1	0.3	0.0	0.2	0.2	0.1	0.0	0.1	0.0	5.8	0.1	0.1	0.0	0.1	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.0	0.0	0.0	0.1	5.5	4.5	0.4	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	34.3	40.6	0.0	49.7	54.2	2.4	0.0	4.7	0.5	0.9	0.9	15.3	7.7	0.0	0.5	3.9	0.0	5.7	1.1	0.0	1.2	31.6	1.3	1.0	2.1	0.0	0.0	1.8	6.2	0.1	0.0	0.3	0.0	0.3	13.9	0.2	0.3	13.0	4.2	0.0	58.8	1.0	0.1	1.5	0.0	0.2	0.0	1.4	5.3	0.0	0.2	20.2	35.7	0.0	0.0	0.0	2.3	31.3	0.0	0.4	0.0	5.6	0.0	6.3	1.0	4.5	2.5	0.3	0.0	0.4	0.0	1.0	0.1	0.5	0.0	6.0	6.6	5.7	0.8	1.0	2.0	0.4	5.5	0.0	0.1	1.4	0.1	0.5
SCN4B	LQT10	ENSG00000177098	"Sodium voltage-gated channel beta subunit 4"	Q8IWT1	11	118133377-118152888	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 109.6;tongue: 56.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 12.3;Excitatory neurons: 18.2;Sertoli cells: 46.0;Smooth muscle cells: 38.8"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;HBEC3-KT: 1.0;NTERA-2: 1.4;U-2 OS: 1.2"	"Region enriched"	"Detected in all"	11	"basal ganglia: 816.3"	"Region enriched"	"Detected in many"	4	"basal ganglia: 134.6"	HPA017293	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA017293: AB_2184174"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-3)"	"unprognostic (9.17e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.31e-4)"	23.5	5.4	2.6	1.2	86.6	0.0	9.2	41.3	109.6	2.1	0.0	2.6	2.4	3.1	1.6	5.3	5.4	3.2	11.8	2.1	14.0	2.1	0.4	8.9	2.1	53.3	15.4	0.5	5.1	6.8	2.7	1.8	45.9	2.2	2.1	0.9	2.5	2.3	30.4	3.9	4.7	7.1	15.2	0.0	2.9	0.7	23.1	8.6	14.5	56.8	0.7	3.0	1.4	28.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	86.6	41.3	109.6	2.1	14.0	53.3	15.4	45.9	15.2	23.1	28.5	12.3	0.0	0.0	2.9	0.0	1.3	0.6	2.0	2.8	1.7	0.5	5.7	4.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.1	3.0	0.0	0.0	18.2	0.0	0.1	3.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	2.0	1.2	1.4	8.7	2.1	1.1	0.0	1.9	0.0	0.5	0.0	1.5	1.4	0.0	0.0	1.5	0.0	0.1	0.0	0.1	5.8	0.8	46.0	0.6	38.8	0.1	0.6	0.5	1.1	0.0	0.1	0.0	0.0	0.2
SCN5A	"CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1"	ENSG00000183873	"Sodium voltage-gated channel alpha subunit 5"	Q14524	3	38548057-38649687	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"heart muscle: 42.8"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 77.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"LHCN-M2: 27.6;RH-30: 22.8"	"Group enriched"	"Detected in many"	5	"amygdala: 3.1;basal ganglia: 10.1;hypothalamus: 6.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 5.4"	HPA063346			Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA063346: "	"unprognostic (9.29e-4)"	"unprognostic (4.05e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.16e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.95e-3)"	0.2	0.1	1.9	0.1	1.2	0.2	0.2	0.0	0.7	1.7	0.0	0.2	0.2	0.7	0.0	0.1	0.3	0.1	42.8	0.2	1.5	0.0	0.0	0.1	0.0	0.0	0.7	0.5	0.0	0.0	0.4	0.2	0.0	0.3	0.1	2.0	0.2	0.5	1.6	0.1	0.2	0.3	0.2	0.1	0.1	0.3	2.6	0.0	0.2	1.0	0.0	0.4	0.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.1	0.4	0.1	0.0	0.2	3.6	0.0	0.0	0.0	1.0	0.5	2.7	0.0	0.4	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.4	0.0	2.1	2.8	0.4	0.0	0.0	27.6	1.4	0.0	0.0	2.6	0.0	0.0	0.0	22.8	0.0	0.0	3.2	0.4	3.1	0.0	0.0	0.0	0.8	0.0	0.0	5.7	0.0	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.2	0.0	0.7	0.2	1.5	0.0	0.7	0.0	0.2	2.6	0.2	0.1	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	2.7	0.0	0.3	77.1	0.0	0.1	0.0	14.6	0.2	0.0	0.0	0.0	0.1	1.2	0.1	3.2	2.8	0.0	0.0	0.5	0.0	0.3	3.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	6.3	0.3	0.6	0.2	0.0	3.7	0.0	0.6	0.0	1.5	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.9	0.0	7.3	3.1	0.2	1.0	0.0	0.0	0.0	0.1	0.1	0.0	1.4
SDHA	"FP, SDH2, SDHF"	ENSG00000073578	"Succinate dehydrogenase complex flavoprotein subunit A"	P31040	5	218241-257082	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Cardiomyopathy, Disease variant, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 601.0;skeletal muscle: 479.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB034929, HPA041981, HPA064582"	Enhanced		Supported	Nucleoli,Mitochondria		No	No		360000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoli	"CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293"	"prognostic unfavorable (6.00e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (9.53e-8)"	"unprognostic (1.11e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.79e-1)"	70.6	148.0	60.5	29.6	62.7	38.4	65.8	78.7	71.3	50.2	63.2	131.9	148.9	53.2	27.3	67.1	50.3	33.9	601.0	60.8	73.4	139.1	276.8	54.3	43.1	74.1	62.7	65.8	71.5	122.9	44.8	28.8	75.7	46.3	82.1	42.7	66.8	35.6	479.0	58.9	116.8	36.1	61.7	66.4	115.6	56.4	71.7	41.8	49.6	224.8	36.5	63.2	56.3	63.7	88.4	154.2	54.8	95.0	96.9	68.5	154.1	63.3	81.8	107.2	108.4	163.9	115.9	108.3	218.6	70.2	92.1	111.8	102.4	129.7	66.3	241.9	98.9	50.1	390.8	224.1	60.0	69.5	70.7	70.6	84.3	83.6	33.7	93.6	123.9	83.5	84.6	83.1	48.7	155.8	93.9	206.9	19.3	101.4	193.5	119.0	84.6	223.2	245.4	122.7	62.3	35.4	332.5	205.5	90.7	36.1	115.0	93.2	91.1	80.3	82.1	48.2	52.5	93.0	40.9	79.8	81.6	99.9	52.5	66.6	70.8	88.1	95.2	85.7	86.8	79.5	92.5	94.5	93.3	73.3	89.2	85.0	14.1	85.5	74.7	59.5	149.3	111.3	60.5	62.7	78.7	71.3	60.8	73.4	74.1	62.7	75.7	61.7	71.7	63.7	29.4	35.3	71.1	20.2	50.9	61.2	81.4	105.8	31.3	51.0	24.6	17.0	272.6	64.3	78.5	75.4	102.2	109.6	39.3	169.7	142.8	94.7	58.7	39.1	30.1	39.1	47.5	56.8	34.4	44.9	102.8	49.4	47.9	48.5	43.7	64.8	47.5	167.0	67.5	101.0	39.9	96.3	105.8	41.0	55.0	28.8	68.3	38.8	90.7	12.2	60.2	50.7	52.5	19.1	37.9	54.2	100.1	55.7	67.5	37.0	274.4	190.7	75.2	87.2	78.9	33.2	51.7	96.9	54.3	40.9	35.9	154.7	56.7	85.0	160.1	88.2
SGCD	"CMD1L, DAGD, LGMD2F"	ENSG00000170624	"Sarcoglycan delta"	Q92629	5	155870344-156767788	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 39.1;skeletal muscle: 42.9;tongue: 33.3"	"Group enriched"	"Detected in many"	4	"Astrocytes: 365.7;Cardiomyocytes: 107.8;Excitatory neurons: 193.0;Inhibitory neurons: 161.2;Microglial cells: 124.6;Oligodendrocyte precursor cells: 417.2;Oligodendrocytes: 196.4"	"Cancer enriched"	"Detected in many"	5	"melanoma: 10.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 16.1;fHDF/TERT166: 25.7;LHCN-M2: 12.7;RH-30: 18.2;SK-MEL-30: 27.0;U-138 MG: 24.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 68: Oligodendrocytes - Mixed function"				"unprognostic (2.23e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.55e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.99e-2)"	"unprognostic (4.10e-2)"	"unprognostic (9.65e-3)"	"unprognostic (5.37e-2)"	"unprognostic (5.60e-3)"	"unprognostic (3.66e-3)"	5.4	4.2	3.2	2.1	2.0	0.0	3.3	1.6	3.6	6.8	0.0	7.9	2.0	8.2	2.5	6.2	2.9	9.3	39.1	2.9	2.7	1.3	2.0	5.0	0.4	4.2	3.8	8.8	1.0	9.9	1.5	0.6	4.3	6.0	3.6	1.6	1.9	5.2	42.9	1.6	2.7	13.4	3.9	1.4	2.9	1.3	2.0	0.7	17.8	33.3	0.5	6.6	3.1	6.6	0.0	6.4	0.0	0.0	5.8	9.2	0.0	16.1	5.5	0.0	0.2	0.0	0.0	0.0	0.0	25.7	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	8.5	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	3.0	0.1	0.0	0.0	27.0	0.0	0.0	0.0	0.0	24.1	0.0	4.3	0.0	0.1	0.1	0.0	4.1	0.0	9.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.0	1.6	3.6	2.9	2.7	4.2	3.8	4.3	3.9	2.0	6.6	0.7	0.0	0.5	365.7	0.0	3.6	0.0	0.0	0.0	3.5	4.0	2.2	107.8	0.0	0.0	0.0	54.2	0.0	1.6	0.1	0.0	0.1	6.9	6.1	1.5	1.7	1.8	0.0	193.0	0.0	0.0	27.4	0.0	16.3	0.0	11.3	3.3	1.6	0.2	21.9	161.2	0.0	0.0	0.0	2.5	13.3	19.0	0.8	24.9	124.6	0.0	0.3	0.0	417.2	196.4	0.0	0.0	15.4	0.7	0.8	0.0	0.3	0.0	1.2	0.0	38.5	5.9	0.0	0.4	0.5	3.1	0.1	1.0	9.4	0.0	0.2
SGO1	"NY-BR-85, SGOL1"	ENSG00000129810	"Shugoshin 1"	Q5FBB7	3	20160593-20186206	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.7;lymphoid tissue: 13.0;testis: 6.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 16.5;Extravillous trophoblasts: 42.6;Granulosa cells: 20.3;Hofbauer cells: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basophil: 10.0;memory B-cell: 8.8;naive B-cell: 8.9;plasmacytoid DC: 4.1;T-reg: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035501, HPA069302, HPA069857"	Enhanced		Enhanced	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Kinetochore, Cytosol"	"HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214"	"unprognostic (6.87e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.55e-6)"	"unprognostic (9.49e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (1.52e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.64e-1)"	0.3	0.1	0.3	3.3	0.7	8.7	0.5	0.9	0.5	0.4	0.0	2.1	2.3	0.4	0.0	1.9	0.1	0.4	0.1	0.3	0.4	0.3	0.6	0.3	6.2	0.8	0.6	0.2	0.1	0.2	0.0	1.7	0.6	0.2	2.8	0.1	0.4	0.1	0.1	1.1	2.5	1.0	0.3	1.4	1.5	6.7	0.6	13.0	0.2	0.0	6.6	0.9	0.7	1.2	20.3	23.9	29.9	18.5	1.4	2.6	20.2	21.3	10.1	31.2	33.6	16.5	24.0	30.7	10.6	8.6	21.2	11.4	28.7	11.3	37.6	40.9	19.6	34.6	15.6	12.8	0.2	32.0	28.8	0.3	0.9	33.3	13.1	4.0	18.5	34.9	31.3	52.2	24.6	19.4	52.4	15.4	30.0	20.3	17.0	31.8	38.4	17.7	7.5	14.9	14.2	15.4	23.6	27.2	13.1	22.7	18.2	21.3	4.7	22.5	27.3	20.5	43.3	22.8	57.4	35.2	12.5	31.1	35.0	10.0	0.1	1.4	0.2	0.2	0.1	8.8	0.6	0.7	0.3	8.9	0.2	0.3	1.4	0.3	0.2	4.1	2.6	0.6	0.3	0.7	0.9	0.5	0.3	0.4	0.8	0.6	0.6	0.3	0.6	1.2	0.1	0.0	0.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.0	3.4	0.0	0.0	0.0	1.8	0.0	16.5	1.5	0.0	0.0	1.1	0.0	2.3	1.6	1.2	0.0	0.0	0.0	1.8	42.6	3.3	0.0	2.9	1.3	20.3	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	4.9	1.0	4.3	0.0	0.0
SNTA1	"LQT12, SNT1, TACIP1"	ENSG00000101400	"Syntrophin alpha 1"	Q13424	20	33407957-33443763	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"	"Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 198.3;skeletal muscle: 307.9;tongue: 327.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 117.2;Cardiomyocytes: 175.1;Muller glia cells: 83.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 10.4"	"Group enriched"	"Detected in many"	4	"B-cells: 5.7;dendritic cells: 10.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 66.5"	"Low region specificity"	"Detected in all"							"CAB037059, HPA067154"	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB037059: AB_261497, HPA067154: "	"unprognostic (2.25e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (9.60e-6)"	"unprognostic (5.68e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-2)"	"prognostic favorable (7.08e-4)"	"unprognostic (2.16e-1)"	"prognostic favorable (3.72e-4)"	"unprognostic (1.99e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.29e-2)"	"unprognostic (7.60e-2)"	39.2	18.7	162.7	4.5	179.8	2.0	25.5	158.2	198.3	24.9	127.9	23.7	6.6	16.9	8.0	22.6	20.4	7.6	195.9	158.1	149.3	23.0	16.6	8.0	5.9	167.9	166.0	20.6	13.5	20.9	12.4	3.1	144.5	19.6	3.0	15.0	31.3	18.1	307.9	15.0	13.7	9.3	147.4	5.0	23.8	19.3	178.7	3.4	77.8	327.9	5.2	38.6	17.0	144.5	13.0	6.5	2.9	28.2	66.5	13.0	2.8	9.8	13.6	18.3	15.2	16.9	4.3	9.3	11.6	16.8	33.4	16.9	8.4	5.4	3.2	1.9	10.8	0.5	15.7	23.9	18.8	0.9	1.6	12.0	6.7	8.0	3.0	10.1	2.8	8.8	22.8	3.5	9.3	1.6	17.7	2.2	1.6	1.9	37.2	11.1	20.8	10.3	3.8	11.6	12.3	10.6	38.5	11.5	19.4	2.2	17.8	1.6	4.6	9.0	17.5	36.1	9.2	21.2	11.7	5.6	19.5	1.7	1.4	0.0	0.0	0.0	0.9	0.0	1.9	5.7	0.9	0.9	0.0	2.8	0.3	0.7	0.0	0.0	0.0	10.4	1.1	0.3	162.7	179.8	158.2	198.3	158.1	149.3	167.9	166.0	144.5	147.4	178.7	144.5	4.6	3.2	2.0	117.2	5.1	3.2	4.7	1.3	1.2	5.7	6.2	8.0	175.1	8.6	1.9	1.8	4.2	1.2	4.9	1.3	39.2	2.0	1.0	1.2	3.7	4.4	4.2	5.7	12.7	2.6	1.9	13.4	5.1	4.1	0.0	10.1	3.9	9.1	1.9	0.0	8.3	1.6	8.2	1.9	2.3	2.3	25.1	1.6	5.4	10.3	0.0	83.7	3.1	5.0	6.3	3.3	1.6	28.2	2.3	5.7	5.4	33.5	0.8	36.5	26.3	12.7	36.7	1.8	4.9	3.5	2.8	0.8	9.3	3.2	1.6	5.6
TAZ	"BTHS, CMD3A, EFE, EFE2, G4.5, TAZ1, XAP-2"	ENSG00000102125	Tafazzin	Q16635	X	154411524-154421726	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039557	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA039557: AB_10672899"	"unprognostic (1.14e-1)"	"prognostic favorable (5.70e-4)"	"unprognostic (4.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (8.29e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.68e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (1.22e-7)"	"unprognostic (4.00e-3)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.79e-2)"	19.0	13.8	37.2	8.5	38.1	41.4	17.2	38.1	44.4	18.1	37.0	18.3	9.7	15.1	7.6	21.7	16.6	8.7	43.5	37.0	37.0	22.3	21.9	21.4	17.9	39.3	37.6	18.5	21.3	12.1	14.5	6.6	38.5	17.9	11.7	8.4	13.6	10.2	47.0	18.7	22.9	12.3	37.7	39.2	17.4	4.5	37.9	14.1	18.5	65.6	16.0	18.4	18.4	39.4	24.5	28.6	9.3	11.7	18.3	13.4	18.4	6.9	21.0	15.3	17.1	8.5	29.6	28.2	43.6	16.4	36.6	28.4	17.2	16.6	12.3	25.5	19.6	5.5	20.0	16.4	25.8	12.3	11.8	15.4	35.6	11.7	31.7	12.9	25.6	30.9	12.1	34.9	18.1	17.6	29.0	33.2	2.4	24.9	27.9	21.4	16.2	40.1	24.2	9.0	11.8	17.9	5.3	17.9	26.6	11.1	10.5	16.0	15.5	10.4	11.9	25.5	15.2	55.9	30.6	66.2	13.7	36.6	13.3	5.8	11.1	17.5	12.4	10.4	11.5	12.5	16.6	15.5	14.5	18.7	14.1	12.0	9.9	12.7	7.8	7.9	15.4	9.4	37.2	38.1	38.1	44.4	37.0	37.0	39.3	37.6	38.5	37.7	37.9	39.4	36.2	6.4	11.8	37.2	29.3	10.8	7.9	10.5	14.8	21.6	11.1	15.6	21.1	14.3	13.0	9.2	18.8	5.0	29.7	13.6	5.9	14.7	1.1	6.5	9.6	18.5	6.1	9.7	22.4	16.5	10.1	12.4	23.4	9.6	18.4	19.2	15.0	7.9	24.4	10.1	28.4	15.9	12.2	19.9	16.5	2.0	11.5	20.4	14.2	14.0	21.7	14.2	15.5	23.1	39.7	13.4	12.2	9.1	17.2	8.3	19.6	5.9	8.0	25.6	13.1	12.4	11.3	10.4	3.8	16.8	11.2	2.9	25.6	9.2	15.8	6.7
TCAP	"CMD1N, LGMD2G, T-cap, TELE, telethonin"	ENSG00000173991	Titin-cap	O15273	17	39665349-39666554	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	47	"heart muscle: 5162.1;skeletal muscle: 15829.0;tongue: 5831.4"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 2473.2"	"Group enriched"	"Detected in many"	8	"head and neck cancer: 20.2;prostate cancer: 11.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 5.3;SK-BR-3: 8.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 15.8"	"Low region specificity"	"Detected in some"			"CAB004591, HPA026477"	Enhanced					NA	NA		36000	"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB004591: AB_628340, HPA026477: AB_1857888"	"unprognostic (5.29e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.40e-3)"	"unprognostic (4.32e-3)"	"unprognostic (8.79e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-4)"	"unprognostic (2.62e-1)"	"unprognostic (4.51e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"prognostic favorable (4.55e-4)"	4.1	4.2	13.0	0.8	16.2	2.9	5.7	13.7	16.1	3.0	11.4	3.2	0.7	2.2	0.0	188.9	2.5	1.8	5162.1	12.1	13.0	3.1	3.4	8.4	3.3	13.2	14.3	3.5	2.7	0.9	5.3	0.9	13.2	107.1	0.1	1.1	137.6	1.6	15829.0	5.5	2.5	0.8	12.2	3.2	2.6	3.5	14.1	1.0	5.0	5831.4	0.9	1.7	3.0	13.0	0.1	2.5	1.7	2.2	0.2	0.3	0.6	0.4	0.2	0.4	0.5	0.9	1.5	1.0	1.6	0.3	1.7	0.9	0.3	0.0	0.0	0.9	2.6	0.7	2.0	0.4	0.1	0.6	0.3	0.7	0.3	1.0	0.1	1.0	0.2	1.1	1.6	0.3	0.0	1.1	0.7	5.3	1.0	0.9	0.6	0.7	1.5	0.7	0.8	0.2	1.0	1.7	1.3	8.4	1.1	0.9	0.6	1.1	1.1	0.8	1.0	1.4	0.5	3.7	2.0	0.5	0.6	1.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	13.0	16.2	13.7	16.1	12.1	13.0	13.2	14.3	13.2	12.2	14.1	13.0	3.3	0.0	0.0	8.1	0.7	1.7	0.5	0.3	0.0	1.5	1.5	0.9	2473.2	5.7	0.3	1.8	0.0	0.1	0.3	0.4	1.9	0.3	0.4	0.9	0.5	29.0	3.0	1.3	2.2	0.0	0.0	68.5	1.5	0.6	0.0	0.8	2.2	0.0	0.4	10.1	2.7	1.1	0.0	0.6	2.0	0.1	0.3	2.9	1.8	1.0	0.1	0.8	0.0	1.0	2.6	0.5	0.6	0.4	0.9	0.7	0.5	0.3	0.6	1.7	6.6	336.9	25.4	1.0	1.2	0.0	2.0	0.4	1.9	0.5	1.2	0.7
TECRL	"DKFZp313B2333, DKFZp313D0829, GPSN2L, SRD5A2L2, TERL"	ENSG00000205678	"Trans-2,3-enoyl-CoA reductase like"	Q5HYJ1	4	64275257-64409468	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"heart muscle: 554.3"	"Cell type enriched"	"Detected in some"	35	"Cardiomyocytes: 1775.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"																					0.0	0.3	0.1	0.1	0.3	1.0	0.6	0.8	0.3	0.0	0.2	0.0	0.0	0.2	0.0	0.4	0.1	0.1	554.3	0.1	0.5	0.0	0.0	0.2	0.4	0.3	0.1	0.1	0.5	0.1	0.0	0.1	0.4	1.7	0.0	0.5	0.3	0.0	56.2	1.0	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.6	1.9	0.0	0.3	0.0	0.9	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.8	0.3	0.1	0.5	0.3	0.1	0.4	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1775.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.2	0.0	0.0	50.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TGFB3	"ARVD, ARVD1"	ENSG00000119699	"Transforming growth factor beta 3"	P10600	14	75958097-75983011	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"		"Growth factor, Mitogen"	"Cancer-related genes, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 28.8;Late spermatids: 48.9;Leydig cells: 27.1;Sertoli cells: 32.9;Smooth muscle cells: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"SK-BR-3: 104.6;T-47d: 75.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA063582			Approved	Vesicles	"Secreted to blood"	NA	NA	44800			"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA063582: AB_2685049"	"unprognostic (7.84e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (4.01e-7)"	"unprognostic (6.38e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.27e-3)"	22.2	13.0	43.4	15.8	45.8	1.0	15.6	33.5	58.4	46.6	18.4	12.8	4.1	25.5	9.6	7.7	14.5	36.6	27.9	31.2	38.4	20.5	17.6	25.7	7.2	40.9	42.3	8.0	27.7	9.9	8.3	55.4	40.0	43.6	4.8	1.8	10.8	17.9	38.6	5.0	6.6	34.3	38.9	5.3	14.1	4.5	42.2	6.5	12.3	11.0	8.8	45.8	16.2	70.1	1.1	1.5	1.1	13.4	2.1	4.3	0.4	1.0	1.5	0.7	0.7	0.8	3.4	0.1	1.0	2.8	0.4	0.9	2.9	0.7	0.3	0.8	1.5	0.1	3.5	1.5	2.7	0.6	0.9	10.2	0.4	1.0	0.4	2.3	3.2	2.7	1.5	6.3	0.8	7.0	0.8	0.8	0.4	0.8	5.3	3.3	4.2	0.7	1.2	0.6	21.9	6.3	4.3	104.6	0.8	1.5	75.2	0.5	0.8	2.0	4.5	2.1	5.8	0.8	1.3	0.4	3.6	1.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.4	45.8	33.5	58.4	31.2	38.4	40.9	42.3	40.0	38.9	42.2	70.1	8.6	0.0	2.8	5.5	0.8	4.5	1.2	2.1	1.2	0.7	15.1	6.1	3.6	0.0	3.3	1.8	4.2	0.5	1.2	1.3	0.0	0.5	16.4	2.6	9.9	10.2	0.0	0.0	1.3	1.3	0.4	28.8	0.0	2.4	0.0	0.5	7.9	0.8	0.9	0.0	3.0	2.6	6.1	0.6	4.4	48.9	27.1	0.9	10.6	1.0	0.7	2.1	3.1	5.5	4.7	0.4	0.1	12.8	0.5	20.6	1.4	0.4	4.2	3.9	32.9	13.9	24.4	0.4	1.4	2.4	3.1	1.4	1.3	1.6	0.4	0.8
TMEM43	"ARVD5, DKFZp586G1919, LUMA, MGC3222"	ENSG00000170876	"Transmembrane protein 43"	Q9BTV4	3	14125015-14143680	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Cardiomyopathy, Disease variant, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 137.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA019198	Approved					NA	NA		34000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA019198: AB_1858118"	"unprognostic (3.65e-3)"	"unprognostic (2.52e-1)"	"unprognostic (4.03e-2)"	"unprognostic (4.66e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (5.77e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.19e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.18e-1)"	75.4	34.3	23.1	36.8	23.8	21.0	61.3	23.0	25.3	66.8	23.5	56.7	23.5	89.1	31.0	69.5	63.9	47.1	64.7	23.2	25.0	27.7	19.6	58.1	30.2	27.5	25.1	82.6	27.3	25.6	30.6	57.6	25.9	43.3	29.4	15.9	37.9	65.2	60.8	108.7	40.0	82.5	23.6	31.2	34.8	15.2	25.5	26.0	47.0	45.8	33.7	56.1	66.4	25.2	41.5	45.7	44.1	58.3	173.4	180.6	104.6	80.1	164.8	129.9	93.0	37.5	54.1	19.5	55.7	201.3	64.3	88.3	47.1	70.9	92.9	48.7	38.0	35.3	45.6	53.8	109.3	51.4	40.4	136.0	173.6	107.9	133.0	103.6	94.8	36.2	56.1	47.8	76.6	54.3	23.4	43.2	48.4	62.8	75.3	32.2	46.8	78.2	59.4	70.4	12.9	35.5	101.0	59.3	66.5	37.3	37.5	74.3	86.4	118.7	63.7	120.6	76.0	32.1	54.3	25.1	89.3	68.4	108.7	81.3	51.5	100.3	68.7	45.5	64.0	36.8	66.8	62.7	67.4	31.6	44.5	49.0	157.2	79.9	49.2	42.6	65.7	69.7	23.1	23.8	23.0	25.3	23.2	25.0	27.5	25.1	25.9	23.6	25.5	25.2	44.2	137.8	46.8	17.9	16.8	43.7	32.2	31.0	39.9	6.2	19.9	29.7	13.4	15.7	52.9	18.4	14.6	31.2	43.2	9.3	0.0	34.9	0.6	17.3	58.1	37.4	4.9	22.5	24.1	10.0	65.6	68.0	20.9	34.4	28.4	16.1	23.6	8.9	17.8	6.7	20.6	8.3	8.2	16.1	33.5	3.9	43.2	19.8	30.2	15.9	26.8	8.4	16.5	30.2	23.9	22.4	9.7	70.7	15.6	35.8	8.8	9.0	16.2	8.6	32.9	43.6	39.3	5.6	12.0	44.1	45.5	37.5	32.1	17.6	11.5	30.2
TMPO	"LAP2, LEMD4, TP"	ENSG00000120802	Thymopoietin	"P42166, P42167"	12	98515579-98550351	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding	Cardiomyopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 139.9"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 172.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008150, CAB009847, HPA070805"	Enhanced		Enhanced	"Nuclear membrane"		NA	Yes		190000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"		"CAB009847: AB_2205450, HPA008150: AB_1079235, HPA070805: "	"unprognostic (2.36e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.90e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-3)"	"prognostic unfavorable (9.34e-4)"	"unprognostic (6.01e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.26e-2)"	17.1	13.9	8.4	44.0	9.4	93.2	24.3	19.1	15.1	23.2	10.1	34.5	34.1	30.8	34.4	27.0	22.8	17.7	11.0	9.1	9.6	21.7	37.2	21.9	78.7	9.7	8.9	56.2	25.3	17.8	8.4	29.4	9.6	17.2	36.4	20.7	16.5	19.1	12.2	22.7	39.6	22.3	8.8	39.1	35.7	23.1	9.6	139.9	15.2	12.2	78.1	20.7	20.7	14.2	180.5	117.5	283.3	145.5	23.1	30.7	166.2	145.0	77.1	193.9	139.5	129.5	88.9	314.4	86.2	85.6	70.7	113.0	240.8	110.1	177.1	217.7	148.5	269.1	103.3	86.5	21.2	315.4	170.8	17.6	35.4	115.0	61.2	66.9	112.8	192.0	231.8	118.1	122.0	114.7	514.9	248.6	170.1	167.2	108.6	421.3	187.2	218.6	69.3	167.7	221.9	132.2	248.9	155.2	79.3	110.6	174.3	149.2	60.4	111.1	96.5	76.8	150.8	125.9	231.9	344.0	32.0	179.5	151.0	48.6	30.4	13.4	18.9	54.1	20.5	22.4	21.9	21.6	23.4	27.2	30.0	23.5	2.4	20.7	75.9	12.9	28.5	30.5	8.4	9.4	19.1	15.1	9.1	9.6	9.7	8.9	9.6	8.8	9.6	14.2	45.4	32.1	27.9	3.6	70.1	27.8	23.7	18.7	28.5	21.1	21.2	28.6	9.0	25.8	33.5	31.3	12.5	36.0	48.5	63.0	31.3	19.5	42.7	29.5	29.8	38.0	28.7	172.1	20.3	31.5	89.7	32.2	56.1	42.7	29.1	70.1	34.2	50.0	38.2	10.1	15.3	63.4	16.2	63.1	34.9	32.1	28.6	73.4	17.8	23.4	63.5	20.3	54.6	14.6	19.1	26.7	28.5	40.6	81.9	21.1	33.7	33.1	25.6	52.6	19.7	27.3	32.0	54.0	59.4	62.8	23.3	11.8	60.8	32.4	62.4	21.8
TNNC1	TNNC	ENSG00000114854	"Troponin C1, slow skeletal and cardiac type"	P63316	3	52451100-52454041	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	36	"heart muscle: 8734.3;skeletal muscle: 21081.1;tongue: 12403.9"	"Cell type enriched"	"Detected in many"	10	"Cardiomyocytes: 3550.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 27.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 68.2;CAPAN-2: 33.5;EFO-21: 65.2;HeLa: 49.1;Hep G2: 46.1;HSkMC: 67.2;U-2 OS: 97.7"	"Region enriched"	"Detected in all"	4	"cerebral cortex: 87.0"	"Group enriched"	"Detected in some"	6	"midbrain: 7.6;spinal cord: 7.1"	"CAB002450, HPA044848, HPA056897"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Mitochondria"		NA	NA		990000	"Cluster 13: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Actin filaments, Mitochondria"		"CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269"	"unprognostic (2.18e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.15e-2)"	"unprognostic (4.86e-1)"	8.4	10.9	0.7	0.8	0.8	0.7	19.1	2.7	1.1	7.7	7.3	4.0	1.1	2.8	41.7	387.3	2.8	3.3	8734.3	1.2	0.7	19.2	4.0	78.5	3.9	0.8	0.9	2.4	6.8	1.6	17.6	5.2	1.0	170.1	4.1	0.4	120.8	2.2	21081.1	18.9	3.3	0.8	0.8	2.8	5.7	10.6	0.8	4.3	14.4	12403.9	1.6	5.3	5.4	0.7	0.7	5.2	3.6	0.6	0.2	0.5	8.0	0.4	0.3	0.3	0.4	68.2	33.5	0.5	65.2	9.9	0.1	0.4	0.1	0.3	0.0	1.2	1.6	0.5	49.1	46.1	0.3	0.3	0.1	67.2	1.2	0.0	0.7	0.6	0.0	2.0	0.2	5.1	2.0	0.1	0.2	0.8	0.5	15.1	0.7	0.1	2.9	2.3	3.3	13.0	0.2	0.0	0.5	6.7	0.1	3.9	26.7	0.5	0.0	0.1	97.7	0.8	0.2	2.8	1.3	0.9	0.3	0.7	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.8	0.1	0.7	0.8	2.7	1.1	1.2	0.7	0.8	0.9	1.0	0.8	0.8	0.7	0.2	125.0	12.6	0.0	0.3	1.5	1.7	4.0	0.6	0.2	0.5	0.3	3550.1	5.7	7.9	3.7	2.1	59.0	0.1	1.6	27.4	11.8	0.7	66.4	6.7	39.8	330.7	0.4	0.0	13.0	5.1	52.7	0.5	98.8	0.0	0.8	0.7	0.7	4.9	0.0	0.0	1.7	2.0	0.0	1.4	5.8	22.4	2.6	5.4	0.0	0.1	1.2	0.0	0.0	0.0	6.5	0.3	177.6	0.1	0.8	0.5	1.3	2.8	0.1	0.0	241.8	36.0	2.1	1.0	0.1	0.9	31.1	2.8	1.3	2.0	6.8
TNNI3	"CMD2A, CMH7, TNNC1"	ENSG00000129991	"Troponin I3, cardiac type"	P19429	19	55151767-55157773	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	622	"heart muscle: 10813.5"	"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 12618.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 13.0;HMC-1: 20.3;K-562: 39.1;OE19: 54.6"	"Region enhanced"	"Detected in many"		"olfactory bulb: 10.9"	"Low region specificity"	"Detected in many"			"CAB009349, HPA046428"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		2400000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	Vesicles	"CAB009349: AB_793465, HPA046428: AB_2679661"	"unprognostic (2.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.62e-3)"	"unprognostic (9.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.17e-3)"	"unprognostic (4.02e-3)"	"unprognostic (8.89e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.82e-2)"	1.1	3.0	0.3	0.0	0.5	0.0	17.3	0.2	0.4	0.7	0.7	0.7	0.0	0.3	0.1	0.8	6.2	0.9	10813.5	0.6	0.2	1.0	1.1	7.3	1.6	0.5	2.8	1.4	2.3	0.2	0.6	1.0	1.3	2.4	0.0	0.2	1.3	0.0	6.5	1.2	0.6	0.0	0.6	0.4	0.7	3.7	0.3	0.1	1.5	2.4	0.0	0.4	0.6	0.3	1.2	0.6	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.4	0.0	0.3	1.8	6.3	0.0	1.1	1.1	1.2	0.3	0.0	0.0	13.0	3.0	0.0	1.9	0.5	0.0	20.3	0.0	0.6	0.1	0.3	0.1	0.1	0.8	39.1	0.8	0.0	0.6	0.2	0.0	0.7	54.6	0.5	1.9	0.4	0.1	1.8	0.0	0.1	2.2	0.0	0.0	0.2	0.0	2.8	9.5	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.6	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.4	0.6	0.2	0.5	2.8	1.3	0.6	0.3	0.3	0.1	0.0	0.0	0.0	0.2	6.9	0.0	0.8	13.6	0.0	1.0	0.9	12618.4	8.6	1.8	5.5	0.0	1.4	0.1	0.4	0.0	0.7	56.2	3.5	0.1	131.3	1.8	0.0	0.0	0.2	0.5	202.7	0.0	1.3	0.0	996.2	0.0	0.0	2.2	1.7	0.2	0.4	2.0	0.3	0.7	222.9	0.3	4.6	1.8	1.9	0.0	4.2	0.0	0.0	0.1	1.0	0.0	1.9	0.0	0.0	0.0	0.1	11.2	0.5	0.0	0.4	123.6	6.4	16.1	0.7	2.8	2.5	0.6	1.2	1.0	0.1
TNNI3K	CARK	ENSG00000116783	"TNNI3 interacting kinase"	Q59H18	1	74235387-74544428	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"heart muscle: 58.7"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 27.0;Early spermatids: 32.0;Late spermatids: 6.6;Proximal tubular cells: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CAPAN-2: 1.0"															NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (1.04e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.66e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.59e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.20e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.77e-2)"	1.8	1.4	3.6	0.3	3.6	0.1	1.4	4.9	7.2	1.0	2.0	2.0	0.4	1.3	2.5	0.6	1.5	0.4	58.7	3.7	3.9	3.4	0.4	0.9	0.4	3.3	3.2	1.5	0.4	0.7	2.3	0.0	3.6	1.1	0.5	5.2	0.8	0.4	1.5	1.6	0.8	0.9	3.5	1.4	1.1	4.0	3.5	0.4	1.0	0.6	0.5	1.4	0.9	4.8	0.0	0.1	0.2	0.0	0.1	0.4	0.0	0.0	0.3	0.0	0.2	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.6	3.6	4.9	7.2	3.7	3.9	3.3	3.2	3.6	3.5	3.5	4.8	0.1	0.0	0.0	0.0	0.0	0.9	0.1	0.2	0.0	1.2	0.2	0.3	27.0	0.0	0.1	1.8	0.0	0.0	0.0	0.1	1.9	0.1	32.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	6.6	0.9	0.2	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	8.0	0.1	0.5	0.0	0.6	0.8	0.5	1.4	0.0	0.3	0.1	0.1	0.0	0.0	0.2
TNNT2	"CMD1D, CMH2, CMPD2"	ENSG00000118194	"Troponin T2, cardiac type"	P45379	1	201359008-201377764	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	205	"heart muscle: 10670.6"	"Cell type enriched"	"Detected in many"	32	"Cardiomyocytes: 12561.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"RH-30: 1077.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.8"	"CAB015371, HPA015774, HPA017888"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Focal adhesion sites,Microtubules"		No	No		57000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Nucleoli"	"Focal adhesion sites, Microtubules"	"CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355"	"unprognostic (1.45e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.33e-4)"	"unprognostic (1.85e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.98e-2)"	2.2	4.9	12.4	0.6	13.9	0.1	11.9	11.7	20.4	2.3	11.7	1.3	0.3	3.2	0.8	7.8	1.9	3.8	10670.6	16.8	11.6	51.9	2.3	22.0	2.7	11.6	11.6	1.3	5.0	0.0	4.5	10.3	11.6	6.1	0.1	0.4	3.6	0.7	16.5	21.7	1.6	0.1	11.6	0.7	2.0	1.7	11.6	2.1	2.0	9.4	0.5	19.3	5.0	15.8	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.5	0.0	0.0	6.7	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.5	0.0	44.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	1.1	0.0	0.0	2.2	3.3	0.0	0.0	1077.7	0.0	0.7	0.4	1.1	0.8	0.1	2.0	0.0	61.2	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	13.9	11.7	20.4	16.8	11.6	11.6	11.6	11.6	11.6	11.6	15.8	0.6	3.2	3.0	0.3	0.0	3.4	1.4	1.7	1.8	3.9	0.9	1.7	12561.8	0.0	1.1	1.8	0.0	3.5	0.0	2.3	0.0	0.4	11.6	1.2	0.2	93.3	0.0	0.0	9.4	0.4	1.2	385.3	1.1	2.4	0.0	0.0	0.0	0.0	3.1	0.0	0.5	1.7	0.0	0.0	0.8	19.3	0.6	0.3	0.0	1.9	2.6	0.0	0.0	0.5	0.7	1.2	1.4	1.2	0.0	2.1	0.8	0.9	0.7	0.6	0.0	8.7	145.8	0.5	0.2	2.5	7.2	4.2	0.1	0.8	3.2	1.5
TPM1	"C15orf13, CMH3"	ENSG00000140416	"Tropomyosin 1"	P09493	15	63042632-63071915	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 10621.0;skeletal muscle: 12678.0;tongue: 5183.6"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 13012.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 48.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 14.1;granulocytes: 48.7;monocytes: 19.2"	"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 3141.3;SuSa: 3810.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, CAB017698, HPA047089, HPA053624"	Supported		Approved	"Actin filaments,Cytosol"		NA	NA		120000000	"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Actin filaments"	Cytosol	"CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (7.30e-4)"	372.0	103.6	49.8	232.9	53.2	21.6	348.8	52.4	53.9	577.4	59.3	2947.3	289.6	1566.9	250.5	639.0	823.8	288.0	10621.0	53.3	42.2	215.5	94.8	247.1	48.1	42.5	44.3	320.3	383.4	37.5	70.6	206.4	43.7	809.6	523.1	83.9	258.2	1545.5	12678.0	150.7	680.8	1754.9	44.8	134.3	976.5	52.3	50.0	21.1	156.8	5183.6	29.4	1511.0	425.8	42.2	554.5	357.3	418.1	20.9	143.1	89.9	1335.5	1509.1	552.8	905.9	669.2	253.9	107.6	1.7	677.7	1517.1	602.7	295.9	361.8	243.4	597.0	14.5	50.9	81.2	376.3	124.5	403.3	3.8	17.9	125.7	138.0	742.1	198.2	3141.3	243.2	14.7	8.7	20.4	695.3	286.4	25.6	7.1	496.0	129.0	61.1	9.0	146.5	15.8	1308.7	298.8	101.1	71.7	180.9	284.4	65.1	3810.3	204.8	15.3	1095.8	1178.8	572.0	181.6	1094.8	5.9	4.3	7.8	335.9	22.4	842.1	48.7	9.9	4.8	4.0	19.2	3.1	5.5	3.6	4.3	14.1	5.6	4.0	3.6	10.7	1.9	14.3	2.4	6.3	15.6	49.8	53.2	52.4	53.9	53.3	42.2	42.5	44.3	43.7	44.8	50.0	42.2	542.3	57.7	86.3	19.9	12.1	71.9	202.0	344.1	18.2	49.0	450.1	953.1	13012.4	346.0	147.0	318.2	383.7	212.1	20.6	561.3	187.9	2502.6	6.5	147.2	614.4	294.3	267.7	137.0	44.2	1671.1	3094.8	557.1	279.3	211.2	52.0	85.3	175.6	138.1	201.5	52.2	53.2	964.7	183.1	42.5	72.1	27.3	205.0	114.3	81.8	111.5	47.5	47.4	28.8	36.2	6.0	2372.3	623.4	1130.3	8.8	244.3	724.7	361.1	104.2	447.5	1038.7	484.0	1685.9	27.4	82.2	29.4	50.4	103.0	29.0	130.7	385.3	198.2
TRDN	TRISK	ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 421.6;skeletal muscle: 1944.1;tongue: 1018.2"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 1145.1;Muller glia cells: 765.7;Skeletal myocytes: 398.6"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 2.2;prostate cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.9"	"Region enriched"	"Detected in some"	10	"olfactory bulb: 11.0"	"Region enriched"	"Detected in some"	23	"olfactory bulb: 28.9"	"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA038226: AB_10795574, HPA058226: AB_2683643"	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	16.3	2.6	4.2	0.0	3.7	0.0	2.0	4.0	5.8	0.7	3.1	0.4	0.0	1.7	10.4	18.5	12.5	0.2	421.6	3.0	12.5	0.4	0.1	0.4	0.1	6.7	7.0	1.3	0.1	0.0	15.3	0.2	7.9	17.0	0.3	83.5	13.1	0.9	1944.1	0.6	0.2	1.0	9.2	0.1	0.1	5.1	10.2	0.3	0.3	1018.2	0.1	0.0	0.6	6.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.7	4.0	5.8	3.0	12.5	6.7	7.0	7.9	9.2	10.2	6.3	0.3	0.0	0.0	4.2	0.0	0.0	0.5	0.0	0.0	7.9	0.0	0.3	1145.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	68.0	0.0	0.0	6.0	0.0	0.0	1.1	0.0	0.0	38.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.4	35.5	13.1	0.5	1.8	0.0	0.0	765.7	0.0	3.0	3.2	0.0	0.0	11.3	0.0	0.0	0.0	0.2	0.0	21.8	0.0	398.6	7.1	1.3	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TRPM4	FLJ20041	ENSG00000130529	"Transient receptor potential cation channel subfamily M member 4"	Q8TD43	19	49157741-49211836	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 179.2;Hepatocytes: 81.7;Intestinal goblet cells: 114.8;Paneth cells: 77.1;Undifferentiated cells: 88.9"	"Cancer enriched"	"Detected in all"	4	"prostate cancer: 85.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 3.3;granulocytes: 2.8;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"OE19: 32.7;RT4: 60.8;SK-BR-3: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041169	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA041169: AB_2677343"	"unprognostic (8.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.86e-2)"	"prognostic favorable (2.88e-7)"	"unprognostic (1.62e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.53e-7)"	"unprognostic (8.46e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.00e-2)"	10.8	6.1	5.8	6.1	5.4	4.6	13.5	8.5	7.0	11.5	4.8	46.1	25.3	9.9	2.5	13.1	9.2	7.4	23.0	5.9	4.5	22.8	15.4	16.0	1.8	6.2	7.4	3.3	10.1	3.7	5.6	5.3	6.9	35.7	12.9	1.3	27.3	6.2	14.0	26.6	22.9	3.4	4.2	5.5	20.6	5.4	6.6	1.0	17.3	5.3	1.9	13.7	14.4	5.1	11.9	9.0	2.1	9.5	7.7	6.6	6.6	10.0	6.0	2.7	3.7	6.1	18.7	0.4	2.7	6.8	3.6	15.7	1.3	3.0	1.0	0.2	3.4	1.9	4.0	3.7	6.6	0.3	11.7	9.3	13.6	5.3	2.6	3.3	4.6	1.0	4.9	2.1	6.9	17.4	0.8	0.9	1.0	32.7	13.3	4.1	2.0	0.6	4.6	60.8	0.8	2.2	4.1	38.6	2.2	0.7	22.6	3.7	11.8	14.4	7.8	7.9	0.2	3.9	4.3	0.4	7.9	7.4	5.3	2.2	4.3	0.7	0.3	2.5	0.2	0.5	0.2	0.2	3.3	0.5	0.3	0.3	2.8	0.5	1.0	3.1	0.2	1.4	5.8	5.4	8.5	7.0	5.9	4.5	6.2	7.4	6.9	4.2	6.6	5.1	12.8	32.1	2.6	9.8	3.5	12.5	15.3	9.9	9.1	2.0	19.0	14.6	16.7	17.2	12.3	14.7	0.0	6.6	0.2	179.2	19.6	7.9	2.9	17.5	8.2	11.7	21.7	0.0	5.4	18.5	6.8	6.0	71.4	36.2	5.7	2.9	11.4	81.7	19.9	0.0	8.5	114.8	14.2	9.8	19.0	3.1	6.8	8.5	39.2	9.4	12.8	6.7	0.0	3.5	0.9	32.9	77.1	7.2	7.6	35.5	55.3	3.8	8.9	2.6	32.9	2.2	8.5	6.1	15.7	8.4	11.5	3.4	1.9	4.1	88.9	33.1
TTN	"CMD1G, CMH9, CMPD4, FLJ32040, LGMD2J, MYLK5, TMD"	ENSG00000155657	Titin	Q8WZ42	2	178525989-178830802	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 167.2;skeletal muscle: 920.6;tongue: 369.5"	"Cell type enriched"	"Detected in many"	16	"Cardiomyocytes: 24394.9"	"Cancer enriched"	"Detected in single"	4	"head and neck cancer: 1.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RH-30: 1.9"	"Not detected"	"Not detected"							"HPA007042, CAB022682, HPA030048"	Enhanced					NA	NA		16000000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB022682: , HPA007042: AB_1080292, HPA030048: AB_2732451"	"unprognostic (1.00e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.49e-4)"	"unprognostic (1.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-2)"	0.6	0.4	2.7	0.5	2.4	4.3	0.5	2.8	4.9	0.3	0.0	0.4	0.4	0.4	0.2	2.7	0.3	0.7	167.2	1.9	3.4	0.2	0.3	1.2	1.4	11.2	4.4	0.7	1.7	0.0	0.8	0.5	6.6	2.7	0.0	1.9	7.0	0.0	920.6	0.8	0.6	0.0	3.2	0.7	0.4	1.6	4.8	0.7	0.6	369.5	0.4	0.2	0.3	5.3	0.3	0.1	0.7	0.4	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.7	0.1	1.0	0.2	0.0	0.7	0.7	0.0	0.0	0.0	1.0	0.8	1.5	1.3	0.4	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.7	0.6	0.7	0.9	0.5	0.1	0.2	0.7	1.0	0.2	0.1	0.7	0.5	1.9	0.6	0.0	0.2	0.4	0.7	0.1	0.5	0.0	0.6	0.3	1.0	0.7	0.0	0.0	0.3	0.2	1.4	0.2	1.4	0.0	0.5	0.3	1.8	0.2	0.5	0.4	0.2	0.1	6.1	0.9	0.7	0.1	5.7	2.0	2.6	1.0	3.6	0.2	0.2	6.0	0.1	2.7	2.4	2.8	4.9	1.9	3.4	11.2	4.4	6.6	3.2	4.8	5.3	10.9	16.0	173.4	43.8	32.1	0.9	1.6	0.0	2.8	102.7	1.7	0.5	24394.9	30.0	6.2	0.0	20.9	0.7	6.8	0.1	1.9	14.1	43.2	3.4	6.8	99.1	4.2	3.0	25.1	28.3	0.3	502.5	3.6	7.2	10.1	0.7	2.5	0.6	0.3	16.8	31.3	0.1	0.0	0.8	0.8	6.4	1.2	26.2	0.0	25.3	0.6	12.0	2.1	11.6	4.9	0.5	0.1	4.5	10.6	0.2	0.3	0.4	2.9	27.8	0.0	1466.9	104.7	9.3	1.5	2.3	0.1	0.4	24.3	2.8	0.5	0.1
VCL		ENSG00000035403	Vinculin	P18206	10	73995193-74121363	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 339.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 568.3;hTERT-RPE1: 547.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002131, CAB002453, HPA063777"	Enhanced		Enhanced	"Focal adhesion sites"		NA	NA		750000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Focal adhesion sites"		"CAB002453: AB_564057, HPA002131: AB_1080570, HPA063777: AB_2685121"	"unprognostic (8.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.37e-3)"	85.8	19.1	9.9	52.2	10.6	41.5	45.3	8.4	11.3	73.9	33.4	180.3	35.3	167.6	45.9	92.2	75.9	69.4	132.2	10.5	11.3	37.2	24.1	68.7	18.7	10.3	10.3	45.2	40.3	51.3	13.8	88.6	13.3	131.7	73.1	12.5	31.6	151.9	136.9	37.9	52.7	224.7	9.9	41.9	63.5	41.3	12.1	12.8	39.6	144.1	23.9	135.7	56.3	8.4	147.2	97.0	174.2	123.8	213.2	246.2	95.8	188.5	568.3	126.3	141.9	88.4	124.0	6.5	153.1	331.6	86.3	183.3	115.7	95.0	132.5	12.3	49.6	69.4	92.2	37.2	116.5	14.1	101.8	205.0	25.0	171.5	154.8	547.4	171.0	11.6	50.7	14.3	213.1	25.2	2.0	16.6	82.8	69.9	342.4	24.0	90.9	18.6	180.4	185.8	6.5	25.8	104.7	117.2	53.9	152.8	54.5	21.2	230.9	136.9	57.0	67.0	179.4	2.6	6.0	28.4	160.0	38.9	39.7	15.0	13.6	36.2	14.9	17.1	10.4	5.6	7.1	7.8	20.7	2.3	2.6	5.3	11.2	4.4	19.0	8.0	1.9	28.3	9.9	10.6	8.4	11.3	10.5	11.3	10.3	10.3	13.3	9.9	12.1	8.4	68.0	99.3	39.7	56.5	13.4	114.7	161.4	68.4	30.7	13.4	39.4	58.5	339.5	37.1	79.8	42.3	85.5	51.5	46.7	91.2	3.9	60.8	5.0	98.2	152.6	60.4	38.3	5.9	63.2	61.6	78.6	74.4	66.3	149.1	35.4	45.5	56.7	34.4	23.6	16.8	47.5	44.5	22.4	31.9	51.0	7.5	50.1	77.9	26.6	55.3	44.7	9.7	61.8	18.6	4.6	125.5	48.3	76.8	8.0	100.1	13.7	14.8	37.7	34.5	105.2	49.6	179.9	18.6	13.7	45.6	93.1	39.7	18.3	44.5	48.7	94.8